<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLOS ONE</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10456195</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pone.0290538</article-id>
    <article-id pub-id-type="publisher-id">PONE-D-23-17727</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>RNA viruses</subject>
              <subj-group>
                <subject>Flaviviruses</subject>
                <subj-group>
                  <subject>Hepacivirus</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Medical microbiology</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Flaviviruses</subject>
                  <subj-group>
                    <subject>Hepacivirus</subject>
                    <subj-group>
                      <subject>Hepatitis C virus</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and health sciences</subject>
        <subj-group>
          <subject>Pathology and laboratory medicine</subject>
          <subj-group>
            <subject>Pathogens</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Flaviviruses</subject>
                  <subj-group>
                    <subject>Hepacivirus</subject>
                    <subj-group>
                      <subject>Hepatitis C virus</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>Viral pathogens</subject>
              <subj-group>
                <subject>Flaviviruses</subject>
                <subj-group>
                  <subject>Hepacivirus</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Medical microbiology</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Hepatitis viruses</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and health sciences</subject>
        <subj-group>
          <subject>Pathology and laboratory medicine</subject>
          <subj-group>
            <subject>Pathogens</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Hepatitis viruses</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>Viral pathogens</subject>
              <subj-group>
                <subject>Hepatitis viruses</subject>
                <subj-group>
                  <subject>Hepatitis C virus</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Molecular Biology</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Sequencing Techniques</subject>
              <subj-group>
                <subject>Protein Sequencing</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Molecular Biology Techniques</subject>
          <subj-group>
            <subject>Sequencing Techniques</subject>
            <subj-group>
              <subject>Protein Sequencing</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Blood Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                  <subj-group>
                    <subject>T Cells</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Immune Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                  <subj-group>
                    <subject>T Cells</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
              <subj-group>
                <subject>T Cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
              <subj-group>
                <subject>T Cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Chemistry</subject>
          <subj-group>
            <subject>Chemical Properties</subject>
            <subj-group>
              <subject>Physicochemical Properties</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Chemistry</subject>
          <subj-group>
            <subject>Physical Chemistry</subject>
            <subj-group>
              <subject>Chemical Properties</subject>
              <subj-group>
                <subject>Physicochemical Properties</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Physics</subject>
          <subj-group>
            <subject>Physical Properties</subject>
            <subj-group>
              <subject>Physicochemical Properties</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Infectious Disease Control</subject>
              <subj-group>
                <subject>Vaccines</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Infectious Disease Control</subject>
              <subj-group>
                <subject>Vaccines</subject>
                <subj-group>
                  <subject>Viral Vaccines</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Vaccines</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Immune Physiology</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Immune System Proteins</subject>
              <subj-group>
                <subject>Antibodies</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Vaccination and Immunization</subject>
            <subj-group>
              <subject>Vaccine Development</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Vaccination and Immunization</subject>
            <subj-group>
              <subject>Vaccine Development</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Public and Occupational Health</subject>
          <subj-group>
            <subject>Preventive Medicine</subject>
            <subj-group>
              <subject>Vaccination and Immunization</subject>
              <subj-group>
                <subject>Vaccine Development</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TROLLOPE: A novel sequence-based stacked approach for the accelerated discovery of linear T-cell epitopes of hepatitis C virus</article-title>
      <alt-title alt-title-type="running-head">TROLLOPE</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Charoenkwan</surname>
          <given-names>Phasit</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Waramit</surname>
          <given-names>Sajee</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chumnanpuen</surname>
          <given-names>Pramote</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schaduangrat</surname>
          <given-names>Nalini</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Modern Management and Information Technology, College of Arts, Media and Technology, Chiang Mai University, Chiang Mai, Thailand</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, Thailand</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Omics Center for Agriculture, Bioresources, Food, and Health, Kasetsart University (OmiKU), Bangkok, Thailand</addr-line>
    </aff>
    <aff id="aff004">
      <label>4</label>
      <addr-line>Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Raju</surname>
          <given-names>Nagarajan</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Emory University, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>watshara.sho@mahidol.ac.th</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>18</volume>
    <issue>8</issue>
    <elocation-id>e0290538</elocation-id>
    <history>
      <date date-type="received">
        <day>7</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>10</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Charoenkwan et al</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Charoenkwan et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pone.0290538.pdf"/>
    <abstract>
      <p>Hepatitis C virus (HCV) infection is a concerning health issue that causes chronic liver diseases. Despite many successful therapeutic outcomes, no effective HCV vaccines are currently available. Focusing on T cell activity, the primary effector for HCV clearance, T cell epitopes of HCV (TCE-HCV) are considered promising elements to accelerate HCV vaccine efficacy. Thus, accurate and rapid identification of TCE-HCVs is recommended to obtain more efficient therapy for chronic HCV infection. In this study, a novel sequence-based stacked approach, termed TROLLOPE, is proposed to accurately identify TCE-HCVs from sequence information. Specifically, we employed 12 different sequence-based feature descriptors from heterogeneous perspectives, such as physicochemical properties, composition-transition-distribution information and composition information. These descriptors were used in cooperation with 12 popular machine learning (ML) algorithms to create 144 base-classifiers. To maximize the utility of these base-classifiers, we used a feature selection strategy to determine a collection of potential base-classifiers and integrated them to develop the meta-classifier. Comprehensive experiments based on both cross-validation and independent tests demonstrated the superior predictive performance of TROLLOPE compared with conventional ML classifiers, with cross-validation and independent test accuracies of 0.745 and 0.747, respectively. Finally, a user-friendly online web server of TROLLOPE (<ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>) has been developed to serve research efforts in the large-scale identification of potential TCE-HCVs for follow-up experimental verification.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution>National Research Council of Thailand and Mahidol University</institution>
        </funding-source>
        <award-id>N42A660380</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>Watshara</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution>Specific League Funds from Mahidol University</institution>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>Watshara</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This project is funded by National Research Council of Thailand (NRCT) and Mahidol University (N42A660380), and the Specific League Funds from Mahidol University.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="7"/>
      <table-count count="6"/>
      <page-count count="22"/>
    </counts>
    <custom-meta-group>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All the data used in this study are available at <ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All the data used in this study are available at <ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>1. Introduction</title>
    <p>Hepatitis C Virus (HCV) is an RNA virus that is associated with progressive liver damage. This virus usually transmits through the contact of blood from an infected person, including the reuse of substandard medical equipment in healthcare settings and the sharing of contaminated needles and syringes in injection drug users (IDU). HCV infection often leads to curable acute hepatitis C; however, it can also result in an asymptomatic chronic condition that can lead to serious illnesses, including liver fibrosis, cirrhosis, and even fatal hepatocellular carcinoma [<xref rid="pone.0290538.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0290538.ref002" ref-type="bibr">2</xref>]. By combining translational and clinical research efforts, treatments for HCV have evolved from recombinant interferon α (IFNα) and nucleoside analogue ribavirin (RBV) to direct-acting antiviral agents (DAAs). These treatment options can be administered as monotherapy or in combination to achieve superior outcomes [<xref rid="pone.0290538.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0290538.ref004" ref-type="bibr">4</xref>]. Currently, treatment approaches primarily focus on pan-genotypic regimens designed to target multiple viral non-structural (NS) complexes that aim to achieve high efficiency in treating most HCV genotypes [<xref rid="pone.0290538.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0290538.ref006" ref-type="bibr">6</xref>]. Despite the success of HCV therapeutic schemes, access to diagnosis and treatment remains limited in certain populations. According to the World Health Organization (WHO), approximately 58 million people worldwide are affected by chronic HCV infection, yet only 21% of them have been clinically diagnosed. Additionally, the disease is also responsible for approximately 400,000 deaths each year due to cirrhosis and hepatocellular carcinoma [<xref rid="pone.0290538.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0290538.ref008" ref-type="bibr">8</xref>]. This is considered inconsistent with the announcement to reduce new HCV infections by 90% by 2030 and achieve complete HCV elimination as the ultimate goal. According to WHO, the number of diagnosed HCV patients is underestimated, and access to the tests is still limited in some populations. Therefore, HCV vaccine development is essentially required to prevent transmission. An effective HCV vaccine will greatly impact the control of the disease, especially among IDUs. It is worth noting that the process of vaccine production should be cost-effective to ensure worldwide fair access. Despite substantial positive outcomes in treating HCV patients, the lack of available preventative vaccines hinders significant progress toward the goal of HCV elimination [<xref rid="pone.0290538.ref009" ref-type="bibr">9</xref>].</p>
    <p>One major challenge in vaccine development is the genetic diversity of HCV, which consists of 8 genotypes and 86 subtypes. These variants exhibit approximately 30 percent variability in amino acids compared to each other [<xref rid="pone.0290538.ref010" ref-type="bibr">10</xref>]. To achieve the greatest benefit, an ideal vaccine should focus on targeting the genetically conserved regions of the HCV genome. This approach would broaden the immune response across multiple genotypes and involve both humoral and cellular immunity, thereby maximizing the chance of success. Many studies have demonstrated the feasibility of neutralizing HCV infection through the transfer of polyclonal antibodies obtained from chronic HCV patients to chimeric mice and chimpanzees [<xref rid="pone.0290538.ref011" ref-type="bibr">11</xref>–<xref rid="pone.0290538.ref013" ref-type="bibr">13</xref>]. Nonetheless, the envelope genes (E1 and E2) of HCV exhibit significant diversity, resulting in a wide range of evolved epitopes that are resistant to antibody binding. This evolutionary adaptation benefits the viral escape from immune responses [<xref rid="pone.0290538.ref014" ref-type="bibr">14</xref>–<xref rid="pone.0290538.ref016" ref-type="bibr">16</xref>]. Additionally, the specific roles of antibodies in combating HCV infection have not been clearly defined yet, which further complicates the development of antibody-based vaccines [<xref rid="pone.0290538.ref016" ref-type="bibr">16</xref>]. In contrast, several vaccine studies have concentrated on enhancing HCV-specific T-cell activity [<xref rid="pone.0290538.ref017" ref-type="bibr">17</xref>]. Specifically, CD4<sup>+</sup> T cells play a crucial role in maintaining T-cell populations, while CD8<sup>+</sup> T cells serve as the primary effectors responsible for eliminating viral-infected cells [<xref rid="pone.0290538.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0290538.ref021" ref-type="bibr">21</xref>]. To date, various non-structural proteins (NS) of HCV have been found to possess prominent targeting features for CD8<sup>+</sup> T cells, indicating the feasibility of vaccine development. However, this strategy essentially relies on the presence of HCV antigenic peptides in an HLA-restricted manner [<xref rid="pone.0290538.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0290538.ref023" ref-type="bibr">23</xref>].</p>
    <p>Until now, several HCV vaccine platforms, such as DNA-based immunization, virus-like particles (VLPs), and short peptide- or epitope-encapsulating lysosomes [<xref rid="pone.0290538.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0290538.ref026" ref-type="bibr">26</xref>], have demonstrated promising outcomes in terms of HCV protection. However, some of these still need particular improvements to enhance their effectiveness [<xref rid="pone.0290538.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0290538.ref028" ref-type="bibr">28</xref>]. One of the challenges lies in the rational design of immunogenic epitopes [<xref rid="pone.0290538.ref029" ref-type="bibr">29</xref>], as the traditional vaccine design approaches are considered less effective for HCV due to high genome heterogeneity and mutagenicity [<xref rid="pone.0290538.ref030" ref-type="bibr">30</xref>]. Thus, an alternative approach is required, and <italic toggle="yes">in silico</italic> studies have shown great benefits by predicting immunogenic epitopes to be incorporated into the vaccine platform and enhance its efficacy. Many <italic toggle="yes">in silico</italic> predictions of TCE-HCV have demonstrated promising outcomes in terms of cytotoxic T cell responses in BALB/c and transgenic mice. These findings suggest the potential of HCV-polytope vaccine candidates. However, some of the predicted epitopes have achieved only marginal success and require additional support [<xref rid="pone.0290538.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0290538.ref033" ref-type="bibr">33</xref>]. Therefore, it is desirable to accurately identify TCE-HCV using sequence information alone, without relying on structural information, before embarking on costly <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> investigations.</p>
    <p>To date, several computational approaches have been developed to complement experimental studies in the identification of TCEs. For example, Dhanda et al. [<xref rid="pone.0290538.ref034" ref-type="bibr">34</xref>] developed a support vector machine (SVM)-based predictor, named IL4pred, to predict IL4 inducing peptides. They constructed a benchmark dataset consisting of 904 IL4 inducing and 742 non-IL4 inducing peptides. Using this dataset, various sequence-based feature descriptors were employed, such as amino acid composition (AAC), amino acids pair (AAP), dipeptide composition (DPC), and motif information, to train IL4pred. Among the feature descriptors, AAP and motif information were selected for the development of IL4pred. IL4pred achieved cross-validation and independent test accuracies of 0.758 and 0.690, respectively. Further information regarding related computational approaches developed for the identification of TCEs can be found in references [<xref rid="pone.0290538.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0290538.ref037" ref-type="bibr">37</xref>]. However, at present, there is no sequence-based predictor specifically designed for identifying and characterizing TCE-HCVs. Keeping this issue in mind, we present a novel sequence-based stacked approach, termed TROLLOPE (predicToR Of Linear t-ceLl epitOPEs of hepatitis C virus), to specifically identify TCE-HCVs using primary sequence information. To the best of our knowledge, TROLLOPE is the first computational approach developed for specifically identifying TCE-HCVs. To develop TROLLOPE, we first constructed a benchmark dataset consisting of 446 TCE-HCVs and 525 non-TCE-HCVs. Based on this dataset, we extracted 12 different types of sequence-based feature encoding schemes from several perspectives, such as physicochemical properties, composition-transition-distribution information and composition information. These feature descriptors were then used to create 144 base-classifiers by using 12 powerful ML algorithms. To maximize the performance of TROLLOPE, we employed a customized genetic algorithm to determine a collection of potential base-classifiers and integrated them to develop the meta-classifier using the stacking strategy. Experimental results demonstrate that TROLLOPE outperforms conventional ML classifiers, achieving superior performance.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>2. Materials and methods</title>
    <sec id="sec003">
      <title>2.1 Overall framework of TROLLOPE</title>
      <p>As seen in <bold><xref rid="pone.0290538.g001" ref-type="fig">Fig 1</xref></bold>, the development and performance assessment of TROLLOPE involve five main steps: dataset preparation, feature representation, stacked model development, performance evaluation, and online web server deployment. In the first step, we collected the positive and negative datasets from the IEDB database [<xref rid="pone.0290538.ref038" ref-type="bibr">38</xref>]. In the second step, we employed well-known feature encoding schemes to represent TCE-HCVs and non-TCE-HCVs. After that, in the development of stacked model, it consists of two levels of learning stages. The classifiers developed in the first and second stages are known as the base-classifier and meta-classifier, respectively. In the fourth step, we assessed the performance of base-classifiers and meta-classifiers to conduct a comparative analysis and select the final stacked model. Finally, the best stacked model was employed to develop an online web server, providing convenient identification of TCE-HCVs.</p>
      <fig position="float" id="pone.0290538.g001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>System flowchart of the proposed TROLLOPE.</title>
          <p>The development and performance assessment of TROLLOPE involves five main steps: dataset preparation, feature representation, stacked model development, performance evaluation, and online web server deployment.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g001" position="float"/>
      </fig>
    </sec>
    <sec id="sec004">
      <title>2.2 Data collection and curation</title>
      <p>According to the previously established B-cell response of the HCV dataset [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>], the positive and negative samples were collected from Immune Epitope Database (IEDB) version 2.26. Specifically, the dataset used in this study was created by selecting “Hepatitis C virus” (ID 11103) as the source organism. The main criteria for the inclusion of experimental outcomes were related to T cell assays in human, mouse and non-human primates. Among these, peptide sequences annotated as ‘positive’ were considered as the positive samples (referred to as TCE-HCVs) whereas those annotated as ‘negative’ were included as the negative samples (referred to as non-TCE-HCVs). The length of peptide sequences was filtered to 8–10 amino acid residues to select compatible epitopes capable of being accommodated through HLA I molecules and recognizing by CD8<sup>+</sup> T cells [<xref rid="pone.0290538.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0290538.ref041" ref-type="bibr">41</xref>]. As a result, we obtained 711 TCE-HCVs and 790 non-TCE-HCVs. Among these sequences, redundant samples were excluded using Venny (<ext-link xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html" ext-link-type="uri">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>). Therefore, 446 TCE-HCVs and 525 non-TCE-HCVs were considered as the benchmark dataset and used for constructing the proposed model. Finally, the benchmark dataset was randomly divided to generate the training and independent test datasets, comprising 80% (i.e., 357 TCE-HCVs and 420 non-TCE-HCVs) and 20% (i.e., 89 TCE-HCVs and 105 non-TCE-HCVs) of the data, respectively.</p>
    </sec>
    <sec id="sec005">
      <title>2.3 Informative feature selection</title>
      <p>In this study, our customized genetic algorithm, called GA-SAR [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>], was employed to determine informative features while securing high prediction performance [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>–<xref rid="pone.0290538.ref045" ref-type="bibr">45</xref>]. In general, GA-SAR is categorized as one of commonly-used non-deterministic methods that utilize the biological evolution of a population [<xref rid="pone.0290538.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0290538.ref047" ref-type="bibr">47</xref>]. The GA-SAR’s chromosome used herein comprises binary for feature selection and parametric genes for ML parameter optimization. The feature importance selection based on the GA-SAR method can be described as follows. First, we randomly constructed an initial population of <italic toggle="yes">Pop</italic> individuals and assess the performance of all <italic toggle="yes">Pop</italic> individuals based on the 10-fold cross-validation test. Second, we utilize a commonly-used tournament selection to obtain the best <italic toggle="yes">Pop</italic> for constructing a mating pool. Third, the self-assessment-report operation (SAR) between the best <italic toggle="yes">Pop</italic> and each other individual <italic toggle="yes">Pop</italic> was used to create the new children. Finally, the maximum number of generations is used as the stopping condition. Herein, the parameters and their values for the GA-SAR contain <italic toggle="yes">r</italic><sub><italic toggle="yes">begin</italic></sub>  =  5, <italic toggle="yes">m</italic><sub><italic toggle="yes">stop</italic></sub>   =   20, <italic toggle="yes">P</italic><sub><italic toggle="yes">m</italic></sub>  =   0.05, and <italic toggle="yes">Pop</italic> = 20 [<xref rid="pone.0290538.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0290538.ref049" ref-type="bibr">49</xref>]. Detailed information about this algorithm is reported in our previous studies [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0290538.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>].</p>
    </sec>
    <sec id="sec006">
      <title>2.4 Stacked model development</title>
      <p>Ensemble learning strategies integrate heterogeneous outputs from different prediction models to create a single prediction. These strategies include average scoring, majority voting, and the stacking strategy [<xref rid="pone.0290538.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0290538.ref051" ref-type="bibr">51</xref>]. Among these strategies, stacking is known as the most powerful one [<xref rid="pone.0290538.ref049" ref-type="bibr">49</xref>–<xref rid="pone.0290538.ref053" ref-type="bibr">53</xref>]. This approach was first presented by Wolpert [<xref rid="pone.0290538.ref054" ref-type="bibr">54</xref>] to improve prediction performance. Therefore, we employed the stacking strategy to develop TROLLOPE. In general, the stacking ensemble framework consists of two main levels of learning stages, where the prediction models developed from the first and second learning stages are referred to as the base-classifier and meta-classifier, respectively. The design and development process of TROLLOPE is illustrated in <bold><xref rid="pone.0290538.g001" ref-type="fig">Fig 1</xref></bold>.</p>
      <p>In the first learning stage, we employ 12 different ML algorithms (ADA, DT, ET, KNN, LGBM, LR, MLP, NB, PLS, RF, SVM, and XGB) to obtain the crucial pattern of TCE-HCV [<xref rid="pone.0290538.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0290538.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0290538.ref056" ref-type="bibr">56</xref>]. Then, each ML algorithm was train with 12 well-known feature descriptors (AAC, AAI, APAAC, CTD, CTDC, CTDD, CTDT, DDE, DPC, PAAC, PCP and TPC [<xref rid="pone.0290538.ref057" ref-type="bibr">57</xref>–<xref rid="pone.0290538.ref060" ref-type="bibr">60</xref>]) to construct 12 base-classifiers. The details of all the feature encodings and ML methods used herein are recorded in <bold><xref rid="pone.0290538.t001" ref-type="table">Table 1</xref></bold> and <bold>S1 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, respectively. As a result, 144 base-classifiers were obtained by using the Scikit-learn package in Python programming language [<xref rid="pone.0290538.ref061" ref-type="bibr">61</xref>]. Specifically, a grid search based on the 10-fold cross-validation procedure was used to determine the optimal parameters of all the 144 base-classifiers and avoid overfitting. Here, the base-classifiers having the highest area under the receiver operating characteristics (ROC) curve (AUC) were deemed as the powerful classifiers.</p>
      <table-wrap position="float" id="pone.0290538.t001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Summary of 12 different feature descriptors along with their corresponding description and dimension.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t001" id="pone.0290538.t001g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Descriptors<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Description</th>
                <th align="left" rowspan="1" colspan="1">Dimension</th>
                <th align="left" rowspan="1" colspan="1">Reference</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">AAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 20 amino acids</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">20</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">AAI</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">All biochemical and biophysical properties extracted from the AAindex database</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">531</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">APAAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Amphiphilic pseudo-amino acid composition</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">22</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref091" ref-type="bibr">91</xref>, <xref rid="pone.0290538.ref092" ref-type="bibr">92</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTD</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Composition, transition and distribution</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">273</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Percentage of particular amino acid property groups</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDD</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Percentage of mutual conversion in amino acid properties</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDT</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Distribution of amino acid properties in sequences</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">105</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">DDE</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Dipeptide deviation from expected mean</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">400</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">DPC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 400 dipeptides</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">400</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">PAAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Pseudo amino acid composition</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref091" ref-type="bibr">91</xref>, <xref rid="pone.0290538.ref092" ref-type="bibr">92</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">PCP</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Selected important physical and chemical properties</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">11</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">TPC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 8000 tripeptides</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">8000</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="t001fn001">
            <p><sup>a</sup>AAC: amino acid composition, AAI: amino acid composition and physicochemical properties, APAAC: pseudo amino acid composition, CTD: composition translation and distribution, CTDC: CTD composition, CTDT: CTD distribution (CTDT), CTDT: CTD transition (CTDT), DDE: dipeptide deviation from expected mean, DPC: dipeptide composition, PAAC: pseudo amino acid composition, PCP: physicochemical properties, TPC: tripeptide composition.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In the second step, we utilized each base-classifier to generate a probabilistic feature (PF) exhibiting the probabilistic score of being TCE-HCV. To be specific, we randomly divided the training dataset into 10 subsets (i.e., <inline-formula id="pone.0290538.e001"><alternatives><graphic xlink:href="pone.0290538.e001.jpg" id="pone.0290538.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1,2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>10</mml:mn></mml:math></alternatives></inline-formula>) based on the 10-fold cross-validation procedure. In the stacking strategy, each D<sub>i</sub> was treated as the validation set, while the remaining nine subsets was treated as the training set, which was used for training a subset-based prediction model. Then, 10 subset-based prediction models were obtained and used to calculate 10 different probabilistic scores for each peptide sequence on the independent test dataset. Thus, the 10 different probabilistic scores were averaged to create the PF. As a result, 144 PFs derived from all the 144 base-classifiers were obtained and used to construct a new probabilistic feature vector (referred to as APF). For a given sequence <italic toggle="yes">P</italic>, its probabilistic feature vector can be represented as follows:
<disp-formula id="pone.0290538.e002"><alternatives><graphic xlink:href="pone.0290538.e002.jpg" id="pone.0290538.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi><mml:mo>=</mml:mo><mml:mn>1,2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>12</mml:mn></mml:math></alternatives><label>(1)</label></disp-formula>
where PF<sub>i,j</sub> is the probabilistic feature generated by the base-classifier trained with the <italic toggle="yes">i</italic><sup><italic toggle="yes">th</italic></sup> ML algorithm in conjunction with the <italic toggle="yes">j</italic><sup><italic toggle="yes">th</italic></sup> feature encoding. Finally, the APF is represented with a 144-D probabilistic feature vector.</p>
      <p>In the third learning stage, we utilized the APF to train the PLS-based meta-classifier. In the meanwhile, to enhance the performance of the meta-classifier, we used the GA-SAR method to determine <italic toggle="yes">m</italic> informative PFs, where <italic toggle="yes">m</italic> &lt;&lt; 144. The GA-SAR’s chromosome used herein comprises 144 genes and 10-bit gene for encoding #Components of PLS-based meta-classifier, where #Components ∈ {10, 20, 30, 40, …, 1000} (<bold>S1 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>). By doing this, we obtained a <italic toggle="yes">m</italic>-D probabilistic feature vector (referred to as OPF) generated from the selected base-classifiers. Finally, we obtained two PLS-based meta-classifiers and selected the best-performing one for TROLLOPE construction based on the cross-validation AUC.</p>
    </sec>
    <sec id="sec007">
      <title>2.5 Statistical metrics</title>
      <p>The performance of the proposed model and related conventional ML classifiers was determined using five standard evaluation metrics, including AUC, sensitivity (Sn), specificity (Sp), accuracy (ACC), and Matthew’s correlation coefficient (MCC) [<xref rid="pone.0290538.ref062" ref-type="bibr">62</xref>–<xref rid="pone.0290538.ref064" ref-type="bibr">64</xref>]. These evaluation metrics are computed as follows:
<disp-formula id="pone.0290538.e003"><alternatives><graphic xlink:href="pone.0290538.e003.jpg" id="pone.0290538.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(2)</label></disp-formula>
<disp-formula id="pone.0290538.e004"><alternatives><graphic xlink:href="pone.0290538.e004.jpg" id="pone.0290538.e004g" position="anchor"/><mml:math id="M4" display="block" overflow="scroll"><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(3)</label></disp-formula>
<disp-formula id="pone.0290538.e005"><alternatives><graphic xlink:href="pone.0290538.e005.jpg" id="pone.0290538.e005g" position="anchor"/><mml:math id="M5" display="block" overflow="scroll"><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(4)</label></disp-formula>
<disp-formula id="pone.0290538.e006"><alternatives><graphic xlink:href="pone.0290538.e006.jpg" id="pone.0290538.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac></mml:math></alternatives><label>(5)</label></disp-formula>
where TN represents true negatives (e.g., the number of correctly predicted non-TCE-HCV) and TP represents true positives (e.g., the number of correctly predicted TCE-HCVs). On the other hand, FN represents false negatives (e.g., the number of TCE-HCVs predicted as non-TCE-HCVs), while FP represents false positives (e.g., the number of non-TCE-HCVs predicted as TCE-HCVs).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec008">
    <title>3. Results and discussion</title>
    <sec id="sec009">
      <title>3.1 Performance evaluation of different feature encodings and ML methods</title>
      <p>In this section, we investigated the prediction capability of various base-classifiers trained with different feature encodings and ML methods in TCE-HCV prediction. For each base-classifier, we evaluated its performance using both the 10-fold cross-validation and independent tests. As mentioned earlier, we determined the best-performing base-classifiers in terms of cross-validation AUC. The detailed results of the10-fold cross-validation and independent tests for all the 144 BCs are recorded in <bold>Figs <xref rid="pone.0290538.g002" ref-type="fig">2</xref> and <xref rid="pone.0290538.g003" ref-type="fig">3</xref></bold> and <bold>S2, S3 Tables in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. From <bold><xref rid="pone.0290538.g002" ref-type="fig">Fig 2</xref></bold>, we notice that 8 out of the 10 top-ranked powerful base-classifiers were developed based on DDE, DPC, and TPC, i.e., SVM-TPC, LR-TPC, SVM-DDE, RF-TPC, RF-DDE, SVM-DPC, RF-DPC, NB-TPC, and ET-DPC with corresponding AUC values of 0.791, 0.786, 0.780, 0.772, 0.771, 0.769, 0.769, 0.768, 0.762, respectively. This indicates that these three feature descriptors are beneficial in TCE-HCV prediction. Interestingly, the AUC values of SVM-TPC and LR-TPC were over 0.780 in terms of the 10-fold cross-validation test. It could be stated that SVM-TPC is deemed as the best-performing classifier in TCE-HCV prediction. As seen in <bold>S2 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, the ACC, Sn, Sp, and MCC of SVM-TPC were 0.696, 0.440, 0.914, and 0.407, respectively. On the other hand, this base-classifier achieved the eighth highest AUC of 0.798 in the independent test results, while the highest AUC of 0.833 was achieved by ET-CTDT (<bold>S3 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>). These results demonstrate that the single feature-based models provide a less stable performance for TCE-HCV prediction. Thus, we were motived to develop a stacked model by integrating heterogonous ML classifiers in order to yield a more accurate and stable TCE-HCV prediction.</p>
      <fig position="float" id="pone.0290538.g002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Performance evaluations of top-30 base-classifiers.</title>
          <p>(<bold>A-B</bold>) Cross-validation AUC and ACC of top-30 base-classifiers. (<bold>C-D</bold>) Independent AUC and ACC of top-30 base-classifiers.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g002" position="float"/>
      </fig>
      <fig position="float" id="pone.0290538.g003">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <p>Performance comparison of TROLLOPE and top-five base-classifiers on the training (<bold>A–B</bold>) and independent (<bold>C–D</bold>) datasets.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g003" position="float"/>
      </fig>
    </sec>
    <sec id="sec010">
      <title>3.2 Construction and optimization of stacked models</title>
      <p>As mentioned above, we developed RF-based meta-classifiers that cooperate with two new probabilistic feature vectors, namely APF and OPF. The APF and OPF are represented with 144-D and <italic toggle="yes">m</italic>-D probabilistic feature vectors, respectively. The optimal number of <italic toggle="yes">m</italic> out of 144 probabilistic features was determined using the GA-SAR method. After optimizing the 144-D probabilistic feature vector, the optimal number of <italic toggle="yes">m</italic> was found to be 6. Specifically, the top-six informative probabilistic features were generated based on six different base-classifiers, inducing SVM-TPC, RF-CTDD, SVM-DDE, XGB-AAI, XGB-PCP, and ET-APAAC. The performance of the APF and OPF was evaluated based on both the 10-fold cross-validation and independent tests (<bold><xref rid="pone.0290538.t002" ref-type="table">Table 2</xref></bold>). As can be seen from <bold><xref rid="pone.0290538.t002" ref-type="table">Table 2</xref></bold>, the OPF outperforms APF in terms of the 10-fold cross-validation results, with a 4.90% increase in ACC, a 4.21% increase in Sn, a 5.48% increase in Sp, a 9.75% increase in MCC, and a 1.65% increase in AUC. In terms of the performance on the independent test dataset, the OPF achieved the best AUC, ACC, and MCC with an increase of 1.11, 1.03 and 2.42%, respectively. Altogether, the OPF in conjunction with the RF-based meta-classifier was selected for the construction of TROLLOPE.</p>
      <table-wrap position="float" id="pone.0290538.t002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Cross-validation and independent test results of stacked models trained with APF and OPF feature vectors.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t002" id="pone.0290538.t002g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">Dimension</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">SP</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">APF</td>
                <td align="left" rowspan="1" colspan="1">144</td>
                <td align="left" rowspan="1" colspan="1">0.696</td>
                <td align="left" rowspan="1" colspan="1">0.644</td>
                <td align="left" rowspan="1" colspan="1">0.740</td>
                <td align="left" rowspan="1" colspan="1">0.389</td>
                <td align="left" rowspan="1" colspan="1">0.792</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">OPF</td>
                <td align="left" rowspan="1" colspan="1">15</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">APF</td>
                <td align="left" rowspan="1" colspan="1">144</td>
                <td align="left" rowspan="1" colspan="1">0.737</td>
                <td align="left" rowspan="1" colspan="1">0.652</td>
                <td align="left" rowspan="1" colspan="1">0.810</td>
                <td align="left" rowspan="1" colspan="1">0.469</td>
                <td align="left" rowspan="1" colspan="1">0.816</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">OPF</td>
                <td align="left" rowspan="1" colspan="1">15</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec011">
      <title>3.3 Performance comparison between TROLLOPE and related ML methods</title>
      <p>To reveal the effectiveness of our proposed model TROLLOPE, we compared its performance with related ML methods. However, there is no existing computational model designed for TCE-HCV identification. Thus, the performance of TROLLOPE is compared with related ML methods, involving BLAST-based predictor, two well-known ensemble strategies (i.e., the average scoring and majority voting), and its base-classifiers, in terms of both 10-fold cross-validation and independent tests. Firstly, we compared the performance of TROLLOPE with the BLAST-based predictor. The BLAST-based predictor is a well-known similarity-based approach for identifying proteins [<xref rid="pone.0290538.ref065" ref-type="bibr">65</xref>]. <bold>S4 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold> summarizes the independent test results of the BLAST-based predictor based on different E-values. As can be seen from <bold>S4 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, TROLLOPE clearly outperforms the BLAST-based predictor in terms of ACC, Sn, Sp, and MCC. Secondly, we conducted a comparative experiment between TROLLOPE and the selected ensemble strategies. <bold><xref rid="pone.0290538.t003" ref-type="table">Table 3</xref></bold> provides the comparative results of the three ensemble strategies. We noticed that both cross-validation and independent test results of TROLLOPE were better than that of the two compared ensemble strategies in terms of all five measures, with the exception of Sp on the independent test dataset. To be specific, the AUC of TROLLOPE were 2.93–2.97% and 2.56–3.33% better than that of the two related ensemble strategies in terms of cross-validation and independent tests, respectively, highlighting the effectiveness of the stacking strategy over other ensemble strategies. Finally, the performance of TROLLOPE was compared against its constituent base-classifiers. For convenience of discussion, we selected the top-five base-classifiers (i.e., SVM-TPC, LR-TPC, SVM-DDE, RF-TPC, and RF-DDE) for conducting our comparative results. From <bold>Figs <xref rid="pone.0290538.g003" ref-type="fig">3</xref> and <xref rid="pone.0290538.g004" ref-type="fig">4</xref></bold> and <bold><xref rid="pone.0290538.t004" ref-type="table">Table 4</xref></bold> along with <bold>S1 Fig in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, several observations can be summarized as follows: (i) TROLLOPE attains the overall best cross-validation results in terms of ACC, Sn, MCC, and AUC; (ii) The ACC, MCC, and AUC of TROLLOPE are higher than most top-five base-classifiers in terms of the independent test dataset, with the exception of SVM-DDE; (iii) TROLLOPE demonstrates a significant improvement, achieving a 2.06% increase in ACC, a 7.87% increase in Sn, a 4.52% increase in MCC, and a 2.92% increase in AUC compared to the best-performing base-classifier (i.e., SVM-TPC); and (iv) Based on the distributed stochastic neighbor embedding (t-SNE) method [<xref rid="pone.0290538.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0290538.ref067" ref-type="bibr">67</xref>], TROLLOPE demonstrates greater discriminative power in making accurate predictions (<bold><xref rid="pone.0290538.g004" ref-type="fig">Fig 4</xref></bold>). Overall, our comparative analysis revealed that the stacking strategy used in TROLLOPE proved beneficial in terms of providing more accurate and reliable identification of TCE-HCV.</p>
      <fig position="float" id="pone.0290538.g004">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>t-distributed stochastic neighbor embedding (t-SNE) distribution of positive and negative samples on the training dataset, where TCE-HCV and non-TCE-HCV are represented with red and blue dots, respectively.</title>
          <p>TROLLOPE (<bold>A</bold>) and top-five base-classifiers (<bold>B-F</bold>).</p>
        </caption>
        <graphic xlink:href="pone.0290538.g004" position="float"/>
      </fig>
      <table-wrap position="float" id="pone.0290538.t003">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>Performance comparison of different models trained based on different ensemble strategies.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t003" id="pone.0290538.t003g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Ensemble strategy</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">Average score</td>
                <td align="left" rowspan="1" colspan="1">0.690</td>
                <td align="left" rowspan="1" colspan="1">0.647</td>
                <td align="left" rowspan="1" colspan="1">0.726</td>
                <td align="left" rowspan="1" colspan="1">0.374</td>
                <td align="left" rowspan="1" colspan="1">0.779</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Majority voting</td>
                <td align="left" rowspan="1" colspan="1">0.689</td>
                <td align="left" rowspan="1" colspan="1">0.613</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.370</td>
                <td align="left" rowspan="1" colspan="1">0.779</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Stacking</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">Average score</td>
                <td align="left" rowspan="1" colspan="1">0.727</td>
                <td align="left" rowspan="1" colspan="1">0.674</td>
                <td align="left" rowspan="1" colspan="1">0.771</td>
                <td align="left" rowspan="1" colspan="1">0.448</td>
                <td align="left" rowspan="1" colspan="1">0.801</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Majority voting</td>
                <td align="left" rowspan="1" colspan="1">0.706</td>
                <td align="left" rowspan="1" colspan="1">0.607</td>
                <td align="left" rowspan="1" colspan="1">0.790</td>
                <td align="left" rowspan="1" colspan="1">0.405</td>
                <td align="left" rowspan="1" colspan="1">0.794</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Stacking</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <table-wrap position="float" id="pone.0290538.t004">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t004</object-id>
        <label>Table 4</label>
        <caption>
          <title>Performance comparison of TROLLOPE and top-five ML classifiers.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t004" id="pone.0290538.t004g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Method</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">RF-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.682</td>
                <td align="left" rowspan="1" colspan="1">0.669</td>
                <td align="left" rowspan="1" colspan="1">0.693</td>
                <td align="left" rowspan="1" colspan="1">0.363</td>
                <td align="left" rowspan="1" colspan="1">0.771</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">RF-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.700</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.838</td>
                <td align="left" rowspan="1" colspan="1">0.399</td>
                <td align="left" rowspan="1" colspan="1">0.772</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.699</td>
                <td align="left" rowspan="1" colspan="1">0.639</td>
                <td align="left" rowspan="1" colspan="1">0.750</td>
                <td align="left" rowspan="1" colspan="1">0.394</td>
                <td align="left" rowspan="1" colspan="1">0.780</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">LR-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.705</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.836</td>
                <td align="left" rowspan="1" colspan="1">0.409</td>
                <td align="left" rowspan="1" colspan="1">0.786</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.696</td>
                <td align="left" rowspan="1" colspan="1">0.440</td>
                <td align="left" rowspan="1" colspan="1">0.914</td>
                <td align="left" rowspan="1" colspan="1">0.407</td>
                <td align="left" rowspan="1" colspan="1">0.791</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TROLLOPE</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">RF-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.722</td>
                <td align="left" rowspan="1" colspan="1">0.753</td>
                <td align="left" rowspan="1" colspan="1">0.695</td>
                <td align="left" rowspan="1" colspan="1">0.447</td>
                <td align="left" rowspan="1" colspan="1">0.799</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">RF-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.711</td>
                <td align="left" rowspan="1" colspan="1">0.517</td>
                <td align="left" rowspan="1" colspan="1">0.876</td>
                <td align="left" rowspan="1" colspan="1">0.426</td>
                <td align="left" rowspan="1" colspan="1">0.786</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.758</td>
                <td align="left" rowspan="1" colspan="1">0.697</td>
                <td align="left" rowspan="1" colspan="1">0.810</td>
                <td align="left" rowspan="1" colspan="1">0.511</td>
                <td align="left" rowspan="1" colspan="1">0.822</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">LR-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.716</td>
                <td align="left" rowspan="1" colspan="1">0.539</td>
                <td align="left" rowspan="1" colspan="1">0.867</td>
                <td align="left" rowspan="1" colspan="1">0.434</td>
                <td align="left" rowspan="1" colspan="1">0.796</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.727</td>
                <td align="left" rowspan="1" colspan="1">0.663</td>
                <td align="left" rowspan="1" colspan="1">0.781</td>
                <td align="left" rowspan="1" colspan="1">0.448</td>
                <td align="left" rowspan="1" colspan="1">0.798</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TROLLOPE</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec012">
      <title>3.4 Analysis of the contribution of new probabilistic features</title>
      <p>In this section, we investigated the discriminative power of the new probabilistic features (OPF) for identifying TCE-HCVs. Firstly, we compared the performance of OPF with well-known sequence-based feature descriptors, involving AAC, AAI, APAAC, CTD, CTDC, CTDD, CTDT, DDE, DPC, PAAC, PCP and TPC. By doing this, each feature was used to develop a PLS-based model and its performance was evaluated based on the 10-fold cross-validation and independent tests. <bold>Tables <xref rid="pone.0290538.t005" ref-type="table">5</xref> and <xref rid="pone.0290538.t006" ref-type="table">6</xref></bold> record their detailed 10-fold cross-validation and independent test results. As seen from <bold><xref rid="pone.0290538.t005" ref-type="table">Table 5</xref></bold>, among the 12 well-known feature descriptors, the highest AUC of 0.772 is achieved using TPC. This indicates that TPC exhibits greater discriminative power compared to other feature descriptors. Furthermore, <bold>Tables <xref rid="pone.0290538.t005" ref-type="table">5</xref> and <xref rid="pone.0290538.t006" ref-type="table">6</xref></bold> show that the OPF achieves higher ACC, Sn, MCC, and AUC values compared to 12 well-known feature descriptors in terms of both the 10-fold cross-validation and independent tests. Impressively, on the independent test dataset, the OPF outperforms TPC in terms of MCC, Sn, ACC, and AUC, with an increase of 13.84, 11.24, 6.70, and 6.00%, respectively. Secondly, we employed the t-SNE method to analyze the feature space of OPF and top-three informative sequence-based feature descriptors (i.e., DDE, DPC, and TPC) to visualize their distributions. As can be seen from <bold><xref rid="pone.0290538.g005" ref-type="fig">Fig 5</xref></bold>, the feature space derived from OPF exhibits clearer and more distinct clusters as compared to DDE, DPC, and TPC. Our comparative analysis revealed that our new probabilistic features exhibited more discriminative power in identifying TCE-HCV compared to well-known sequence-based feature descriptors, resulting in improved performance.</p>
      <fig position="float" id="pone.0290538.g005">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g005</object-id>
        <label>Fig 5</label>
        <caption>
          <p>t-SNE plots of our new feature OPF (<bold>A</bold>) and top-three feature descriptors (<bold>B-D</bold>) (i.e. DDE, DPC, and TPC) on the training dataset.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g005" position="float"/>
      </fig>
      <table-wrap position="float" id="pone.0290538.t005">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t005</object-id>
        <label>Table 5</label>
        <caption>
          <title>Cross-validation results of our new feature and conventional feature descriptor.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t005" id="pone.0290538.t005g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDC</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.401</td>
                <td align="left" rowspan="1" colspan="1">0.655</td>
                <td align="left" rowspan="1" colspan="1">0.056</td>
                <td align="left" rowspan="1" colspan="1">0.558</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PCP</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.325</td>
                <td align="left" rowspan="1" colspan="1">0.719</td>
                <td align="left" rowspan="1" colspan="1">0.045</td>
                <td align="left" rowspan="1" colspan="1">0.569</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAI</td>
                <td align="left" rowspan="1" colspan="1">0.548</td>
                <td align="left" rowspan="1" colspan="1">0.446</td>
                <td align="left" rowspan="1" colspan="1">0.636</td>
                <td align="left" rowspan="1" colspan="1">0.084</td>
                <td align="left" rowspan="1" colspan="1">0.601</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDT</td>
                <td align="left" rowspan="1" colspan="1">0.595</td>
                <td align="left" rowspan="1" colspan="1">0.496</td>
                <td align="left" rowspan="1" colspan="1">0.679</td>
                <td align="left" rowspan="1" colspan="1">0.180</td>
                <td align="left" rowspan="1" colspan="1">0.616</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDD</td>
                <td align="left" rowspan="1" colspan="1">0.593</td>
                <td align="left" rowspan="1" colspan="1">0.554</td>
                <td align="left" rowspan="1" colspan="1">0.626</td>
                <td align="left" rowspan="1" colspan="1">0.182</td>
                <td align="left" rowspan="1" colspan="1">0.630</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAC</td>
                <td align="left" rowspan="1" colspan="1">0.584</td>
                <td align="left" rowspan="1" colspan="1">0.516</td>
                <td align="left" rowspan="1" colspan="1">0.643</td>
                <td align="left" rowspan="1" colspan="1">0.160</td>
                <td align="left" rowspan="1" colspan="1">0.632</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PAAC</td>
                <td align="left" rowspan="1" colspan="1">0.602</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.657</td>
                <td align="left" rowspan="1" colspan="1">0.198</td>
                <td align="left" rowspan="1" colspan="1">0.638</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTD</td>
                <td align="left" rowspan="1" colspan="1">0.600</td>
                <td align="left" rowspan="1" colspan="1">0.566</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.196</td>
                <td align="left" rowspan="1" colspan="1">0.644</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">APAAC</td>
                <td align="left" rowspan="1" colspan="1">0.615</td>
                <td align="left" rowspan="1" colspan="1">0.533</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.222</td>
                <td align="left" rowspan="1" colspan="1">0.645</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DPC</td>
                <td align="left" rowspan="1" colspan="1">0.664</td>
                <td align="left" rowspan="1" colspan="1">0.616</td>
                <td align="left" rowspan="1" colspan="1">0.705</td>
                <td align="left" rowspan="1" colspan="1">0.324</td>
                <td align="left" rowspan="1" colspan="1">0.697</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DDE</td>
                <td align="left" rowspan="1" colspan="1">0.685</td>
                <td align="left" rowspan="1" colspan="1">0.602</td>
                <td align="left" rowspan="1" colspan="1">0.755</td>
                <td align="left" rowspan="1" colspan="1">0.363</td>
                <td align="left" rowspan="1" colspan="1">0.726</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TPC</td>
                <td align="left" rowspan="1" colspan="1">0.694</td>
                <td align="left" rowspan="1" colspan="1">0.670</td>
                <td align="left" rowspan="1" colspan="1">0.714</td>
                <td align="left" rowspan="1" colspan="1">0.385</td>
                <td align="left" rowspan="1" colspan="1">0.758</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">OPF (This study)</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <table-wrap position="float" id="pone.0290538.t006">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t006</object-id>
        <label>Table 6</label>
        <caption>
          <title>Independent test results of our new feature and conventional feature descriptor.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t006" id="pone.0290538.t006g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDC</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.371</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.101</td>
                <td align="left" rowspan="1" colspan="1">0.598</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PCP</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.348</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.078</td>
                <td align="left" rowspan="1" colspan="1">0.574</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAI</td>
                <td align="left" rowspan="1" colspan="1">0.598</td>
                <td align="left" rowspan="1" colspan="1">0.528</td>
                <td align="left" rowspan="1" colspan="1">0.657</td>
                <td align="left" rowspan="1" colspan="1">0.187</td>
                <td align="left" rowspan="1" colspan="1">0.620</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDT</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.393</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.082</td>
                <td align="left" rowspan="1" colspan="1">0.600</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDD</td>
                <td align="left" rowspan="1" colspan="1">0.582</td>
                <td align="left" rowspan="1" colspan="1">0.472</td>
                <td align="left" rowspan="1" colspan="1">0.676</td>
                <td align="left" rowspan="1" colspan="1">0.151</td>
                <td align="left" rowspan="1" colspan="1">0.618</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAC</td>
                <td align="left" rowspan="1" colspan="1">0.572</td>
                <td align="left" rowspan="1" colspan="1">0.528</td>
                <td align="left" rowspan="1" colspan="1">0.610</td>
                <td align="left" rowspan="1" colspan="1">0.138</td>
                <td align="left" rowspan="1" colspan="1">0.593</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PAAC</td>
                <td align="left" rowspan="1" colspan="1">0.577</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.590</td>
                <td align="left" rowspan="1" colspan="1">0.152</td>
                <td align="left" rowspan="1" colspan="1">0.594</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTD</td>
                <td align="left" rowspan="1" colspan="1">0.582</td>
                <td align="left" rowspan="1" colspan="1">0.483</td>
                <td align="left" rowspan="1" colspan="1">0.667</td>
                <td align="left" rowspan="1" colspan="1">0.152</td>
                <td align="left" rowspan="1" colspan="1">0.628</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">APAAC</td>
                <td align="left" rowspan="1" colspan="1">0.603</td>
                <td align="left" rowspan="1" colspan="1">0.573</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.201</td>
                <td align="left" rowspan="1" colspan="1">0.599</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DPC</td>
                <td align="left" rowspan="1" colspan="1">0.639</td>
                <td align="left" rowspan="1" colspan="1">0.584</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.271</td>
                <td align="left" rowspan="1" colspan="1">0.731</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DDE</td>
                <td align="left" rowspan="1" colspan="1">0.680</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.781</td>
                <td align="left" rowspan="1" colspan="1">0.353</td>
                <td align="left" rowspan="1" colspan="1">0.741</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TPC</td>
                <td align="left" rowspan="1" colspan="1">0.680</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.355</td>
                <td align="left" rowspan="1" colspan="1">0.767</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">OPF (This study)</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec013">
      <title>3.5 Characterization of linear T-cell epitopes of hepatitis C virus</title>
      <p>The analysis and characterization of feature importance for each type of features are crucial for providing a better understanding of TCE-HCVs. Therefore, we employed an interpretable approach, named the Shapley Additive exPlanations (SHAP), to rank and evaluate the feature importance for TROLLOPE and its constituent base-classifiers. Until now, the SHAP method has been successfully used in various bioinformatics tasks [<xref rid="pone.0290538.ref068" ref-type="bibr">68</xref>–<xref rid="pone.0290538.ref071" ref-type="bibr">71</xref>]. Firstly, the top-six informative probabilistic features of TROLLOPE were assessed for their importance in TCE-HCV identification. <bold><xref rid="pone.0290538.g006" ref-type="fig">Fig 6</xref></bold> shows the SHAP values of the top-six informative probabilistic features, where positive and negative SHAP values indicate a high probability that the predictions are TCE-HCVs and non-TCE-HCVs, respectively. <bold><xref rid="pone.0290538.g006" ref-type="fig">Fig 6A</xref></bold> illustrates that most of the top-six informative probabilistic features (with the exception of XGB-AAI) significantly contribute to TCE-HCV prediction, as indicated by their high SHAP values. Secondly, to gain deeper insights into TCE-HCVs, we applied the SHAP method to analyze two of the six base-classifiers (i.e., XGB-AAI and XGB-PCP). Previously, AAI and PCP have been recognized as crucial features for analyzing and charactering various protein functions [<xref rid="pone.0290538.ref072" ref-type="bibr">72</xref>–<xref rid="pone.0290538.ref076" ref-type="bibr">76</xref>]. As seen in <bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7</xref></bold>, the important physicochemical properties, such as helical structure conformation (TANS770102, ISOY800106, AURR980118, and WERD780103), beta-sheet structure (CHOP780211) and other conformational characteristics of epitopes (MAXF760103 and VASM830101) play a significant role in TCE-HCV prediction.</p>
      <fig position="float" id="pone.0290538.g006">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g006</object-id>
        <label>Fig 6</label>
        <caption>
          <title>Feature importance analysis for TROLLOPE prediction.</title>
          <p>(A) Scatter plot of top-15 informative probabilistic features. (B) The average absolute SHAP values of top-15 informative probabilistic features.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g006" position="float"/>
      </fig>
      <fig position="float" id="pone.0290538.g007">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g007</object-id>
        <label>Fig 7</label>
        <caption>
          <p>Feature importance analysis for XGB-AAI (A-B) and XGB-PCP (C-D) predictions. (A, C) Scatter plot of top 20 informative features. (B, D) The average absolute SHAP values of top 20 informative features.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g007" position="float"/>
      </fig>
      <p>Certain amino acid residues in the position preceding a given residue may have specific structural preferences, such as helical propensity or beta-sheet propensity. These important physicochemical properties can provide insights into the preferred amino acids or structural motifs in that position, which can impact the overall conformation and stability of the epitope. Moreover, the hydrophobicity of amino acids within HCV epitopes can significantly influence their structural stability and conformation. In the feature lists of XGB-PCP and XGB-AAI, the presence of "hydrophobic" and "CIDH920104" or Normalized hydrophobicity scales for alpha/beta-proteins (Cid et al., 1992), respectively, indicates that hydrophobic tend to be buried within the protein core, while hydrophilic residues preferentially reside on the protein surface. A balance of hydrophobic and hydrophilic residues within the epitope can contribute to its structural integrity and proper folding, which can potentially influence its antigenicity and immunogenicity [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>].</p>
      <p>Since aromatic residues have hydrophobic properties, they can participate in hydrophobic interactions with other hydrophobic regions on antibodies or immune receptors. Therefore, the “aromatic” feature from XGB-PCP was also listed in the top ranked feature (<bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7C and 7D</xref></bold>). These interactions contribute to the stability and specificity of the antigen-antibody or antigen-receptor binding. In addition, the mean area buried on transfer (ROSG850101) could also be indicative of the hydrophobicity scale of the desired epitopes. Notably, the “aliphatic” feature could also be grouped together with the hydrophobic and aromatic features. The aliphatic residues, such as alanine (Ala), valine (Val), leucine (Leu), and isoleucine (Ile), are non-polar and play important roles in the hydrophobic region of epitopes. These residues have various effects on antigen recognition and immune response [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>]. These important features can also influence the exposure and presentation of epitopes on antigens. In some cases, hydrophobic regions within the antigen may be buried within the protein structure, making the epitope less accessible for recognition by immune receptors. Alternatively, hydrophobic patches on the surface of an antigen may be more exposed and accessible, facilitating the binding and recognition of the epitope by immune cells or antibodies.</p>
      <p>On the other hand, the charged amino acids, including positively charged (basic) residues such as lysine (Lys) and arginine (Arg), as well as negatively charged (acidic) residues such as aspartic acid (Asp) and glutamic acid (Glu), can also play important roles in epitopes. Interestingly, the “charged”, “polar”, “positively-charged” and “negatively-charged” features from XGB-PCP were also found as the key physicochemical properties in <bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7C and 7D</xref></bold>. This evidence was well supported by the FAUJ880111 or Positive charge [<xref rid="pone.0290538.ref078" ref-type="bibr">78</xref>] feature from XGB-AAI prediction (<bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7A and 7B</xref></bold>). The presence of charged residues within an epitope can have several effects on antigen recognition and immune response, via electrostatic interactions, to enhance the strength of the binding and play a crucial role in determining the binding affinity and specificity of the epitope [<xref rid="pone.0290538.ref079" ref-type="bibr">79</xref>]. Moreover, charged residues can influence the processing and presentation of epitopes by antigen-presenting cells (APCs) affecting their proteolytic cleavage, degradation, and subsequent presentation on the cell surface via major histocompatibility complex (MHC) molecules [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>]. For example, the E2 protein and domain 1 of the HCV-core protein contain frequent positively charged amino acids (Lys and Arg) that are involved in RNA binding, promotes dimerization of the viral RNA, and play a significant role in nucleocapsid (NC) formation and core envelopment by endosomal membranes [<xref rid="pone.0290538.ref080" ref-type="bibr">80</xref>].</p>
      <p>In terms of the receptor-epitope binding and specificity on T-cell, NAKH920103 and NAKH920102 represent the role of specific regions on transmembrane proteins (single-spanning proteins). The CYT2 region in NAKH920102 property, which refers to the C-terminal region of a single-spanning protein, may contribute to the amino acid composition within this region, affecting their recognition by antibodies or T-cells [<xref rid="pone.0290538.ref079" ref-type="bibr">79</xref>]. More importantly, the importance of epitope diversity is crucial for vaccine design. The role of potential mutability on HCV epitope function refers to how the mutability, or the propensity to undergo genetic variations, of epitopes can impact their function and interactions with the immune system [<xref rid="pone.0290538.ref081" ref-type="bibr">81</xref>]. The presence of both relative mutability (JOND920102) and relative stability scale extracted from mutation experiments (ZHOH040102) features from XGB-AAI prediction were reasonable. Contributing to this epitope diversity issue, RADA880106, PRAM820103 and SNEP660102 have been reported to capture the variation in amino acid properties that contributes most significantly to the structural diversity of HCV epitopes [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>]. Compared to previously reported B-cell epitopes of hepatitis C [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>], the feature “Principal component I (PCI) [<xref rid="pone.0290538.ref082" ref-type="bibr">82</xref>]” or SNEP660101 was found to be among the top-10 properties ranked by the accuracy differences. This finding may reflect the different key features that are important for predicting B-cell and T-cell epitopes. On the other hand, the principal component II (PCII) might capture the variation in amino acid properties that contributes most significantly to the structural diversity of HCV epitopes. PCII represents the orthogonal direction to PCI, which generally captures the primary source of variation. PCII can capture additional variations in epitope properties, such as side chain flexibility, polarity, or charge distribution, which can influence the conformational flexibility and structural dynamics of epitopes [<xref rid="pone.0290538.ref083" ref-type="bibr">83</xref>]. Epitopes with different PCII scores may exhibit distinct structural features or conformational preferences, potentially impacting their function and interaction with immune receptors.</p>
    </sec>
    <sec id="sec014">
      <title>3.6 Case studies</title>
      <p>In this study, we conducted case studies to evaluate the prediction capability of our stacked model TROLLOPE in practical real‐life situations and compared its performance with the top-five base-classifiers. Specifically, we collected six experimentally verified TCE-HCVs from two previous studies [<xref rid="pone.0290538.ref084" ref-type="bibr">84</xref>]. The criteria for HCV epitopes selection in this case study were as follows: 1) they have to be experimentally verified from published research papers, 2) only short peptides (8–11 amino acid residues) that are CD8+ T-cell specific epitopes will be considered (not B-cell specific or CD4+ T-cell epitopes), and 3) these TCE-HCVs should not be found in both the training and independent test datasets. Detailed information about the six TCE-HCVs in the case studies is provided in <bold>S5 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. In the meanwhile, the prediction results for these TCE-HCVs based on TROLLOPE and the top-five base-classifiers are summarized in <bold>S6 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. As can be seen, TROLLOPE, along with SVM-TPC and SVM-DDE, can correctly predict all six TCE-HCVs.</p>
      <p>Taken together, these findings suggest that TROLLOPE can serve as a useful computational tool for accurately prioritizing high-potential TCE-HCVs from a large number of non-characterized peptides, as evidenced by its performance in both the independent test and case studies.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec015">
    <title>4. Conclusions</title>
    <p>This study presents a novel computational approach, termed TROLLOPE, which aims to provide fast and accurate prediction of TCE-HCV. Specifically, we extracted 12 different types of sequence-based feature encoding schemes from several perspectives, such as physicochemical properties, composition-transition-distribution information and composition information, and employed 12 powerful ML algorithms to develop a stacked model. The major contributions of this study are as follows: (i) TROLLOPE is the first computational tool developed specifically for identifying TCE-HCV using sequence information alone; (ii) The new probabilistic features generated based on TROLLOPE offer more discriminative information compared to commonly used feature encodings; (iii) The experimental results, in terms of both cross-validation and independent test results, revealed that TROLLOPE significantly outperformed conventional ML classifiers; and (iv) A user-friendly online web server of TROLLOPE is developed for serving experimental scientists to easily access and utilize the tool for their desired prediction tasks (<ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>). It is anticipated that TROLLOPE could be utilized to accelerate the large-scale identification of potential TCE-HCV from non-characterized peptides. However, there are some limitations that can be addressed in future work. Firstly, although our probabilistic features have more discriminative ability in TCE-HCV identification, there is still room for further improvement. For future work, we plan to fuse our probabilistic features with fingerprint descriptors (i.e., Estate, MACCS, and PubChem [<xref rid="pone.0290538.ref085" ref-type="bibr">85</xref>–<xref rid="pone.0290538.ref087" ref-type="bibr">87</xref>]) and sequence-to-vector encodings (i.e., word2vec). Secondly, the performance of TROLLOPE might be improved by combining it with powerful deep learning (DL) approaches, such as deep neural network (DNN) and transfer learning [<xref rid="pone.0290538.ref088" ref-type="bibr">88</xref>, <xref rid="pone.0290538.ref089" ref-type="bibr">89</xref>]. Thirdly, we are motivated to develop a new ML framework that are capable of identifying multiple viral agents.</p>
  </sec>
  <sec id="sec016" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pone.0290538.s001" position="float" content-type="local-data">
      <label>S1 File</label>
      <caption>
        <p>(DOCX)</p>
      </caption>
      <media xlink:href="pone.0290538.s001.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pone.0290538.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Manns</surname><given-names>M. P.</given-names></name><etal>et al.</etal>, "<article-title>Hepatitis C virus infection</article-title>," <source><italic toggle="yes">Nat Rev Dis Primers</italic></source>, vol. <volume>3</volume>, p. <fpage>17006</fpage>, <month>Mar</month><day>2</day><year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrdp.2017.6</pub-id><?supplied-pmid 28252637?><pub-id pub-id-type="pmid">28252637</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Pol</surname><given-names>S.</given-names></name> and <name><surname>Lagaye</surname><given-names>S.</given-names></name>, "<article-title>The remarkable history of the hepatitis C virus</article-title>," <source><italic toggle="yes">Genes Immun</italic></source>, vol. <volume>20</volume>, no. <issue>5</issue>, pp. <fpage>436</fpage>–<lpage>446</lpage>, <month>May</month>
<year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41435-019-0066-z</pub-id>
<?supplied-pmid 31019253?><pub-id pub-id-type="pmid">31019253</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>E.</given-names></name>, <name><surname>Ghany</surname><given-names>M. G.</given-names></name>, and <name><surname>Liang</surname><given-names>T. J.</given-names></name>, "<article-title>The application and mechanism of action of ribavirin in therapy of hepatitis C</article-title>," <source><italic toggle="yes">Antivir Chem Chemother</italic></source>, vol. <volume>23</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>12</lpage>, <month>Sep</month><day>25</day><year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3851/IMP2125</pub-id><?supplied-pmid 22592135?><pub-id pub-id-type="pmid">22592135</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Dustin</surname><given-names>L. B.</given-names></name>, <name><surname>Bartolini</surname><given-names>B.</given-names></name>, <name><surname>Capobianchi</surname><given-names>M. R.</given-names></name>, and <name><surname>Pistello</surname><given-names>M.</given-names></name>, "<article-title>Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy</article-title>," <source><italic toggle="yes">Clin Microbiol Infect</italic></source>, vol. <volume>22</volume>, no. <issue>10</issue>, pp. <fpage>826</fpage>–<lpage>832</lpage>, <month>Oct</month><year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cmi.2016.08.025</pub-id><?supplied-pmid 27592089?><pub-id pub-id-type="pmid">27592089</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Bhattacharjee</surname><given-names>C.</given-names></name>, <name><surname>Singh</surname><given-names>M.</given-names></name>, <name><surname>Das</surname><given-names>D.</given-names></name>, <name><surname>Chaudhuri</surname><given-names>S.</given-names></name>, and <name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name>, "<article-title>Current therapeutics against HCV</article-title>," <source><italic toggle="yes">Virusdisease</italic></source>, vol. <volume>32</volume>, no. <issue>2</issue>, pp. <fpage>228</fpage>–<lpage>243</lpage>, <month>Jun</month><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s13337-021-00697-0</pub-id><?supplied-pmid 34307769?><pub-id pub-id-type="pmid">34307769</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Manns</surname><given-names>M. P.</given-names></name> and <name><surname>Maasoumy</surname><given-names>B.</given-names></name>, "<article-title>Breakthroughs in hepatitis C research: from discovery to cure</article-title>," <source><italic toggle="yes">Nat Rev Gastroenterol Hepatol</italic></source>, vol. <volume>19</volume>, no. <issue>8</issue>, pp. <fpage>533</fpage>–<lpage>550</lpage>, <month>Aug</month>
<year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41575-022-00608-8</pub-id>
<?supplied-pmid 35595834?><pub-id pub-id-type="pmid">35595834</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><collab>WHO</collab>, <source>Global progress report on HIV, viral hepatitis and sexually transmitted infections</source>, <year>2021</year>. [Online]. Available: <ext-link xlink:href="https://www.who.int/publications/i/item/9789240027077" ext-link-type="uri">https://www.who.int/publications/i/item/9789240027077</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><collab>WHO</collab>, <source>Updated recommendations on treatment of dolescents and children with chronic HCV infection, and HCV simplified service elivery and diagnostics</source>., <year>2022</year>. [Online]. Available: <ext-link xlink:href="https://www.who.int/publications/i/item/9789240052734" ext-link-type="uri">https://www.who.int/publications/i/item/9789240052734</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Manne</surname><given-names>V.</given-names></name>, <name><surname>Ryan</surname><given-names>J.</given-names></name>, <name><surname>Wong</surname><given-names>J.</given-names></name>, <name><surname>Vengayil</surname><given-names>G.</given-names></name>, <name><surname>Basit</surname><given-names>S. A.</given-names></name>, and <name><surname>Gish</surname><given-names>R. G.</given-names></name>, "<article-title>Hepatitis C Vaccination: Where We Are and Where We Need to Be</article-title>," <source><italic toggle="yes">Pathogens</italic></source>, vol. <volume>10</volume>, no. <issue>12</issue>, <month>Dec</month><day>14</day><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/pathogens10121619</pub-id><?supplied-pmid 34959574?><pub-id pub-id-type="pmid">34959574</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Hedskog</surname><given-names>C.</given-names></name><etal>et al.</etal>, "<article-title>Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification</article-title>," <source><italic toggle="yes">Open Forum Infect Dis</italic></source>, vol. <volume>6</volume>, no. <issue>3</issue>, p. ofz076, <month>Mar</month><year>2019</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Vanwolleghem</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>47</volume>, no. <issue>6</issue>, pp. <fpage>1846</fpage>–<lpage>55</lpage>, <month>Jun</month><year>2008</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.22244</pub-id><?supplied-pmid 18452146?><pub-id pub-id-type="pmid">18452146</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Meuleman</surname><given-names>P.</given-names></name><etal>et al.</etal>, "<article-title>In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>53</volume>, no. <issue>3</issue>, pp. <fpage>755</fpage>–<lpage>62</lpage>, <month>Mar</month><year>2011</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.24171</pub-id><?supplied-pmid 21319203?><pub-id pub-id-type="pmid">21319203</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Bukh</surname><given-names>J.</given-names></name><etal>et al.</etal>, "<article-title>Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge</article-title>," <source><italic toggle="yes">J Virol</italic></source>, vol. <volume>89</volume>, no. <issue>17</issue>, pp. <fpage>9128</fpage>–<lpage>32</lpage>, <month>Sep</month><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.01194-15</pub-id><?supplied-pmid 26085160?><pub-id pub-id-type="pmid">26085160</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>J. R.</given-names></name><etal>et al.</etal>, "<article-title>Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance</article-title>," <source><italic toggle="yes">J Clin Invest</italic></source>, vol. <volume>125</volume>, no. <issue>1</issue>, pp. <fpage>437</fpage>–<lpage>47</lpage>, <month>Jan</month><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1172/JCI78794</pub-id><?supplied-pmid 25500884?><pub-id pub-id-type="pmid">25500884</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>El-Diwany</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1</article-title>," <source><italic toggle="yes">PLoS Pathog</italic></source>, vol. <volume>13</volume>, no. <issue>2</issue>, p. <fpage>e1006235</fpage>, <month>Feb</month><year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.ppat.1006235</pub-id><?supplied-pmid 28235087?><pub-id pub-id-type="pmid">28235087</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>A. L.</given-names></name>, "<article-title>Challenges and Promise of a Hepatitis C Virus Vaccine</article-title>," <source><italic toggle="yes">Cold Spring Harb Perspect Med</italic></source>, vol. <volume>10</volume>, no. <issue>2</issue>, <month>Feb</month><day>3</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/cshperspect.a036947</pub-id><?supplied-pmid 31548228?><pub-id pub-id-type="pmid">31548228</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Lechner</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Analysis of successful immune responses in persons infected with hepatitis C virus</article-title>," <source><italic toggle="yes">J Exp Med</italic></source>, vol. <volume>191</volume>, no. <issue>9</issue>, pp. <fpage>1499</fpage>–<lpage>512</lpage>, <month>May</month><day>1</day><year>2000</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1084/jem.191.9.1499</pub-id><?supplied-pmid 10790425?><pub-id pub-id-type="pmid">10790425</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>K. M.</given-names></name><etal>et al.</etal>, "<article-title>Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>33</volume>, no. <issue>1</issue>, pp. <fpage>267</fpage>–<lpage>76</lpage>, <month>Jan</month><year>2001</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/jhep.2001.21162</pub-id><?supplied-pmid 11124845?><pub-id pub-id-type="pmid">11124845</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Grakoui</surname><given-names>A.</given-names></name><etal>et al.</etal>, "<article-title>HCV persistence and immune evasion in the absence of memory T cell help</article-title>," <source><italic toggle="yes">Science</italic></source>, vol. <volume>302</volume>, no. <issue>5645</issue>, pp. <fpage>659</fpage>–<lpage>62</lpage>, <month>Oct</month><day>24</day><year>2003</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1088774</pub-id><?supplied-pmid 14576438?><pub-id pub-id-type="pmid">14576438</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Schulze Zur Wiesch</surname><given-names>J.</given-names></name><etal>et al.</etal>, "<article-title>Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence</article-title>," <source><italic toggle="yes">J Exp Med</italic></source>, vol. <volume>209</volume>, no. <issue>1</issue>, pp. <fpage>61</fpage>–<lpage>75</lpage>, <month>Jan</month><day>16</day><year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1084/jem.20100388</pub-id><?supplied-pmid 22213804?><pub-id pub-id-type="pmid">22213804</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Abdel-Hakeem</surname><given-names>M. S.</given-names></name>, <name><surname>Bedard</surname><given-names>N.</given-names></name>, <name><surname>Murphy</surname><given-names>D.</given-names></name>, <name><surname>Bruneau</surname><given-names>J.</given-names></name>, and <name><surname>Shoukry</surname><given-names>N. H.</given-names></name>, "<article-title>Signatures of protective memory immune responses during hepatitis C virus reinfection</article-title>," <source><italic toggle="yes">Gastroenterology</italic></source>, vol. <volume>147</volume>, no. <issue>4</issue>, pp. <fpage>870</fpage>–<lpage>881 e8</lpage>, <month>Oct</month><year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/j.gastro.2014.07.005</pub-id><?supplied-pmid 25038432?><pub-id pub-id-type="pmid">25038432</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>S.</given-names></name>, <name><surname>Lauer</surname><given-names>G.</given-names></name>, <name><surname>Isba</surname><given-names>R.</given-names></name>, <name><surname>Walker</surname><given-names>B.</given-names></name>, and <name><surname>Klenerman</surname><given-names>P.</given-names></name>, "<article-title>Cellular immune responses against hepatitis C virus: the evidence base 2002</article-title>," <source><italic toggle="yes">Clin Exp Immunol</italic></source>, vol. <volume>128</volume>, no. <issue>2</issue>, pp. <fpage>195</fpage>–<lpage>203</lpage>, <month>May</month><year>2002</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01840.x</pub-id><?supplied-pmid 11985510?><pub-id pub-id-type="pmid">11985510</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Thimme</surname><given-names>R.</given-names></name>, "<article-title>T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine</article-title>," <source><italic toggle="yes">J Hepatol</italic></source>, vol. <volume>74</volume>, no. <issue>1</issue>, pp. <fpage>220</fpage>–<lpage>229</lpage>, <month>Jan</month><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jhep.2020.09.022</pub-id><?supplied-pmid 33002569?><pub-id pub-id-type="pmid">33002569</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Shirai</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines</article-title>," <source><italic toggle="yes">J Infect Dis</italic></source>, vol. <volume>173</volume>, no. <issue>1</issue>, pp. <fpage>24</fpage>–<lpage>31</lpage>, <month>Jan</month><year>1996</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/infdis/173.1.24</pub-id><?supplied-pmid 8537666?><pub-id pub-id-type="pmid">8537666</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Engler</surname><given-names>O. B.</given-names></name><etal>et al.</etal>, "<article-title>A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins</article-title>," <source><italic toggle="yes">Vaccine</italic></source>, vol. <volume>23</volume>, no. <issue>1</issue>, pp. <fpage>58</fpage>–<lpage>68</lpage>, <month>Nov</month><day>15</day><year>2004</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.05.009</pub-id><?supplied-pmid 15519708?><pub-id pub-id-type="pmid">15519708</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Christiansen</surname><given-names>D.</given-names></name><etal>et al.</etal>, "<article-title>Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine</article-title>," <source><italic toggle="yes">Sci Rep</italic></source>, vol. <volume>8</volume>, no. <issue>1</issue>, p. <fpage>6483</fpage>, <month>Apr</month><day>24</day><year>2018</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-24762-9</pub-id><?supplied-pmid 29691437?><pub-id pub-id-type="pmid">29691437</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>J. R.</given-names></name>, <name><surname>Barnes</surname><given-names>E.</given-names></name>, and <name><surname>Cox</surname><given-names>A. L.</given-names></name>, "<article-title>Approaches, Progress, and Challenges to Hepatitis C Vaccine Development</article-title>," <source><italic toggle="yes">Gastroenterology</italic></source>, vol. <volume>156</volume>, no. <issue>2</issue>, pp. <fpage>418</fpage>–<lpage>430</lpage>, <month>Jan</month><year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.060</pub-id><?supplied-pmid 30268785?><pub-id pub-id-type="pmid">30268785</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Yechezkel</surname><given-names>I.</given-names></name>, <name><surname>Law</surname><given-names>M.</given-names></name>, and <name><surname>Tzarum</surname><given-names>N.</given-names></name>, "<article-title>From Structural Studies to HCV Vaccine Design</article-title>," <source><italic toggle="yes">Viruses</italic></source>, vol. <volume>13</volume>, no. <issue>5</issue>, <month>May</month><day>4</day><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/v13050833</pub-id><?supplied-pmid 34064532?><pub-id pub-id-type="pmid">34064532</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Duncan</surname><given-names>J. D.</given-names></name>, <name><surname>Urbanowicz</surname><given-names>R. A.</given-names></name>, <name><surname>Tarr</surname><given-names>A. W.</given-names></name>, and <name><surname>Ball</surname><given-names>J. K.</given-names></name>, "<article-title>Hepatitis C Virus Vaccine: Challenges and Prospects</article-title>," <source><italic toggle="yes">Vaccines (Basel)</italic></source>, vol. <volume>8</volume>, no. <issue>1</issue>, <month>Feb</month><day>17</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/vaccines8010090</pub-id><?supplied-pmid 32079254?><pub-id pub-id-type="pmid">32079254</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Sunita</surname><given-names>A.</given-names></name><name><surname>Sajid</surname><given-names>Y</given-names></name>. <name><surname>Singh</surname></name>, and <name><surname>Shukla</surname><given-names>P.</given-names></name>, "<article-title>Computational tools for modern vaccine development</article-title>," <source><italic toggle="yes">Hum Vaccin Immunother</italic></source>, vol. <volume>16</volume>, no. <issue>3</issue>, pp. <fpage>723</fpage>–<lpage>735</lpage>, <month>Mar</month><day>3</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/21645515.2019.1670035</pub-id><?supplied-pmid 31545127?><pub-id pub-id-type="pmid">31545127</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Memarnejadian</surname><given-names>A.</given-names></name>, <name><surname>Roohvand</surname><given-names>F.</given-names></name>, <name><surname>Arashkia</surname><given-names>A.</given-names></name>, <name><surname>Rafati</surname><given-names>S.</given-names></name>, and <name><surname>Shokrgozar</surname><given-names>M. A.</given-names></name>, "<article-title>Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice</article-title>," <source><italic toggle="yes">Protein Pept Lett</italic></source>, vol. <volume>16</volume>, no. <issue>7</issue>, pp. <fpage>842</fpage>–<lpage>50</lpage>, <year>2009</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/092986609788681788</pub-id><?supplied-pmid 19601916?><pub-id pub-id-type="pmid">19601916</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Arashkia</surname><given-names>A.</given-names></name>, <name><surname>Roohvand</surname><given-names>F.</given-names></name>, <name><surname>Memarnejadian</surname><given-names>A.</given-names></name>, <name><surname>Aghasadeghi</surname><given-names>M. R.</given-names></name>, and <name><surname>Rafati</surname><given-names>S.</given-names></name>, "<article-title>Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice</article-title>," <source><italic toggle="yes">Virus Genes</italic></source>, vol. <volume>40</volume>, no. <issue>1</issue>, pp. <fpage>44</fpage>–<lpage>52</lpage>, <month>Feb</month><year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11262-009-0417-3</pub-id><?supplied-pmid 19882243?><pub-id pub-id-type="pmid">19882243</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Memarnejadian</surname><given-names>A.</given-names></name> and <name><surname>Roohvand</surname><given-names>F.</given-names></name>, "<article-title>Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine</article-title>," <source><italic toggle="yes">Cell Immunol</italic></source>, vol. <volume>261</volume>, no. <issue>2</issue>, pp. <fpage>93</fpage>–<lpage>8</lpage>, <year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cellimm.2009.11.005</pub-id>
<?supplied-pmid 20056196?><pub-id pub-id-type="pmid">20056196</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Dhanda</surname><given-names>S. K.</given-names></name>, <name><surname>Gupta</surname><given-names>S.</given-names></name>, <name><surname>Vir</surname><given-names>P.</given-names></name>, and <name><surname>Raghava</surname><given-names>G.</given-names></name>, "<article-title>Prediction of IL4 inducing peptides</article-title>," <source><italic toggle="yes">Clinical and Developmental Immunology</italic></source>, vol. <volume>2013</volume>, <year>2013</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2013/263952</pub-id><?supplied-pmid 24489573?><pub-id pub-id-type="pmid">24489573</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Bukhari</surname><given-names>S. N. H.</given-names></name>, <name><surname>Jain</surname><given-names>A.</given-names></name>, <name><surname>Haq</surname><given-names>E.</given-names></name>, <name><surname>Mehbodniya</surname><given-names>A.</given-names></name>, and <name><surname>Webber</surname><given-names>J.</given-names></name>, "<article-title>Machine learning techniques for the prediction of B-cell and T-cell epitopes as potential vaccine targets with a specific focus on SARS-CoV-2 pathogen: A review</article-title>," <source><italic toggle="yes">Pathogens</italic></source>, vol. <volume>11</volume>, no. <issue>2</issue>, p. <fpage>146</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/pathogens11020146</pub-id><?supplied-pmid 35215090?><pub-id pub-id-type="pmid">35215090</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Galanis</surname><given-names>K. A.</given-names></name>, <name><surname>Nastou</surname><given-names>K. C.</given-names></name>, <name><surname>Papandreou</surname><given-names>N. C.</given-names></name>, <name><surname>Petichakis</surname><given-names>G. N.</given-names></name>, <name><surname>Pigis</surname><given-names>D. G.</given-names></name>, and <name><surname>Iconomidou</surname><given-names>V. A.</given-names></name>, "<article-title>Linear B-cell epitope prediction for in silico vaccine design: A performance review of methods available via command-line interface</article-title>," <source><italic toggle="yes">International journal of molecular sciences</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>3210</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijms22063210</pub-id><?supplied-pmid 33809918?><pub-id pub-id-type="pmid">33809918</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Attique</surname><given-names>M.</given-names></name>, <name><surname>Alkhalifah</surname><given-names>T.</given-names></name>, <name><surname>Alturise</surname><given-names>F.</given-names></name>, and <name><surname>Khan</surname><given-names>Y. D.</given-names></name>, "<article-title>DeepBCE: Evaluation of deep learning models for identification of immunogenic B-cell epitopes</article-title>," <source><italic toggle="yes">Computational Biology and Chemistry</italic></source>, vol. <volume>104</volume>, p. <fpage>107874</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2023.107874</pub-id><?supplied-pmid 37126975?><pub-id pub-id-type="pmid">37126975</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Vita</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>The immune epitope database (IEDB) 3.0</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>43</volume>, no. <issue>D1</issue>, pp. <fpage>D405</fpage>–<lpage>D412</lpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gku938</pub-id><?supplied-pmid 25300482?><pub-id pub-id-type="pmid">25300482</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>W. L.</given-names></name>, <name><surname>Tsai</surname><given-names>M. J.</given-names></name>, <name><surname>Hsu</surname><given-names>K. T.</given-names></name>, <name><surname>Wang</surname><given-names>J. R.</given-names></name>, <name><surname>Chen</surname><given-names>Y. H.</given-names></name>, and <name><surname>Ho</surname><given-names>S. Y.</given-names></name>, "<article-title>Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development</article-title>," <source><italic toggle="yes">BMC Med Genomics</italic></source>, vol. <volume>8</volume>, no. <issue>Suppl 4</issue>, p. <fpage>S3</fpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1755-8794-8-S4-S3</pub-id><?supplied-pmid 26680271?><pub-id pub-id-type="pmid">26680271</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Garstka</surname><given-names>M. A.</given-names></name><etal>et al.</etal>, "<article-title>The first step of peptide selection in antigen presentation by MHC class I molecules</article-title>," <source><italic toggle="yes">Proc Natl Acad Sci U S A</italic></source>, vol. <volume>112</volume>, no. <issue>5</issue>, pp. <fpage>1505</fpage>–<lpage>10</lpage>, <month>Feb</month><day>3</day><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1416543112</pub-id><?supplied-pmid 25605945?><pub-id pub-id-type="pmid">25605945</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Wieczorek</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation</article-title>," <source><italic toggle="yes">Front Immunol</italic></source>, vol. <volume>8</volume>, p. <fpage>292</fpage>, <year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2017.00292</pub-id><?supplied-pmid 28367149?><pub-id pub-id-type="pmid">28367149</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Piacham</surname><given-names>T.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>iQSP: A Sequence-Based Tool for the Prediction and Analysis of Quorum Sensing Peptides Using Informative Physicochemical Properties</article-title>," <source><italic toggle="yes">International Journal of Molecular Sciences</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, p. <fpage>75</fpage>, <year>2019</year>.<pub-id pub-id-type="pmid">31861928</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name><etal>et al.</etal>, "<article-title>AMYPred-FRL is a novel approach for accurate prediction of amyloid proteins by using feature representation learning</article-title>," <source><italic toggle="yes">Scientific reports</italic></source>, vol. <volume>12</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>14</lpage>, <year>2022</year>.<pub-id pub-id-type="pmid">34992227</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>SAPPHIRE: A stacking-based ensemble learning framework for accurate prediction of thermophilic proteins</article-title>," <source><italic toggle="yes">Computers in Biology and Medicine</italic></source>, p. <fpage>105704</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.105704</pub-id><?supplied-pmid 35690478?><pub-id pub-id-type="pmid">35690478</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, and <name><surname>Manavalan</surname><given-names>B.</given-names></name>, "<article-title>Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework</article-title>," <source><italic toggle="yes">Iscience</italic></source>, vol. <volume>25</volume>, no. <issue>9</issue>, p. <fpage>104883</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.isci.2022.104883</pub-id><?supplied-pmid 36046193?><pub-id pub-id-type="pmid">36046193</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>J.-H.</given-names></name>, <name><surname>Sun</surname><given-names>D.-W.</given-names></name>, and <name><surname>Pu</surname><given-names>H.</given-names></name>, "<article-title>Combining the genetic algorithm and successive projection algorithm for the selection of feature wavelengths to evaluate exudative characteristics in frozen–thawed fish muscle</article-title>," <source><italic toggle="yes">Food chemistry</italic></source>, vol. <volume>197</volume>, pp. <fpage>855</fpage>–<lpage>863</lpage>, <year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.11.019</pub-id><?supplied-pmid 26617027?><pub-id pub-id-type="pmid">26617027</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Welikala</surname><given-names>R. A.</given-names></name><etal>et al.</etal>, "<article-title>Genetic algorithm based feature selection combined with dual classification for the automated detection of proliferative diabetic retinopathy</article-title>," <source><italic toggle="yes">Computerized Medical Imaging and Graphics</italic></source>, vol. <volume>43</volume>, pp. <fpage>64</fpage>–<lpage>77</lpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compmedimag.2015.03.003</pub-id><?supplied-pmid 25841182?><pub-id pub-id-type="pmid">25841182</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Chiangjong</surname><given-names>W.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab172</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab172</pub-id><?supplied-pmid 33963832?><pub-id pub-id-type="pmid">33963832</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackDPPIV: A novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides</article-title>," <source><italic toggle="yes">Methods</italic></source>, vol. <volume>204</volume>, pp. <fpage>189</fpage>–<lpage>198</lpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ymeth.2021.12.001</pub-id><?supplied-pmid 34883239?><pub-id pub-id-type="pmid">34883239</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Qiang</surname><given-names>X.</given-names></name>, <name><surname>Zhou</surname><given-names>C.</given-names></name>, <name><surname>Ye</surname><given-names>X.</given-names></name>, P.-f. Du, R. Su, and L. Wei, "<article-title>CPPred-FL: a sequence-based predictor for large-scale identification of cell-penetrating peptides by feature representation learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, pp. <fpage>11</fpage>–<lpage>23</lpage>, <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bby091</pub-id><?supplied-pmid 30239616?><pub-id pub-id-type="pmid">30239616</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>DeepVF: a deep learning-based hybrid framework for identifying virulence factors using the stacking strategy</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>3</issue>, p. <fpage>bbaa125</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbaa125</pub-id><?supplied-pmid 32599617?><pub-id pub-id-type="pmid">32599617</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>UMPred-FRL: A new approach for accurate prediction of umami peptides using feature representation learning</article-title>," <source><italic toggle="yes">International Journal of Molecular Sciences</italic></source>, vol. <volume>22</volume>, no. <issue>23</issue>, p. <fpage>13124</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijms222313124</pub-id><?supplied-pmid 34884927?><pub-id pub-id-type="pmid">34884927</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref053">
      <label>53</label>
      <mixed-citation publication-type="journal"><name><surname>Arif</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>StackACPred: Prediction of anticancer peptides by integrating optimized multiple feature descriptors with stacked ensemble approach</article-title>," <source><italic toggle="yes">Chemometrics and Intelligent Laboratory Systems</italic></source>, vol. <volume>220</volume>, p. <fpage>104458</fpage>, <year>2022</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref054">
      <label>54</label>
      <mixed-citation publication-type="journal"><name><surname>Wolpert</surname><given-names>D. H.</given-names></name>, "<article-title>Stacked generalization</article-title>," <source><italic toggle="yes">Neural networks</italic>,</source> vol. <volume>5</volume>, no. <issue>2</issue>, pp. <fpage>241</fpage>–<lpage>259</lpage>, <year>1992</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Porpoise: a new approach for accurate prediction of RNA pseudouridine sites</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab245</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab245</pub-id><?supplied-pmid 34226915?><pub-id pub-id-type="pmid">34226915</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Mishra</surname><given-names>A.</given-names></name>, <name><surname>Pokhrel</surname><given-names>P.</given-names></name>, and <name><surname>Hoque</surname><given-names>M. T.</given-names></name>, "<article-title>StackDPPred: a stacking based prediction of DNA-binding protein from sequence</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>3</issue>, pp. <fpage>433</fpage>–<lpage>441</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty653</pub-id><?supplied-pmid 30032213?><pub-id pub-id-type="pmid">30032213</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><name><surname>Dao</surname><given-names>F.-Y.</given-names></name><etal>et al.</etal>, "<article-title>Identify origin of replication in Saccharomyces cerevisiae using two-step feature selection technique</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>12</issue>, pp. <fpage>2075</fpage>–<lpage>2083</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty943</pub-id><?supplied-pmid 30428009?><pub-id pub-id-type="pmid">30428009</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref058">
      <label>58</label>
      <mixed-citation publication-type="journal"><name><surname>Ding</surname><given-names>C.</given-names></name>, <name><surname>Yuan</surname><given-names>L.-F.</given-names></name>, <name><surname>Guo</surname><given-names>S.-H.</given-names></name>, <name><surname>Lin</surname><given-names>H.</given-names></name>, and <name><surname>Chen</surname><given-names>W.</given-names></name>, "<article-title>Identification of mycobacterial membrane proteins and their types using over-represented tripeptide compositions</article-title>," <source><italic toggle="yes">Journal of proteomics</italic></source>, vol. <volume>77</volume>, pp. <fpage>321</fpage>–<lpage>328</lpage>, <year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jprot.2012.09.006</pub-id><?supplied-pmid 23000219?><pub-id pub-id-type="pmid">23000219</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>C.-Q.</given-names></name><etal>et al.</etal>, "<article-title>iTerm-PseKNC: a sequence-based tool for predicting bacterial transcriptional terminators</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>9</issue>, pp. <fpage>1469</fpage>–<lpage>1477</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty827</pub-id><?supplied-pmid 30247625?><pub-id pub-id-type="pmid">30247625</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>H.-Y.</given-names></name><etal>et al.</etal>, "<article-title>iProEP: a computational predictor for predicting promoter</article-title>," <source><italic toggle="yes">Molecular Therapy-Nucleic Acids</italic></source>, vol. <volume>17</volume>, pp. <fpage>337</fpage>–<lpage>346</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.omtn.2019.05.028</pub-id><?supplied-pmid 31299595?><pub-id pub-id-type="pmid">31299595</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref061">
      <label>61</label>
      <mixed-citation publication-type="journal"><name><surname>Pedregosa</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Scikit-learn: Machine learning in Python</article-title>," <source><italic toggle="yes">the Journal of machine Learning research</italic></source>, vol. <volume>12</volume>, pp. <fpage>2825</fpage>–<lpage>2830</lpage>, <year>2011</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref062">
      <label>62</label>
      <mixed-citation publication-type="journal"><name><surname>Azadpour</surname><given-names>M.</given-names></name>, <name><surname>McKay</surname><given-names>C. M.</given-names></name>, and <name><surname>Smith</surname><given-names>R. L.</given-names></name>, "<article-title>Estimating confidence intervals for information transfer analysis of confusion matrices</article-title>," <source><italic toggle="yes">The Journal of the Acoustical Society of America</italic></source>, vol. <volume>135</volume>, no. <issue>3</issue>, pp. <fpage>EL140</fpage>–<lpage>EL146</lpage>, <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1121/1.4865840</pub-id><?supplied-pmid 24606307?><pub-id pub-id-type="pmid">24606307</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref063">
      <label>63</label>
      <mixed-citation publication-type="journal"><name><surname>Mandrekar</surname><given-names>J. N.</given-names></name>, "<article-title>Receiver operating characteristic curve in diagnostic test assessment</article-title>," <source><italic toggle="yes">Journal of Thoracic Oncology</italic></source>, vol. <volume>5</volume>, no. <issue>9</issue>, pp. <fpage>1315</fpage>–<lpage>1316</lpage>, <year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/JTO.0b013e3181ec173d</pub-id><?supplied-pmid 20736804?><pub-id pub-id-type="pmid">20736804</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref064">
      <label>64</label>
      <mixed-citation publication-type="journal"><name><surname>Ullah</surname><given-names>M.</given-names></name>, <name><surname>Han</surname><given-names>K.</given-names></name>, <name><surname>Hadi</surname><given-names>F.</given-names></name>, <name><surname>Xu</surname><given-names>J.</given-names></name>, <name><surname>Song</surname><given-names>J.</given-names></name>, and <name><surname>Yu</surname><given-names>D.-J.</given-names></name>, "<article-title>PScL-HDeep: image-based prediction of protein subcellular location in human tissue using ensemble learning of handcrafted and deep learned features with two-layer feature selection</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab278</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab278</pub-id><?supplied-pmid 34337652?><pub-id pub-id-type="pmid">34337652</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Ashkenazi</surname><given-names>S.</given-names></name>, <name><surname>Snir</surname><given-names>R.</given-names></name>, and <name><surname>Ofran</surname><given-names>Y.</given-names></name>, "<article-title>Assessing the relationship between conservation of function and conservation of sequence using photosynthetic proteins</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>28</volume>, no. <issue>24</issue>, pp. <fpage>3203</fpage>–<lpage>3210</lpage>, <year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bts608</pub-id><?supplied-pmid 23080118?><pub-id pub-id-type="pmid">23080118</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Van Der Maaten</surname><given-names>L.</given-names></name>, "<article-title>Accelerating t-SNE using tree-based algorithms</article-title>," <source><italic toggle="yes">The Journal of Machine Learning Research</italic></source>, vol. <volume>15</volume>, no. <issue>1</issue>, pp. <fpage>3221</fpage>–<lpage>3245</lpage>, <year>2014</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Van der Maaten</surname><given-names>L.</given-names></name> and <name><surname>Hinton</surname><given-names>G.</given-names></name>, "<article-title>Visualizing data using t-SNE</article-title>," <source><italic toggle="yes">Journal of machine learning research</italic></source>, vol. <volume>9</volume>, no. <issue>11</issue>, <year>2008</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>Q.</given-names></name><etal>et al.</etal>, "<article-title>Identification of active molecules against Mycobacterium tuberculosis through machine learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>5</issue>, p. <fpage>bbab068</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab068</pub-id><?supplied-pmid 33822874?><pub-id pub-id-type="pmid">33822874</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Lv</surname><given-names>Z.</given-names></name>, <name><surname>Cui</surname><given-names>F.</given-names></name>, <name><surname>Zou</surname><given-names>Q.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, and <name><surname>Xu</surname><given-names>L.</given-names></name>, "<article-title>Anticancer peptides prediction with deep representation learning features</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>5</issue>, p. <fpage>bbab008</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab008</pub-id><?supplied-pmid 33529337?><pub-id pub-id-type="pmid">33529337</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>C.</given-names></name><etal>et al.</etal>, "<article-title>ILGBMSH: an interpretable classification model for the shRNA target prediction with ensemble learning algorithm</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>6</issue>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbac429</pub-id><?supplied-pmid 36184189?><pub-id pub-id-type="pmid">36184189</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Bi</surname><given-names>Y.</given-names></name><etal>et al.</etal>, "<article-title>Clarion is a multi-label problem transformation method for identifying mRNA subcellular localizations</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>6</issue>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbac467</pub-id><?supplied-pmid 36341591?><pub-id pub-id-type="pmid">36341591</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>H.-L.</given-names></name>, "<article-title>Propensity scores for prediction and characterization of bioluminescent proteins from sequences</article-title>," <source><italic toggle="yes">PloS one</italic></source>, vol. <volume>9</volume>, no. <issue>5</issue>, p. <fpage>e97158</fpage>, <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0097158</pub-id><?supplied-pmid 24828431?><pub-id pub-id-type="pmid">24828431</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref073">
      <label>73</label>
      <mixed-citation publication-type="journal"><name><surname>Vasylenko</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>SCMBYK: prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides</article-title>," <source><italic toggle="yes">BMC bioinformatics</italic></source>, vol. <volume>17</volume>, no. <issue>19</issue>, pp. <fpage>203</fpage>–<lpage>217</lpage>, <year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12859-016-1371-4</pub-id><?supplied-pmid 28155663?><pub-id pub-id-type="pmid">27153986</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref074">
      <label>74</label>
      <mixed-citation publication-type="journal"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>, <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>, <name><surname>Chen</surname><given-names>H.-A.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Huang</surname><given-names>H.-L.</given-names></name>, and <name><surname>Ho</surname><given-names>S.-Y.</given-names></name>, "<article-title>SCMPSP: Prediction and characterization of photosynthetic proteins based on a scoring card method</article-title>," <source>in <italic toggle="yes">BMC bioinformatics</italic></source>, <year>2015</year>, vol. <volume>16</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>16</lpage>: BioMed Central. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2105-16-S1-S8</pub-id><?supplied-pmid 25708243?><pub-id pub-id-type="pmid">25708243</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref075">
      <label>75</label>
      <mixed-citation publication-type="journal"><name><surname>Liou</surname><given-names>Y.-F.</given-names></name><etal>et al.</etal>, "<article-title>SCMMTP: identifying and characterizing membrane transport proteins using propensity scores of dipeptides</article-title>," <source><italic toggle="yes">BMC genomics</italic></source>, vol. <volume>16</volume>, pp. <fpage>1</fpage>–<lpage>14</lpage>, <year>2015</year>.<pub-id pub-id-type="pmid">25553907</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref076">
      <label>76</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>H.-L.</given-names></name><etal>et al.</etal>, "<part-title>Prediction and analysis of protein solubility using a novel scoring card method with dipeptide composition</part-title>," <source>in <italic toggle="yes">BMC bioinformatics</italic></source>, <year>2012</year>, vol. <volume>13</volume>, pp. <fpage>1</fpage>–<lpage>14</lpage>: <collab>Springer</collab>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref077">
      <label>77</label>
      <mixed-citation publication-type="journal"><name><surname>Raoufi</surname><given-names>E.</given-names></name><etal>et al.</etal>, "<article-title>Epitope prediction by novel immunoinformatics approach: a state-of-the-art review</article-title>," <source><italic toggle="yes">International Journal of Peptide Research and Therapeutics</italic></source>, vol. <volume>26</volume>, pp. <fpage>1155</fpage>–<lpage>1163</lpage>, <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10989-019-09918-z</pub-id><?supplied-pmid 32435171?><pub-id pub-id-type="pmid">32435171</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref078">
      <label>78</label>
      <mixed-citation publication-type="journal"><name><surname>FAUCHÈRE</surname><given-names>J. L.</given-names></name>, <name><surname>Charton</surname><given-names>M.</given-names></name>, <name><surname>Kier</surname><given-names>L. B.</given-names></name>, <name><surname>Verloop</surname><given-names>A.</given-names></name>, and <name><surname>Pliska</surname><given-names>V.</given-names></name>, "<article-title>Amino acid side chain parameters for correlation studies in biology and pharmacology</article-title>," <source><italic toggle="yes">International journal of peptide and protein research</italic></source>, vol. <volume>32</volume>, no. <issue>4</issue>, pp. <fpage>269</fpage>–<lpage>278</lpage>, <year>1988</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1399-3011.1988.tb01261.x</pub-id><?supplied-pmid 3209351?><pub-id pub-id-type="pmid">3209351</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref079">
      <label>79</label>
      <mixed-citation publication-type="journal"><name><surname>Dewi</surname><given-names>S. K.</given-names></name>, <name><surname>Ali</surname><given-names>S.</given-names></name>, and <name><surname>Prasasty</surname><given-names>V. D.</given-names></name>, "<article-title>Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus</article-title>," <source><italic toggle="yes">Current computer-aided drug design</italic></source>, vol. <volume>15</volume>, no. <issue>2</issue>, pp. <fpage>120</fpage>–<lpage>135</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/1573409914666181003151222</pub-id><?supplied-pmid 30280672?><pub-id pub-id-type="pmid">30280672</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref080">
      <label>80</label>
      <mixed-citation publication-type="journal"><name><surname>Ivanyi-Nagy</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>Analysis of hepatitis C virus RNA dimerization and core–RNA interactions</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>34</volume>, no. <issue>9</issue>, pp. <fpage>2618</fpage>–<lpage>2633</lpage>, <year>2006</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkl240</pub-id><?supplied-pmid 16707664?><pub-id pub-id-type="pmid">16707664</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref081">
      <label>81</label>
      <mixed-citation publication-type="journal"><name><surname>Mehrpour</surname><given-names>K.</given-names></name>, <name><surname>Mirzaei</surname><given-names>S. A.</given-names></name>, <name><surname>Savardashtaki</surname><given-names>A.</given-names></name>, <name><surname>Nezafat</surname><given-names>N.</given-names></name>, and <name><surname>Ghasemi</surname><given-names>Y.</given-names></name>, "<article-title>Designing an HCV diagnostic kit for common genotypes of the virus in Iran based on conserved regions of core, NS3-protease, NS4A/B, and NS5A/B antigens: an in silico approach</article-title>," <source><italic toggle="yes">Biologia</italic></source>, vol. <volume>76</volume>, pp. <fpage>281</fpage>–<lpage>296</lpage>, <year>2021</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref082">
      <label>82</label>
      <mixed-citation publication-type="journal"><name><surname>Sneath</surname><given-names>P.</given-names></name>, "<article-title>Relations between chemical structure and biological activity in peptides</article-title>," <source><italic toggle="yes">Journal of theoretical biology</italic></source>, vol. <volume>12</volume>, no. <issue>2</issue>, pp. <fpage>157</fpage>–<lpage>195</lpage>, <year>1966</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0022-5193(66)90112-3</pub-id><?supplied-pmid 4291386?><pub-id pub-id-type="pmid">4291386</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref083">
      <label>83</label>
      <mixed-citation publication-type="journal"><name><surname>Dhanda</surname><given-names>S. K.</given-names></name>, <name><surname>Usmani</surname><given-names>S. S.</given-names></name>, <name><surname>Agrawal</surname><given-names>P.</given-names></name>, <name><surname>Nagpal</surname><given-names>G.</given-names></name>, <name><surname>Gautam</surname><given-names>A.</given-names></name>, and <name><surname>Raghava</surname><given-names>G. P.</given-names></name>, "<article-title>Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>18</volume>, no. <issue>3</issue>, pp. <fpage>467</fpage>–<lpage>478</lpage>, <year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbw025</pub-id><?supplied-pmid 27016393?><pub-id pub-id-type="pmid">27016393</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref084">
      <label>84</label>
      <mixed-citation publication-type="journal"><name><surname>Donnison</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>76</volume>, no. <issue>4</issue>, pp. <fpage>1190</fpage>–<lpage>1202</lpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.32470</pub-id><?supplied-pmid 35313015?><pub-id pub-id-type="pmid">35313015</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref085">
      <label>85</label>
      <mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>A. A.</given-names></name>, <name><surname>Chotpatiwetchkul</surname><given-names>W.</given-names></name>, <name><surname>Phanus-Umporn</surname><given-names>C.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors</article-title>," <source><italic toggle="yes">Journal of Computer-Aided Molecular Design</italic></source>, vol. <volume>35</volume>, pp. <fpage>1037</fpage>–<lpage>1053</lpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10822-021-00418-1</pub-id><?supplied-pmid 34622387?><pub-id pub-id-type="pmid">34622387</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref086">
      <label>86</label>
      <mixed-citation publication-type="journal"><name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Anuwongcharoen</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Lio</surname><given-names>P.</given-names></name>’, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackPR is a new computational approach for large-scale identification of progesterone receptor antagonists using the stacking strategy</article-title>," <source><italic toggle="yes">Scientific Reports</italic></source>, vol. <volume>12</volume>, no. <issue>1</issue>, p. <fpage>16435</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-022-20143-5</pub-id><?supplied-pmid 36180453?><pub-id pub-id-type="pmid">36180453</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref087">
      <label>87</label>
      <mixed-citation publication-type="journal"><name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Anuwongcharoen</surname><given-names>N.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists</article-title>," <source><italic toggle="yes">Journal of Cheminformatics</italic></source>, vol. <volume>15</volume>, no. <issue>1</issue>, p. <fpage>50</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13321-023-00721-z</pub-id><?supplied-pmid 37149650?><pub-id pub-id-type="pmid">37149650</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref088">
      <label>88</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>G.</given-names></name><etal>et al.</etal>, "<article-title>TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>24</volume>, no. <issue>3</issue>, p. <fpage>bbad116</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbad116</pub-id><?supplied-pmid 36960769?><pub-id pub-id-type="pmid">36960769</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref089">
      <label>89</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>MHCRoBERTa: pan-specific peptide–MHC class I binding prediction through transfer learning with label-agnostic protein sequences</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>3</issue>, p. <fpage>bbab595</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab595</pub-id><?supplied-pmid 35443027?><pub-id pub-id-type="pmid">35443027</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref090">
      <label>90</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Z.-R.</given-names></name>, <name><surname>Lin</surname><given-names>H. H.</given-names></name>, <name><surname>Han</surname><given-names>L.</given-names></name>, <name><surname>Jiang</surname><given-names>L.</given-names></name>, <name><surname>Chen</surname><given-names>X.</given-names></name>, and <name><surname>Chen</surname><given-names>Y. Z.</given-names></name>, "<article-title>PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>34</volume>, no. <issue>suppl</issue>_2, pp. <fpage>W32</fpage>–<lpage>W37</lpage>, <year>2006</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkl305</pub-id><?supplied-pmid 16845018?><pub-id pub-id-type="pmid">16845018</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref091">
      <label>91</label>
      <mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>K.-C.</given-names></name>, "<article-title>Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, pp. <fpage>10</fpage>–<lpage>19</lpage>, <year>2005</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bth466</pub-id><?supplied-pmid 15308540?><pub-id pub-id-type="pmid">15308540</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref092">
      <label>92</label>
      <mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>K. C.</given-names></name>, "<article-title>Prediction of protein cellular attributes using pseudo‐amino acid composition</article-title>," <source><italic toggle="yes">Proteins</italic>: <italic toggle="yes">Structure</italic>, <italic toggle="yes">Function</italic>, <italic toggle="yes">and Bioinformatics</italic></source>, vol. <volume>43</volume>, no. <issue>3</issue>, pp. <fpage>246</fpage>–<lpage>255</lpage>, <year>2001</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/prot.1035</pub-id><?supplied-pmid 11288174?><pub-id pub-id-type="pmid">11288174</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref093">
      <label>93</label>
      <mixed-citation publication-type="journal"><name><surname>Tomii</surname><given-names>K.</given-names></name> and <name><surname>Kanehisa</surname><given-names>M.</given-names></name>, "<article-title>Analysis of amino acid indices and mutation matrices for sequence comparison and structure prediction of proteins</article-title>," <source><italic toggle="yes">Protein Engineering</italic></source>, <source><italic toggle="yes">Design and Selection</italic></source>, vol. <volume>9</volume>, no. <issue>1</issue>, pp. <fpage>27</fpage>–<lpage>36</lpage>, <year>1996</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/protein/9.1.27</pub-id>
<?supplied-pmid 9053899?><pub-id pub-id-type="pmid">9053899</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref094">
      <label>94</label>
      <mixed-citation publication-type="journal"><name><surname>Dubchak</surname><given-names>I.</given-names></name>, <name><surname>Muchnik</surname><given-names>I.</given-names></name>, <name><surname>Holbrook</surname><given-names>S. R.</given-names></name>, and <name><surname>Kim</surname><given-names>S.-H.</given-names></name>, "<article-title>Prediction of protein folding class using global description of amino acid sequence</article-title>," <source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source>, vol. <volume>92</volume>, no. <issue>19</issue>, pp. <fpage>8700</fpage>–<lpage>8704</lpage>, <year>1995</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.92.19.8700</pub-id><?supplied-pmid 7568000?><pub-id pub-id-type="pmid">7568000</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref095">
      <label>95</label>
      <mixed-citation publication-type="journal"><name><surname>Ahmad</surname><given-names>S.</given-names></name><etal>et al.</etal>, "<article-title>SCORPION is a stacking-based ensemble learning framework for accurate prediction of phage virion proteins</article-title>," <source><italic toggle="yes">Scientific reports</italic>,</source> vol. <volume>12</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>15</lpage>, <year>2022</year>.<pub-id pub-id-type="pmid">34992227</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLOS ONE</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10456195</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pone.0290538</article-id>
    <article-id pub-id-type="publisher-id">PONE-D-23-17727</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>RNA viruses</subject>
              <subj-group>
                <subject>Flaviviruses</subject>
                <subj-group>
                  <subject>Hepacivirus</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Medical microbiology</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Flaviviruses</subject>
                  <subj-group>
                    <subject>Hepacivirus</subject>
                    <subj-group>
                      <subject>Hepatitis C virus</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and health sciences</subject>
        <subj-group>
          <subject>Pathology and laboratory medicine</subject>
          <subj-group>
            <subject>Pathogens</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Flaviviruses</subject>
                  <subj-group>
                    <subject>Hepacivirus</subject>
                    <subj-group>
                      <subject>Hepatitis C virus</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>Viral pathogens</subject>
              <subj-group>
                <subject>Flaviviruses</subject>
                <subj-group>
                  <subject>Hepacivirus</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Medical microbiology</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Hepatitis viruses</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and health sciences</subject>
        <subj-group>
          <subject>Pathology and laboratory medicine</subject>
          <subj-group>
            <subject>Pathogens</subject>
            <subj-group>
              <subject>Microbial pathogens</subject>
              <subj-group>
                <subject>Viral pathogens</subject>
                <subj-group>
                  <subject>Hepatitis viruses</subject>
                  <subj-group>
                    <subject>Hepatitis C virus</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>Viral pathogens</subject>
              <subj-group>
                <subject>Hepatitis viruses</subject>
                <subj-group>
                  <subject>Hepatitis C virus</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Molecular Biology</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Sequencing Techniques</subject>
              <subj-group>
                <subject>Protein Sequencing</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Molecular Biology Techniques</subject>
          <subj-group>
            <subject>Sequencing Techniques</subject>
            <subj-group>
              <subject>Protein Sequencing</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Blood Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                  <subj-group>
                    <subject>T Cells</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Immune Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                  <subj-group>
                    <subject>T Cells</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
              <subj-group>
                <subject>T Cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
              <subj-group>
                <subject>T Cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Chemistry</subject>
          <subj-group>
            <subject>Chemical Properties</subject>
            <subj-group>
              <subject>Physicochemical Properties</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Chemistry</subject>
          <subj-group>
            <subject>Physical Chemistry</subject>
            <subj-group>
              <subject>Chemical Properties</subject>
              <subj-group>
                <subject>Physicochemical Properties</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Physics</subject>
          <subj-group>
            <subject>Physical Properties</subject>
            <subj-group>
              <subject>Physicochemical Properties</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Infectious Disease Control</subject>
              <subj-group>
                <subject>Vaccines</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Infectious Disease Control</subject>
              <subj-group>
                <subject>Vaccines</subject>
                <subj-group>
                  <subject>Viral Vaccines</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Vaccines</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Immune Physiology</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Immune System Proteins</subject>
              <subj-group>
                <subject>Antibodies</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Vaccination and Immunization</subject>
            <subj-group>
              <subject>Vaccine Development</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Vaccination and Immunization</subject>
            <subj-group>
              <subject>Vaccine Development</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Public and Occupational Health</subject>
          <subj-group>
            <subject>Preventive Medicine</subject>
            <subj-group>
              <subject>Vaccination and Immunization</subject>
              <subj-group>
                <subject>Vaccine Development</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TROLLOPE: A novel sequence-based stacked approach for the accelerated discovery of linear T-cell epitopes of hepatitis C virus</article-title>
      <alt-title alt-title-type="running-head">TROLLOPE</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Charoenkwan</surname>
          <given-names>Phasit</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Waramit</surname>
          <given-names>Sajee</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chumnanpuen</surname>
          <given-names>Pramote</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schaduangrat</surname>
          <given-names>Nalini</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Modern Management and Information Technology, College of Arts, Media and Technology, Chiang Mai University, Chiang Mai, Thailand</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, Thailand</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Omics Center for Agriculture, Bioresources, Food, and Health, Kasetsart University (OmiKU), Bangkok, Thailand</addr-line>
    </aff>
    <aff id="aff004">
      <label>4</label>
      <addr-line>Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Raju</surname>
          <given-names>Nagarajan</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Emory University, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>watshara.sho@mahidol.ac.th</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>18</volume>
    <issue>8</issue>
    <elocation-id>e0290538</elocation-id>
    <history>
      <date date-type="received">
        <day>7</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>10</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Charoenkwan et al</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Charoenkwan et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pone.0290538.pdf"/>
    <abstract>
      <p>Hepatitis C virus (HCV) infection is a concerning health issue that causes chronic liver diseases. Despite many successful therapeutic outcomes, no effective HCV vaccines are currently available. Focusing on T cell activity, the primary effector for HCV clearance, T cell epitopes of HCV (TCE-HCV) are considered promising elements to accelerate HCV vaccine efficacy. Thus, accurate and rapid identification of TCE-HCVs is recommended to obtain more efficient therapy for chronic HCV infection. In this study, a novel sequence-based stacked approach, termed TROLLOPE, is proposed to accurately identify TCE-HCVs from sequence information. Specifically, we employed 12 different sequence-based feature descriptors from heterogeneous perspectives, such as physicochemical properties, composition-transition-distribution information and composition information. These descriptors were used in cooperation with 12 popular machine learning (ML) algorithms to create 144 base-classifiers. To maximize the utility of these base-classifiers, we used a feature selection strategy to determine a collection of potential base-classifiers and integrated them to develop the meta-classifier. Comprehensive experiments based on both cross-validation and independent tests demonstrated the superior predictive performance of TROLLOPE compared with conventional ML classifiers, with cross-validation and independent test accuracies of 0.745 and 0.747, respectively. Finally, a user-friendly online web server of TROLLOPE (<ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>) has been developed to serve research efforts in the large-scale identification of potential TCE-HCVs for follow-up experimental verification.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution>National Research Council of Thailand and Mahidol University</institution>
        </funding-source>
        <award-id>N42A660380</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>Watshara</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution>Specific League Funds from Mahidol University</institution>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3394-8709</contrib-id>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>Watshara</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This project is funded by National Research Council of Thailand (NRCT) and Mahidol University (N42A660380), and the Specific League Funds from Mahidol University.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="7"/>
      <table-count count="6"/>
      <page-count count="22"/>
    </counts>
    <custom-meta-group>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All the data used in this study are available at <ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All the data used in this study are available at <ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>1. Introduction</title>
    <p>Hepatitis C Virus (HCV) is an RNA virus that is associated with progressive liver damage. This virus usually transmits through the contact of blood from an infected person, including the reuse of substandard medical equipment in healthcare settings and the sharing of contaminated needles and syringes in injection drug users (IDU). HCV infection often leads to curable acute hepatitis C; however, it can also result in an asymptomatic chronic condition that can lead to serious illnesses, including liver fibrosis, cirrhosis, and even fatal hepatocellular carcinoma [<xref rid="pone.0290538.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0290538.ref002" ref-type="bibr">2</xref>]. By combining translational and clinical research efforts, treatments for HCV have evolved from recombinant interferon α (IFNα) and nucleoside analogue ribavirin (RBV) to direct-acting antiviral agents (DAAs). These treatment options can be administered as monotherapy or in combination to achieve superior outcomes [<xref rid="pone.0290538.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0290538.ref004" ref-type="bibr">4</xref>]. Currently, treatment approaches primarily focus on pan-genotypic regimens designed to target multiple viral non-structural (NS) complexes that aim to achieve high efficiency in treating most HCV genotypes [<xref rid="pone.0290538.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0290538.ref006" ref-type="bibr">6</xref>]. Despite the success of HCV therapeutic schemes, access to diagnosis and treatment remains limited in certain populations. According to the World Health Organization (WHO), approximately 58 million people worldwide are affected by chronic HCV infection, yet only 21% of them have been clinically diagnosed. Additionally, the disease is also responsible for approximately 400,000 deaths each year due to cirrhosis and hepatocellular carcinoma [<xref rid="pone.0290538.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0290538.ref008" ref-type="bibr">8</xref>]. This is considered inconsistent with the announcement to reduce new HCV infections by 90% by 2030 and achieve complete HCV elimination as the ultimate goal. According to WHO, the number of diagnosed HCV patients is underestimated, and access to the tests is still limited in some populations. Therefore, HCV vaccine development is essentially required to prevent transmission. An effective HCV vaccine will greatly impact the control of the disease, especially among IDUs. It is worth noting that the process of vaccine production should be cost-effective to ensure worldwide fair access. Despite substantial positive outcomes in treating HCV patients, the lack of available preventative vaccines hinders significant progress toward the goal of HCV elimination [<xref rid="pone.0290538.ref009" ref-type="bibr">9</xref>].</p>
    <p>One major challenge in vaccine development is the genetic diversity of HCV, which consists of 8 genotypes and 86 subtypes. These variants exhibit approximately 30 percent variability in amino acids compared to each other [<xref rid="pone.0290538.ref010" ref-type="bibr">10</xref>]. To achieve the greatest benefit, an ideal vaccine should focus on targeting the genetically conserved regions of the HCV genome. This approach would broaden the immune response across multiple genotypes and involve both humoral and cellular immunity, thereby maximizing the chance of success. Many studies have demonstrated the feasibility of neutralizing HCV infection through the transfer of polyclonal antibodies obtained from chronic HCV patients to chimeric mice and chimpanzees [<xref rid="pone.0290538.ref011" ref-type="bibr">11</xref>–<xref rid="pone.0290538.ref013" ref-type="bibr">13</xref>]. Nonetheless, the envelope genes (E1 and E2) of HCV exhibit significant diversity, resulting in a wide range of evolved epitopes that are resistant to antibody binding. This evolutionary adaptation benefits the viral escape from immune responses [<xref rid="pone.0290538.ref014" ref-type="bibr">14</xref>–<xref rid="pone.0290538.ref016" ref-type="bibr">16</xref>]. Additionally, the specific roles of antibodies in combating HCV infection have not been clearly defined yet, which further complicates the development of antibody-based vaccines [<xref rid="pone.0290538.ref016" ref-type="bibr">16</xref>]. In contrast, several vaccine studies have concentrated on enhancing HCV-specific T-cell activity [<xref rid="pone.0290538.ref017" ref-type="bibr">17</xref>]. Specifically, CD4<sup>+</sup> T cells play a crucial role in maintaining T-cell populations, while CD8<sup>+</sup> T cells serve as the primary effectors responsible for eliminating viral-infected cells [<xref rid="pone.0290538.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0290538.ref021" ref-type="bibr">21</xref>]. To date, various non-structural proteins (NS) of HCV have been found to possess prominent targeting features for CD8<sup>+</sup> T cells, indicating the feasibility of vaccine development. However, this strategy essentially relies on the presence of HCV antigenic peptides in an HLA-restricted manner [<xref rid="pone.0290538.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0290538.ref023" ref-type="bibr">23</xref>].</p>
    <p>Until now, several HCV vaccine platforms, such as DNA-based immunization, virus-like particles (VLPs), and short peptide- or epitope-encapsulating lysosomes [<xref rid="pone.0290538.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0290538.ref026" ref-type="bibr">26</xref>], have demonstrated promising outcomes in terms of HCV protection. However, some of these still need particular improvements to enhance their effectiveness [<xref rid="pone.0290538.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0290538.ref028" ref-type="bibr">28</xref>]. One of the challenges lies in the rational design of immunogenic epitopes [<xref rid="pone.0290538.ref029" ref-type="bibr">29</xref>], as the traditional vaccine design approaches are considered less effective for HCV due to high genome heterogeneity and mutagenicity [<xref rid="pone.0290538.ref030" ref-type="bibr">30</xref>]. Thus, an alternative approach is required, and <italic toggle="yes">in silico</italic> studies have shown great benefits by predicting immunogenic epitopes to be incorporated into the vaccine platform and enhance its efficacy. Many <italic toggle="yes">in silico</italic> predictions of TCE-HCV have demonstrated promising outcomes in terms of cytotoxic T cell responses in BALB/c and transgenic mice. These findings suggest the potential of HCV-polytope vaccine candidates. However, some of the predicted epitopes have achieved only marginal success and require additional support [<xref rid="pone.0290538.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0290538.ref033" ref-type="bibr">33</xref>]. Therefore, it is desirable to accurately identify TCE-HCV using sequence information alone, without relying on structural information, before embarking on costly <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> investigations.</p>
    <p>To date, several computational approaches have been developed to complement experimental studies in the identification of TCEs. For example, Dhanda et al. [<xref rid="pone.0290538.ref034" ref-type="bibr">34</xref>] developed a support vector machine (SVM)-based predictor, named IL4pred, to predict IL4 inducing peptides. They constructed a benchmark dataset consisting of 904 IL4 inducing and 742 non-IL4 inducing peptides. Using this dataset, various sequence-based feature descriptors were employed, such as amino acid composition (AAC), amino acids pair (AAP), dipeptide composition (DPC), and motif information, to train IL4pred. Among the feature descriptors, AAP and motif information were selected for the development of IL4pred. IL4pred achieved cross-validation and independent test accuracies of 0.758 and 0.690, respectively. Further information regarding related computational approaches developed for the identification of TCEs can be found in references [<xref rid="pone.0290538.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0290538.ref037" ref-type="bibr">37</xref>]. However, at present, there is no sequence-based predictor specifically designed for identifying and characterizing TCE-HCVs. Keeping this issue in mind, we present a novel sequence-based stacked approach, termed TROLLOPE (predicToR Of Linear t-ceLl epitOPEs of hepatitis C virus), to specifically identify TCE-HCVs using primary sequence information. To the best of our knowledge, TROLLOPE is the first computational approach developed for specifically identifying TCE-HCVs. To develop TROLLOPE, we first constructed a benchmark dataset consisting of 446 TCE-HCVs and 525 non-TCE-HCVs. Based on this dataset, we extracted 12 different types of sequence-based feature encoding schemes from several perspectives, such as physicochemical properties, composition-transition-distribution information and composition information. These feature descriptors were then used to create 144 base-classifiers by using 12 powerful ML algorithms. To maximize the performance of TROLLOPE, we employed a customized genetic algorithm to determine a collection of potential base-classifiers and integrated them to develop the meta-classifier using the stacking strategy. Experimental results demonstrate that TROLLOPE outperforms conventional ML classifiers, achieving superior performance.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>2. Materials and methods</title>
    <sec id="sec003">
      <title>2.1 Overall framework of TROLLOPE</title>
      <p>As seen in <bold><xref rid="pone.0290538.g001" ref-type="fig">Fig 1</xref></bold>, the development and performance assessment of TROLLOPE involve five main steps: dataset preparation, feature representation, stacked model development, performance evaluation, and online web server deployment. In the first step, we collected the positive and negative datasets from the IEDB database [<xref rid="pone.0290538.ref038" ref-type="bibr">38</xref>]. In the second step, we employed well-known feature encoding schemes to represent TCE-HCVs and non-TCE-HCVs. After that, in the development of stacked model, it consists of two levels of learning stages. The classifiers developed in the first and second stages are known as the base-classifier and meta-classifier, respectively. In the fourth step, we assessed the performance of base-classifiers and meta-classifiers to conduct a comparative analysis and select the final stacked model. Finally, the best stacked model was employed to develop an online web server, providing convenient identification of TCE-HCVs.</p>
      <fig position="float" id="pone.0290538.g001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>System flowchart of the proposed TROLLOPE.</title>
          <p>The development and performance assessment of TROLLOPE involves five main steps: dataset preparation, feature representation, stacked model development, performance evaluation, and online web server deployment.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g001" position="float"/>
      </fig>
    </sec>
    <sec id="sec004">
      <title>2.2 Data collection and curation</title>
      <p>According to the previously established B-cell response of the HCV dataset [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>], the positive and negative samples were collected from Immune Epitope Database (IEDB) version 2.26. Specifically, the dataset used in this study was created by selecting “Hepatitis C virus” (ID 11103) as the source organism. The main criteria for the inclusion of experimental outcomes were related to T cell assays in human, mouse and non-human primates. Among these, peptide sequences annotated as ‘positive’ were considered as the positive samples (referred to as TCE-HCVs) whereas those annotated as ‘negative’ were included as the negative samples (referred to as non-TCE-HCVs). The length of peptide sequences was filtered to 8–10 amino acid residues to select compatible epitopes capable of being accommodated through HLA I molecules and recognizing by CD8<sup>+</sup> T cells [<xref rid="pone.0290538.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0290538.ref041" ref-type="bibr">41</xref>]. As a result, we obtained 711 TCE-HCVs and 790 non-TCE-HCVs. Among these sequences, redundant samples were excluded using Venny (<ext-link xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html" ext-link-type="uri">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>). Therefore, 446 TCE-HCVs and 525 non-TCE-HCVs were considered as the benchmark dataset and used for constructing the proposed model. Finally, the benchmark dataset was randomly divided to generate the training and independent test datasets, comprising 80% (i.e., 357 TCE-HCVs and 420 non-TCE-HCVs) and 20% (i.e., 89 TCE-HCVs and 105 non-TCE-HCVs) of the data, respectively.</p>
    </sec>
    <sec id="sec005">
      <title>2.3 Informative feature selection</title>
      <p>In this study, our customized genetic algorithm, called GA-SAR [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>], was employed to determine informative features while securing high prediction performance [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>–<xref rid="pone.0290538.ref045" ref-type="bibr">45</xref>]. In general, GA-SAR is categorized as one of commonly-used non-deterministic methods that utilize the biological evolution of a population [<xref rid="pone.0290538.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0290538.ref047" ref-type="bibr">47</xref>]. The GA-SAR’s chromosome used herein comprises binary for feature selection and parametric genes for ML parameter optimization. The feature importance selection based on the GA-SAR method can be described as follows. First, we randomly constructed an initial population of <italic toggle="yes">Pop</italic> individuals and assess the performance of all <italic toggle="yes">Pop</italic> individuals based on the 10-fold cross-validation test. Second, we utilize a commonly-used tournament selection to obtain the best <italic toggle="yes">Pop</italic> for constructing a mating pool. Third, the self-assessment-report operation (SAR) between the best <italic toggle="yes">Pop</italic> and each other individual <italic toggle="yes">Pop</italic> was used to create the new children. Finally, the maximum number of generations is used as the stopping condition. Herein, the parameters and their values for the GA-SAR contain <italic toggle="yes">r</italic><sub><italic toggle="yes">begin</italic></sub>  =  5, <italic toggle="yes">m</italic><sub><italic toggle="yes">stop</italic></sub>   =   20, <italic toggle="yes">P</italic><sub><italic toggle="yes">m</italic></sub>  =   0.05, and <italic toggle="yes">Pop</italic> = 20 [<xref rid="pone.0290538.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0290538.ref049" ref-type="bibr">49</xref>]. Detailed information about this algorithm is reported in our previous studies [<xref rid="pone.0290538.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0290538.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>].</p>
    </sec>
    <sec id="sec006">
      <title>2.4 Stacked model development</title>
      <p>Ensemble learning strategies integrate heterogeneous outputs from different prediction models to create a single prediction. These strategies include average scoring, majority voting, and the stacking strategy [<xref rid="pone.0290538.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0290538.ref051" ref-type="bibr">51</xref>]. Among these strategies, stacking is known as the most powerful one [<xref rid="pone.0290538.ref049" ref-type="bibr">49</xref>–<xref rid="pone.0290538.ref053" ref-type="bibr">53</xref>]. This approach was first presented by Wolpert [<xref rid="pone.0290538.ref054" ref-type="bibr">54</xref>] to improve prediction performance. Therefore, we employed the stacking strategy to develop TROLLOPE. In general, the stacking ensemble framework consists of two main levels of learning stages, where the prediction models developed from the first and second learning stages are referred to as the base-classifier and meta-classifier, respectively. The design and development process of TROLLOPE is illustrated in <bold><xref rid="pone.0290538.g001" ref-type="fig">Fig 1</xref></bold>.</p>
      <p>In the first learning stage, we employ 12 different ML algorithms (ADA, DT, ET, KNN, LGBM, LR, MLP, NB, PLS, RF, SVM, and XGB) to obtain the crucial pattern of TCE-HCV [<xref rid="pone.0290538.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0290538.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0290538.ref056" ref-type="bibr">56</xref>]. Then, each ML algorithm was train with 12 well-known feature descriptors (AAC, AAI, APAAC, CTD, CTDC, CTDD, CTDT, DDE, DPC, PAAC, PCP and TPC [<xref rid="pone.0290538.ref057" ref-type="bibr">57</xref>–<xref rid="pone.0290538.ref060" ref-type="bibr">60</xref>]) to construct 12 base-classifiers. The details of all the feature encodings and ML methods used herein are recorded in <bold><xref rid="pone.0290538.t001" ref-type="table">Table 1</xref></bold> and <bold>S1 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, respectively. As a result, 144 base-classifiers were obtained by using the Scikit-learn package in Python programming language [<xref rid="pone.0290538.ref061" ref-type="bibr">61</xref>]. Specifically, a grid search based on the 10-fold cross-validation procedure was used to determine the optimal parameters of all the 144 base-classifiers and avoid overfitting. Here, the base-classifiers having the highest area under the receiver operating characteristics (ROC) curve (AUC) were deemed as the powerful classifiers.</p>
      <table-wrap position="float" id="pone.0290538.t001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Summary of 12 different feature descriptors along with their corresponding description and dimension.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t001" id="pone.0290538.t001g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Descriptors<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Description</th>
                <th align="left" rowspan="1" colspan="1">Dimension</th>
                <th align="left" rowspan="1" colspan="1">Reference</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">AAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 20 amino acids</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">20</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">AAI</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">All biochemical and biophysical properties extracted from the AAindex database</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">531</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">APAAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Amphiphilic pseudo-amino acid composition</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">22</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref091" ref-type="bibr">91</xref>, <xref rid="pone.0290538.ref092" ref-type="bibr">92</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTD</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Composition, transition and distribution</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">273</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Percentage of particular amino acid property groups</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDD</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Percentage of mutual conversion in amino acid properties</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">CTDT</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Distribution of amino acid properties in sequences</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">105</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0290538.ref093" ref-type="bibr">93</xref>, <xref rid="pone.0290538.ref094" ref-type="bibr">94</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">DDE</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Dipeptide deviation from expected mean</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">400</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">DPC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 400 dipeptides</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">400</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">PAAC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Pseudo amino acid composition</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">21</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref091" ref-type="bibr">91</xref>, <xref rid="pone.0290538.ref092" ref-type="bibr">92</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">PCP</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Selected important physical and chemical properties</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">11</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref048" ref-type="bibr">48</xref>]</td>
              </tr>
              <tr>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">TPC</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Frequency of 8000 tripeptides</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">8000</td>
                <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">[<xref rid="pone.0290538.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0290538.ref095" ref-type="bibr">95</xref>]</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="t001fn001">
            <p><sup>a</sup>AAC: amino acid composition, AAI: amino acid composition and physicochemical properties, APAAC: pseudo amino acid composition, CTD: composition translation and distribution, CTDC: CTD composition, CTDT: CTD distribution (CTDT), CTDT: CTD transition (CTDT), DDE: dipeptide deviation from expected mean, DPC: dipeptide composition, PAAC: pseudo amino acid composition, PCP: physicochemical properties, TPC: tripeptide composition.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In the second step, we utilized each base-classifier to generate a probabilistic feature (PF) exhibiting the probabilistic score of being TCE-HCV. To be specific, we randomly divided the training dataset into 10 subsets (i.e., <inline-formula id="pone.0290538.e001"><alternatives><graphic xlink:href="pone.0290538.e001.jpg" id="pone.0290538.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1,2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>10</mml:mn></mml:math></alternatives></inline-formula>) based on the 10-fold cross-validation procedure. In the stacking strategy, each D<sub>i</sub> was treated as the validation set, while the remaining nine subsets was treated as the training set, which was used for training a subset-based prediction model. Then, 10 subset-based prediction models were obtained and used to calculate 10 different probabilistic scores for each peptide sequence on the independent test dataset. Thus, the 10 different probabilistic scores were averaged to create the PF. As a result, 144 PFs derived from all the 144 base-classifiers were obtained and used to construct a new probabilistic feature vector (referred to as APF). For a given sequence <italic toggle="yes">P</italic>, its probabilistic feature vector can be represented as follows:
<disp-formula id="pone.0290538.e002"><alternatives><graphic xlink:href="pone.0290538.e002.jpg" id="pone.0290538.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mn>1,3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">j</mml:mi><mml:mo>=</mml:mo><mml:mn>1,2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>12</mml:mn></mml:math></alternatives><label>(1)</label></disp-formula>
where PF<sub>i,j</sub> is the probabilistic feature generated by the base-classifier trained with the <italic toggle="yes">i</italic><sup><italic toggle="yes">th</italic></sup> ML algorithm in conjunction with the <italic toggle="yes">j</italic><sup><italic toggle="yes">th</italic></sup> feature encoding. Finally, the APF is represented with a 144-D probabilistic feature vector.</p>
      <p>In the third learning stage, we utilized the APF to train the PLS-based meta-classifier. In the meanwhile, to enhance the performance of the meta-classifier, we used the GA-SAR method to determine <italic toggle="yes">m</italic> informative PFs, where <italic toggle="yes">m</italic> &lt;&lt; 144. The GA-SAR’s chromosome used herein comprises 144 genes and 10-bit gene for encoding #Components of PLS-based meta-classifier, where #Components ∈ {10, 20, 30, 40, …, 1000} (<bold>S1 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>). By doing this, we obtained a <italic toggle="yes">m</italic>-D probabilistic feature vector (referred to as OPF) generated from the selected base-classifiers. Finally, we obtained two PLS-based meta-classifiers and selected the best-performing one for TROLLOPE construction based on the cross-validation AUC.</p>
    </sec>
    <sec id="sec007">
      <title>2.5 Statistical metrics</title>
      <p>The performance of the proposed model and related conventional ML classifiers was determined using five standard evaluation metrics, including AUC, sensitivity (Sn), specificity (Sp), accuracy (ACC), and Matthew’s correlation coefficient (MCC) [<xref rid="pone.0290538.ref062" ref-type="bibr">62</xref>–<xref rid="pone.0290538.ref064" ref-type="bibr">64</xref>]. These evaluation metrics are computed as follows:
<disp-formula id="pone.0290538.e003"><alternatives><graphic xlink:href="pone.0290538.e003.jpg" id="pone.0290538.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(2)</label></disp-formula>
<disp-formula id="pone.0290538.e004"><alternatives><graphic xlink:href="pone.0290538.e004.jpg" id="pone.0290538.e004g" position="anchor"/><mml:math id="M4" display="block" overflow="scroll"><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(3)</label></disp-formula>
<disp-formula id="pone.0290538.e005"><alternatives><graphic xlink:href="pone.0290538.e005.jpg" id="pone.0290538.e005g" position="anchor"/><mml:math id="M5" display="block" overflow="scroll"><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives><label>(4)</label></disp-formula>
<disp-formula id="pone.0290538.e006"><alternatives><graphic xlink:href="pone.0290538.e006.jpg" id="pone.0290538.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>)</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac></mml:math></alternatives><label>(5)</label></disp-formula>
where TN represents true negatives (e.g., the number of correctly predicted non-TCE-HCV) and TP represents true positives (e.g., the number of correctly predicted TCE-HCVs). On the other hand, FN represents false negatives (e.g., the number of TCE-HCVs predicted as non-TCE-HCVs), while FP represents false positives (e.g., the number of non-TCE-HCVs predicted as TCE-HCVs).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec008">
    <title>3. Results and discussion</title>
    <sec id="sec009">
      <title>3.1 Performance evaluation of different feature encodings and ML methods</title>
      <p>In this section, we investigated the prediction capability of various base-classifiers trained with different feature encodings and ML methods in TCE-HCV prediction. For each base-classifier, we evaluated its performance using both the 10-fold cross-validation and independent tests. As mentioned earlier, we determined the best-performing base-classifiers in terms of cross-validation AUC. The detailed results of the10-fold cross-validation and independent tests for all the 144 BCs are recorded in <bold>Figs <xref rid="pone.0290538.g002" ref-type="fig">2</xref> and <xref rid="pone.0290538.g003" ref-type="fig">3</xref></bold> and <bold>S2, S3 Tables in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. From <bold><xref rid="pone.0290538.g002" ref-type="fig">Fig 2</xref></bold>, we notice that 8 out of the 10 top-ranked powerful base-classifiers were developed based on DDE, DPC, and TPC, i.e., SVM-TPC, LR-TPC, SVM-DDE, RF-TPC, RF-DDE, SVM-DPC, RF-DPC, NB-TPC, and ET-DPC with corresponding AUC values of 0.791, 0.786, 0.780, 0.772, 0.771, 0.769, 0.769, 0.768, 0.762, respectively. This indicates that these three feature descriptors are beneficial in TCE-HCV prediction. Interestingly, the AUC values of SVM-TPC and LR-TPC were over 0.780 in terms of the 10-fold cross-validation test. It could be stated that SVM-TPC is deemed as the best-performing classifier in TCE-HCV prediction. As seen in <bold>S2 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, the ACC, Sn, Sp, and MCC of SVM-TPC were 0.696, 0.440, 0.914, and 0.407, respectively. On the other hand, this base-classifier achieved the eighth highest AUC of 0.798 in the independent test results, while the highest AUC of 0.833 was achieved by ET-CTDT (<bold>S3 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>). These results demonstrate that the single feature-based models provide a less stable performance for TCE-HCV prediction. Thus, we were motived to develop a stacked model by integrating heterogonous ML classifiers in order to yield a more accurate and stable TCE-HCV prediction.</p>
      <fig position="float" id="pone.0290538.g002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Performance evaluations of top-30 base-classifiers.</title>
          <p>(<bold>A-B</bold>) Cross-validation AUC and ACC of top-30 base-classifiers. (<bold>C-D</bold>) Independent AUC and ACC of top-30 base-classifiers.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g002" position="float"/>
      </fig>
      <fig position="float" id="pone.0290538.g003">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <p>Performance comparison of TROLLOPE and top-five base-classifiers on the training (<bold>A–B</bold>) and independent (<bold>C–D</bold>) datasets.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g003" position="float"/>
      </fig>
    </sec>
    <sec id="sec010">
      <title>3.2 Construction and optimization of stacked models</title>
      <p>As mentioned above, we developed RF-based meta-classifiers that cooperate with two new probabilistic feature vectors, namely APF and OPF. The APF and OPF are represented with 144-D and <italic toggle="yes">m</italic>-D probabilistic feature vectors, respectively. The optimal number of <italic toggle="yes">m</italic> out of 144 probabilistic features was determined using the GA-SAR method. After optimizing the 144-D probabilistic feature vector, the optimal number of <italic toggle="yes">m</italic> was found to be 6. Specifically, the top-six informative probabilistic features were generated based on six different base-classifiers, inducing SVM-TPC, RF-CTDD, SVM-DDE, XGB-AAI, XGB-PCP, and ET-APAAC. The performance of the APF and OPF was evaluated based on both the 10-fold cross-validation and independent tests (<bold><xref rid="pone.0290538.t002" ref-type="table">Table 2</xref></bold>). As can be seen from <bold><xref rid="pone.0290538.t002" ref-type="table">Table 2</xref></bold>, the OPF outperforms APF in terms of the 10-fold cross-validation results, with a 4.90% increase in ACC, a 4.21% increase in Sn, a 5.48% increase in Sp, a 9.75% increase in MCC, and a 1.65% increase in AUC. In terms of the performance on the independent test dataset, the OPF achieved the best AUC, ACC, and MCC with an increase of 1.11, 1.03 and 2.42%, respectively. Altogether, the OPF in conjunction with the RF-based meta-classifier was selected for the construction of TROLLOPE.</p>
      <table-wrap position="float" id="pone.0290538.t002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Cross-validation and independent test results of stacked models trained with APF and OPF feature vectors.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t002" id="pone.0290538.t002g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">Dimension</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">SP</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">APF</td>
                <td align="left" rowspan="1" colspan="1">144</td>
                <td align="left" rowspan="1" colspan="1">0.696</td>
                <td align="left" rowspan="1" colspan="1">0.644</td>
                <td align="left" rowspan="1" colspan="1">0.740</td>
                <td align="left" rowspan="1" colspan="1">0.389</td>
                <td align="left" rowspan="1" colspan="1">0.792</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">OPF</td>
                <td align="left" rowspan="1" colspan="1">15</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">APF</td>
                <td align="left" rowspan="1" colspan="1">144</td>
                <td align="left" rowspan="1" colspan="1">0.737</td>
                <td align="left" rowspan="1" colspan="1">0.652</td>
                <td align="left" rowspan="1" colspan="1">0.810</td>
                <td align="left" rowspan="1" colspan="1">0.469</td>
                <td align="left" rowspan="1" colspan="1">0.816</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">OPF</td>
                <td align="left" rowspan="1" colspan="1">15</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec011">
      <title>3.3 Performance comparison between TROLLOPE and related ML methods</title>
      <p>To reveal the effectiveness of our proposed model TROLLOPE, we compared its performance with related ML methods. However, there is no existing computational model designed for TCE-HCV identification. Thus, the performance of TROLLOPE is compared with related ML methods, involving BLAST-based predictor, two well-known ensemble strategies (i.e., the average scoring and majority voting), and its base-classifiers, in terms of both 10-fold cross-validation and independent tests. Firstly, we compared the performance of TROLLOPE with the BLAST-based predictor. The BLAST-based predictor is a well-known similarity-based approach for identifying proteins [<xref rid="pone.0290538.ref065" ref-type="bibr">65</xref>]. <bold>S4 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold> summarizes the independent test results of the BLAST-based predictor based on different E-values. As can be seen from <bold>S4 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, TROLLOPE clearly outperforms the BLAST-based predictor in terms of ACC, Sn, Sp, and MCC. Secondly, we conducted a comparative experiment between TROLLOPE and the selected ensemble strategies. <bold><xref rid="pone.0290538.t003" ref-type="table">Table 3</xref></bold> provides the comparative results of the three ensemble strategies. We noticed that both cross-validation and independent test results of TROLLOPE were better than that of the two compared ensemble strategies in terms of all five measures, with the exception of Sp on the independent test dataset. To be specific, the AUC of TROLLOPE were 2.93–2.97% and 2.56–3.33% better than that of the two related ensemble strategies in terms of cross-validation and independent tests, respectively, highlighting the effectiveness of the stacking strategy over other ensemble strategies. Finally, the performance of TROLLOPE was compared against its constituent base-classifiers. For convenience of discussion, we selected the top-five base-classifiers (i.e., SVM-TPC, LR-TPC, SVM-DDE, RF-TPC, and RF-DDE) for conducting our comparative results. From <bold>Figs <xref rid="pone.0290538.g003" ref-type="fig">3</xref> and <xref rid="pone.0290538.g004" ref-type="fig">4</xref></bold> and <bold><xref rid="pone.0290538.t004" ref-type="table">Table 4</xref></bold> along with <bold>S1 Fig in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>, several observations can be summarized as follows: (i) TROLLOPE attains the overall best cross-validation results in terms of ACC, Sn, MCC, and AUC; (ii) The ACC, MCC, and AUC of TROLLOPE are higher than most top-five base-classifiers in terms of the independent test dataset, with the exception of SVM-DDE; (iii) TROLLOPE demonstrates a significant improvement, achieving a 2.06% increase in ACC, a 7.87% increase in Sn, a 4.52% increase in MCC, and a 2.92% increase in AUC compared to the best-performing base-classifier (i.e., SVM-TPC); and (iv) Based on the distributed stochastic neighbor embedding (t-SNE) method [<xref rid="pone.0290538.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0290538.ref067" ref-type="bibr">67</xref>], TROLLOPE demonstrates greater discriminative power in making accurate predictions (<bold><xref rid="pone.0290538.g004" ref-type="fig">Fig 4</xref></bold>). Overall, our comparative analysis revealed that the stacking strategy used in TROLLOPE proved beneficial in terms of providing more accurate and reliable identification of TCE-HCV.</p>
      <fig position="float" id="pone.0290538.g004">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>t-distributed stochastic neighbor embedding (t-SNE) distribution of positive and negative samples on the training dataset, where TCE-HCV and non-TCE-HCV are represented with red and blue dots, respectively.</title>
          <p>TROLLOPE (<bold>A</bold>) and top-five base-classifiers (<bold>B-F</bold>).</p>
        </caption>
        <graphic xlink:href="pone.0290538.g004" position="float"/>
      </fig>
      <table-wrap position="float" id="pone.0290538.t003">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>Performance comparison of different models trained based on different ensemble strategies.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t003" id="pone.0290538.t003g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Ensemble strategy</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">Average score</td>
                <td align="left" rowspan="1" colspan="1">0.690</td>
                <td align="left" rowspan="1" colspan="1">0.647</td>
                <td align="left" rowspan="1" colspan="1">0.726</td>
                <td align="left" rowspan="1" colspan="1">0.374</td>
                <td align="left" rowspan="1" colspan="1">0.779</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Majority voting</td>
                <td align="left" rowspan="1" colspan="1">0.689</td>
                <td align="left" rowspan="1" colspan="1">0.613</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.370</td>
                <td align="left" rowspan="1" colspan="1">0.779</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Stacking</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">Average score</td>
                <td align="left" rowspan="1" colspan="1">0.727</td>
                <td align="left" rowspan="1" colspan="1">0.674</td>
                <td align="left" rowspan="1" colspan="1">0.771</td>
                <td align="left" rowspan="1" colspan="1">0.448</td>
                <td align="left" rowspan="1" colspan="1">0.801</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Majority voting</td>
                <td align="left" rowspan="1" colspan="1">0.706</td>
                <td align="left" rowspan="1" colspan="1">0.607</td>
                <td align="left" rowspan="1" colspan="1">0.790</td>
                <td align="left" rowspan="1" colspan="1">0.405</td>
                <td align="left" rowspan="1" colspan="1">0.794</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Stacking</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <table-wrap position="float" id="pone.0290538.t004">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t004</object-id>
        <label>Table 4</label>
        <caption>
          <title>Performance comparison of TROLLOPE and top-five ML classifiers.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t004" id="pone.0290538.t004g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Evaluation strategy</th>
                <th align="left" rowspan="1" colspan="1">Method</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cross-validation</td>
                <td align="left" rowspan="1" colspan="1">RF-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.682</td>
                <td align="left" rowspan="1" colspan="1">0.669</td>
                <td align="left" rowspan="1" colspan="1">0.693</td>
                <td align="left" rowspan="1" colspan="1">0.363</td>
                <td align="left" rowspan="1" colspan="1">0.771</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">RF-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.700</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.838</td>
                <td align="left" rowspan="1" colspan="1">0.399</td>
                <td align="left" rowspan="1" colspan="1">0.772</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.699</td>
                <td align="left" rowspan="1" colspan="1">0.639</td>
                <td align="left" rowspan="1" colspan="1">0.750</td>
                <td align="left" rowspan="1" colspan="1">0.394</td>
                <td align="left" rowspan="1" colspan="1">0.780</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">LR-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.705</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.836</td>
                <td align="left" rowspan="1" colspan="1">0.409</td>
                <td align="left" rowspan="1" colspan="1">0.786</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.696</td>
                <td align="left" rowspan="1" colspan="1">0.440</td>
                <td align="left" rowspan="1" colspan="1">0.914</td>
                <td align="left" rowspan="1" colspan="1">0.407</td>
                <td align="left" rowspan="1" colspan="1">0.791</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TROLLOPE</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Independent test</td>
                <td align="left" rowspan="1" colspan="1">RF-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.722</td>
                <td align="left" rowspan="1" colspan="1">0.753</td>
                <td align="left" rowspan="1" colspan="1">0.695</td>
                <td align="left" rowspan="1" colspan="1">0.447</td>
                <td align="left" rowspan="1" colspan="1">0.799</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">RF-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.711</td>
                <td align="left" rowspan="1" colspan="1">0.517</td>
                <td align="left" rowspan="1" colspan="1">0.876</td>
                <td align="left" rowspan="1" colspan="1">0.426</td>
                <td align="left" rowspan="1" colspan="1">0.786</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-DDE</td>
                <td align="left" rowspan="1" colspan="1">0.758</td>
                <td align="left" rowspan="1" colspan="1">0.697</td>
                <td align="left" rowspan="1" colspan="1">0.810</td>
                <td align="left" rowspan="1" colspan="1">0.511</td>
                <td align="left" rowspan="1" colspan="1">0.822</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">LR-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.716</td>
                <td align="left" rowspan="1" colspan="1">0.539</td>
                <td align="left" rowspan="1" colspan="1">0.867</td>
                <td align="left" rowspan="1" colspan="1">0.434</td>
                <td align="left" rowspan="1" colspan="1">0.796</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">SVM-TPC</td>
                <td align="left" rowspan="1" colspan="1">0.727</td>
                <td align="left" rowspan="1" colspan="1">0.663</td>
                <td align="left" rowspan="1" colspan="1">0.781</td>
                <td align="left" rowspan="1" colspan="1">0.448</td>
                <td align="left" rowspan="1" colspan="1">0.798</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TROLLOPE</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec012">
      <title>3.4 Analysis of the contribution of new probabilistic features</title>
      <p>In this section, we investigated the discriminative power of the new probabilistic features (OPF) for identifying TCE-HCVs. Firstly, we compared the performance of OPF with well-known sequence-based feature descriptors, involving AAC, AAI, APAAC, CTD, CTDC, CTDD, CTDT, DDE, DPC, PAAC, PCP and TPC. By doing this, each feature was used to develop a PLS-based model and its performance was evaluated based on the 10-fold cross-validation and independent tests. <bold>Tables <xref rid="pone.0290538.t005" ref-type="table">5</xref> and <xref rid="pone.0290538.t006" ref-type="table">6</xref></bold> record their detailed 10-fold cross-validation and independent test results. As seen from <bold><xref rid="pone.0290538.t005" ref-type="table">Table 5</xref></bold>, among the 12 well-known feature descriptors, the highest AUC of 0.772 is achieved using TPC. This indicates that TPC exhibits greater discriminative power compared to other feature descriptors. Furthermore, <bold>Tables <xref rid="pone.0290538.t005" ref-type="table">5</xref> and <xref rid="pone.0290538.t006" ref-type="table">6</xref></bold> show that the OPF achieves higher ACC, Sn, MCC, and AUC values compared to 12 well-known feature descriptors in terms of both the 10-fold cross-validation and independent tests. Impressively, on the independent test dataset, the OPF outperforms TPC in terms of MCC, Sn, ACC, and AUC, with an increase of 13.84, 11.24, 6.70, and 6.00%, respectively. Secondly, we employed the t-SNE method to analyze the feature space of OPF and top-three informative sequence-based feature descriptors (i.e., DDE, DPC, and TPC) to visualize their distributions. As can be seen from <bold><xref rid="pone.0290538.g005" ref-type="fig">Fig 5</xref></bold>, the feature space derived from OPF exhibits clearer and more distinct clusters as compared to DDE, DPC, and TPC. Our comparative analysis revealed that our new probabilistic features exhibited more discriminative power in identifying TCE-HCV compared to well-known sequence-based feature descriptors, resulting in improved performance.</p>
      <fig position="float" id="pone.0290538.g005">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g005</object-id>
        <label>Fig 5</label>
        <caption>
          <p>t-SNE plots of our new feature OPF (<bold>A</bold>) and top-three feature descriptors (<bold>B-D</bold>) (i.e. DDE, DPC, and TPC) on the training dataset.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g005" position="float"/>
      </fig>
      <table-wrap position="float" id="pone.0290538.t005">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t005</object-id>
        <label>Table 5</label>
        <caption>
          <title>Cross-validation results of our new feature and conventional feature descriptor.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t005" id="pone.0290538.t005g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDC</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.401</td>
                <td align="left" rowspan="1" colspan="1">0.655</td>
                <td align="left" rowspan="1" colspan="1">0.056</td>
                <td align="left" rowspan="1" colspan="1">0.558</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PCP</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.325</td>
                <td align="left" rowspan="1" colspan="1">0.719</td>
                <td align="left" rowspan="1" colspan="1">0.045</td>
                <td align="left" rowspan="1" colspan="1">0.569</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAI</td>
                <td align="left" rowspan="1" colspan="1">0.548</td>
                <td align="left" rowspan="1" colspan="1">0.446</td>
                <td align="left" rowspan="1" colspan="1">0.636</td>
                <td align="left" rowspan="1" colspan="1">0.084</td>
                <td align="left" rowspan="1" colspan="1">0.601</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDT</td>
                <td align="left" rowspan="1" colspan="1">0.595</td>
                <td align="left" rowspan="1" colspan="1">0.496</td>
                <td align="left" rowspan="1" colspan="1">0.679</td>
                <td align="left" rowspan="1" colspan="1">0.180</td>
                <td align="left" rowspan="1" colspan="1">0.616</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDD</td>
                <td align="left" rowspan="1" colspan="1">0.593</td>
                <td align="left" rowspan="1" colspan="1">0.554</td>
                <td align="left" rowspan="1" colspan="1">0.626</td>
                <td align="left" rowspan="1" colspan="1">0.182</td>
                <td align="left" rowspan="1" colspan="1">0.630</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAC</td>
                <td align="left" rowspan="1" colspan="1">0.584</td>
                <td align="left" rowspan="1" colspan="1">0.516</td>
                <td align="left" rowspan="1" colspan="1">0.643</td>
                <td align="left" rowspan="1" colspan="1">0.160</td>
                <td align="left" rowspan="1" colspan="1">0.632</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PAAC</td>
                <td align="left" rowspan="1" colspan="1">0.602</td>
                <td align="left" rowspan="1" colspan="1">0.538</td>
                <td align="left" rowspan="1" colspan="1">0.657</td>
                <td align="left" rowspan="1" colspan="1">0.198</td>
                <td align="left" rowspan="1" colspan="1">0.638</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTD</td>
                <td align="left" rowspan="1" colspan="1">0.600</td>
                <td align="left" rowspan="1" colspan="1">0.566</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.196</td>
                <td align="left" rowspan="1" colspan="1">0.644</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">APAAC</td>
                <td align="left" rowspan="1" colspan="1">0.615</td>
                <td align="left" rowspan="1" colspan="1">0.533</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.222</td>
                <td align="left" rowspan="1" colspan="1">0.645</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DPC</td>
                <td align="left" rowspan="1" colspan="1">0.664</td>
                <td align="left" rowspan="1" colspan="1">0.616</td>
                <td align="left" rowspan="1" colspan="1">0.705</td>
                <td align="left" rowspan="1" colspan="1">0.324</td>
                <td align="left" rowspan="1" colspan="1">0.697</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DDE</td>
                <td align="left" rowspan="1" colspan="1">0.685</td>
                <td align="left" rowspan="1" colspan="1">0.602</td>
                <td align="left" rowspan="1" colspan="1">0.755</td>
                <td align="left" rowspan="1" colspan="1">0.363</td>
                <td align="left" rowspan="1" colspan="1">0.726</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TPC</td>
                <td align="left" rowspan="1" colspan="1">0.694</td>
                <td align="left" rowspan="1" colspan="1">0.670</td>
                <td align="left" rowspan="1" colspan="1">0.714</td>
                <td align="left" rowspan="1" colspan="1">0.385</td>
                <td align="left" rowspan="1" colspan="1">0.758</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">OPF (This study)</td>
                <td align="left" rowspan="1" colspan="1">0.745</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.795</td>
                <td align="left" rowspan="1" colspan="1">0.487</td>
                <td align="left" rowspan="1" colspan="1">0.808</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <table-wrap position="float" id="pone.0290538.t006">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.t006</object-id>
        <label>Table 6</label>
        <caption>
          <title>Independent test results of our new feature and conventional feature descriptor.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0290538.t006" id="pone.0290538.t006g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Feature</th>
                <th align="left" rowspan="1" colspan="1">ACC</th>
                <th align="left" rowspan="1" colspan="1">Sn</th>
                <th align="left" rowspan="1" colspan="1">Sp</th>
                <th align="left" rowspan="1" colspan="1">MCC</th>
                <th align="left" rowspan="1" colspan="1">AUC</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDC</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.371</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.101</td>
                <td align="left" rowspan="1" colspan="1">0.598</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PCP</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.348</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.078</td>
                <td align="left" rowspan="1" colspan="1">0.574</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAI</td>
                <td align="left" rowspan="1" colspan="1">0.598</td>
                <td align="left" rowspan="1" colspan="1">0.528</td>
                <td align="left" rowspan="1" colspan="1">0.657</td>
                <td align="left" rowspan="1" colspan="1">0.187</td>
                <td align="left" rowspan="1" colspan="1">0.620</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDT</td>
                <td align="left" rowspan="1" colspan="1">0.552</td>
                <td align="left" rowspan="1" colspan="1">0.393</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.082</td>
                <td align="left" rowspan="1" colspan="1">0.600</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTDD</td>
                <td align="left" rowspan="1" colspan="1">0.582</td>
                <td align="left" rowspan="1" colspan="1">0.472</td>
                <td align="left" rowspan="1" colspan="1">0.676</td>
                <td align="left" rowspan="1" colspan="1">0.151</td>
                <td align="left" rowspan="1" colspan="1">0.618</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">AAC</td>
                <td align="left" rowspan="1" colspan="1">0.572</td>
                <td align="left" rowspan="1" colspan="1">0.528</td>
                <td align="left" rowspan="1" colspan="1">0.610</td>
                <td align="left" rowspan="1" colspan="1">0.138</td>
                <td align="left" rowspan="1" colspan="1">0.593</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PAAC</td>
                <td align="left" rowspan="1" colspan="1">0.577</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.590</td>
                <td align="left" rowspan="1" colspan="1">0.152</td>
                <td align="left" rowspan="1" colspan="1">0.594</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CTD</td>
                <td align="left" rowspan="1" colspan="1">0.582</td>
                <td align="left" rowspan="1" colspan="1">0.483</td>
                <td align="left" rowspan="1" colspan="1">0.667</td>
                <td align="left" rowspan="1" colspan="1">0.152</td>
                <td align="left" rowspan="1" colspan="1">0.628</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">APAAC</td>
                <td align="left" rowspan="1" colspan="1">0.603</td>
                <td align="left" rowspan="1" colspan="1">0.573</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.201</td>
                <td align="left" rowspan="1" colspan="1">0.599</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DPC</td>
                <td align="left" rowspan="1" colspan="1">0.639</td>
                <td align="left" rowspan="1" colspan="1">0.584</td>
                <td align="left" rowspan="1" colspan="1">0.686</td>
                <td align="left" rowspan="1" colspan="1">0.271</td>
                <td align="left" rowspan="1" colspan="1">0.731</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DDE</td>
                <td align="left" rowspan="1" colspan="1">0.680</td>
                <td align="left" rowspan="1" colspan="1">0.562</td>
                <td align="left" rowspan="1" colspan="1">0.781</td>
                <td align="left" rowspan="1" colspan="1">0.353</td>
                <td align="left" rowspan="1" colspan="1">0.741</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TPC</td>
                <td align="left" rowspan="1" colspan="1">0.680</td>
                <td align="left" rowspan="1" colspan="1">0.629</td>
                <td align="left" rowspan="1" colspan="1">0.724</td>
                <td align="left" rowspan="1" colspan="1">0.355</td>
                <td align="left" rowspan="1" colspan="1">0.767</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">OPF (This study)</td>
                <td align="left" rowspan="1" colspan="1">0.747</td>
                <td align="left" rowspan="1" colspan="1">0.742</td>
                <td align="left" rowspan="1" colspan="1">0.752</td>
                <td align="left" rowspan="1" colspan="1">0.493</td>
                <td align="left" rowspan="1" colspan="1">0.827</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec id="sec013">
      <title>3.5 Characterization of linear T-cell epitopes of hepatitis C virus</title>
      <p>The analysis and characterization of feature importance for each type of features are crucial for providing a better understanding of TCE-HCVs. Therefore, we employed an interpretable approach, named the Shapley Additive exPlanations (SHAP), to rank and evaluate the feature importance for TROLLOPE and its constituent base-classifiers. Until now, the SHAP method has been successfully used in various bioinformatics tasks [<xref rid="pone.0290538.ref068" ref-type="bibr">68</xref>–<xref rid="pone.0290538.ref071" ref-type="bibr">71</xref>]. Firstly, the top-six informative probabilistic features of TROLLOPE were assessed for their importance in TCE-HCV identification. <bold><xref rid="pone.0290538.g006" ref-type="fig">Fig 6</xref></bold> shows the SHAP values of the top-six informative probabilistic features, where positive and negative SHAP values indicate a high probability that the predictions are TCE-HCVs and non-TCE-HCVs, respectively. <bold><xref rid="pone.0290538.g006" ref-type="fig">Fig 6A</xref></bold> illustrates that most of the top-six informative probabilistic features (with the exception of XGB-AAI) significantly contribute to TCE-HCV prediction, as indicated by their high SHAP values. Secondly, to gain deeper insights into TCE-HCVs, we applied the SHAP method to analyze two of the six base-classifiers (i.e., XGB-AAI and XGB-PCP). Previously, AAI and PCP have been recognized as crucial features for analyzing and charactering various protein functions [<xref rid="pone.0290538.ref072" ref-type="bibr">72</xref>–<xref rid="pone.0290538.ref076" ref-type="bibr">76</xref>]. As seen in <bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7</xref></bold>, the important physicochemical properties, such as helical structure conformation (TANS770102, ISOY800106, AURR980118, and WERD780103), beta-sheet structure (CHOP780211) and other conformational characteristics of epitopes (MAXF760103 and VASM830101) play a significant role in TCE-HCV prediction.</p>
      <fig position="float" id="pone.0290538.g006">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g006</object-id>
        <label>Fig 6</label>
        <caption>
          <title>Feature importance analysis for TROLLOPE prediction.</title>
          <p>(A) Scatter plot of top-15 informative probabilistic features. (B) The average absolute SHAP values of top-15 informative probabilistic features.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g006" position="float"/>
      </fig>
      <fig position="float" id="pone.0290538.g007">
        <object-id pub-id-type="doi">10.1371/journal.pone.0290538.g007</object-id>
        <label>Fig 7</label>
        <caption>
          <p>Feature importance analysis for XGB-AAI (A-B) and XGB-PCP (C-D) predictions. (A, C) Scatter plot of top 20 informative features. (B, D) The average absolute SHAP values of top 20 informative features.</p>
        </caption>
        <graphic xlink:href="pone.0290538.g007" position="float"/>
      </fig>
      <p>Certain amino acid residues in the position preceding a given residue may have specific structural preferences, such as helical propensity or beta-sheet propensity. These important physicochemical properties can provide insights into the preferred amino acids or structural motifs in that position, which can impact the overall conformation and stability of the epitope. Moreover, the hydrophobicity of amino acids within HCV epitopes can significantly influence their structural stability and conformation. In the feature lists of XGB-PCP and XGB-AAI, the presence of "hydrophobic" and "CIDH920104" or Normalized hydrophobicity scales for alpha/beta-proteins (Cid et al., 1992), respectively, indicates that hydrophobic tend to be buried within the protein core, while hydrophilic residues preferentially reside on the protein surface. A balance of hydrophobic and hydrophilic residues within the epitope can contribute to its structural integrity and proper folding, which can potentially influence its antigenicity and immunogenicity [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>].</p>
      <p>Since aromatic residues have hydrophobic properties, they can participate in hydrophobic interactions with other hydrophobic regions on antibodies or immune receptors. Therefore, the “aromatic” feature from XGB-PCP was also listed in the top ranked feature (<bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7C and 7D</xref></bold>). These interactions contribute to the stability and specificity of the antigen-antibody or antigen-receptor binding. In addition, the mean area buried on transfer (ROSG850101) could also be indicative of the hydrophobicity scale of the desired epitopes. Notably, the “aliphatic” feature could also be grouped together with the hydrophobic and aromatic features. The aliphatic residues, such as alanine (Ala), valine (Val), leucine (Leu), and isoleucine (Ile), are non-polar and play important roles in the hydrophobic region of epitopes. These residues have various effects on antigen recognition and immune response [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>]. These important features can also influence the exposure and presentation of epitopes on antigens. In some cases, hydrophobic regions within the antigen may be buried within the protein structure, making the epitope less accessible for recognition by immune receptors. Alternatively, hydrophobic patches on the surface of an antigen may be more exposed and accessible, facilitating the binding and recognition of the epitope by immune cells or antibodies.</p>
      <p>On the other hand, the charged amino acids, including positively charged (basic) residues such as lysine (Lys) and arginine (Arg), as well as negatively charged (acidic) residues such as aspartic acid (Asp) and glutamic acid (Glu), can also play important roles in epitopes. Interestingly, the “charged”, “polar”, “positively-charged” and “negatively-charged” features from XGB-PCP were also found as the key physicochemical properties in <bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7C and 7D</xref></bold>. This evidence was well supported by the FAUJ880111 or Positive charge [<xref rid="pone.0290538.ref078" ref-type="bibr">78</xref>] feature from XGB-AAI prediction (<bold><xref rid="pone.0290538.g007" ref-type="fig">Fig 7A and 7B</xref></bold>). The presence of charged residues within an epitope can have several effects on antigen recognition and immune response, via electrostatic interactions, to enhance the strength of the binding and play a crucial role in determining the binding affinity and specificity of the epitope [<xref rid="pone.0290538.ref079" ref-type="bibr">79</xref>]. Moreover, charged residues can influence the processing and presentation of epitopes by antigen-presenting cells (APCs) affecting their proteolytic cleavage, degradation, and subsequent presentation on the cell surface via major histocompatibility complex (MHC) molecules [<xref rid="pone.0290538.ref077" ref-type="bibr">77</xref>]. For example, the E2 protein and domain 1 of the HCV-core protein contain frequent positively charged amino acids (Lys and Arg) that are involved in RNA binding, promotes dimerization of the viral RNA, and play a significant role in nucleocapsid (NC) formation and core envelopment by endosomal membranes [<xref rid="pone.0290538.ref080" ref-type="bibr">80</xref>].</p>
      <p>In terms of the receptor-epitope binding and specificity on T-cell, NAKH920103 and NAKH920102 represent the role of specific regions on transmembrane proteins (single-spanning proteins). The CYT2 region in NAKH920102 property, which refers to the C-terminal region of a single-spanning protein, may contribute to the amino acid composition within this region, affecting their recognition by antibodies or T-cells [<xref rid="pone.0290538.ref079" ref-type="bibr">79</xref>]. More importantly, the importance of epitope diversity is crucial for vaccine design. The role of potential mutability on HCV epitope function refers to how the mutability, or the propensity to undergo genetic variations, of epitopes can impact their function and interactions with the immune system [<xref rid="pone.0290538.ref081" ref-type="bibr">81</xref>]. The presence of both relative mutability (JOND920102) and relative stability scale extracted from mutation experiments (ZHOH040102) features from XGB-AAI prediction were reasonable. Contributing to this epitope diversity issue, RADA880106, PRAM820103 and SNEP660102 have been reported to capture the variation in amino acid properties that contributes most significantly to the structural diversity of HCV epitopes [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>]. Compared to previously reported B-cell epitopes of hepatitis C [<xref rid="pone.0290538.ref039" ref-type="bibr">39</xref>], the feature “Principal component I (PCI) [<xref rid="pone.0290538.ref082" ref-type="bibr">82</xref>]” or SNEP660101 was found to be among the top-10 properties ranked by the accuracy differences. This finding may reflect the different key features that are important for predicting B-cell and T-cell epitopes. On the other hand, the principal component II (PCII) might capture the variation in amino acid properties that contributes most significantly to the structural diversity of HCV epitopes. PCII represents the orthogonal direction to PCI, which generally captures the primary source of variation. PCII can capture additional variations in epitope properties, such as side chain flexibility, polarity, or charge distribution, which can influence the conformational flexibility and structural dynamics of epitopes [<xref rid="pone.0290538.ref083" ref-type="bibr">83</xref>]. Epitopes with different PCII scores may exhibit distinct structural features or conformational preferences, potentially impacting their function and interaction with immune receptors.</p>
    </sec>
    <sec id="sec014">
      <title>3.6 Case studies</title>
      <p>In this study, we conducted case studies to evaluate the prediction capability of our stacked model TROLLOPE in practical real‐life situations and compared its performance with the top-five base-classifiers. Specifically, we collected six experimentally verified TCE-HCVs from two previous studies [<xref rid="pone.0290538.ref084" ref-type="bibr">84</xref>]. The criteria for HCV epitopes selection in this case study were as follows: 1) they have to be experimentally verified from published research papers, 2) only short peptides (8–11 amino acid residues) that are CD8+ T-cell specific epitopes will be considered (not B-cell specific or CD4+ T-cell epitopes), and 3) these TCE-HCVs should not be found in both the training and independent test datasets. Detailed information about the six TCE-HCVs in the case studies is provided in <bold>S5 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. In the meanwhile, the prediction results for these TCE-HCVs based on TROLLOPE and the top-five base-classifiers are summarized in <bold>S6 Table in <xref rid="pone.0290538.s001" ref-type="supplementary-material">S1 File</xref></bold>. As can be seen, TROLLOPE, along with SVM-TPC and SVM-DDE, can correctly predict all six TCE-HCVs.</p>
      <p>Taken together, these findings suggest that TROLLOPE can serve as a useful computational tool for accurately prioritizing high-potential TCE-HCVs from a large number of non-characterized peptides, as evidenced by its performance in both the independent test and case studies.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec015">
    <title>4. Conclusions</title>
    <p>This study presents a novel computational approach, termed TROLLOPE, which aims to provide fast and accurate prediction of TCE-HCV. Specifically, we extracted 12 different types of sequence-based feature encoding schemes from several perspectives, such as physicochemical properties, composition-transition-distribution information and composition information, and employed 12 powerful ML algorithms to develop a stacked model. The major contributions of this study are as follows: (i) TROLLOPE is the first computational tool developed specifically for identifying TCE-HCV using sequence information alone; (ii) The new probabilistic features generated based on TROLLOPE offer more discriminative information compared to commonly used feature encodings; (iii) The experimental results, in terms of both cross-validation and independent test results, revealed that TROLLOPE significantly outperformed conventional ML classifiers; and (iv) A user-friendly online web server of TROLLOPE is developed for serving experimental scientists to easily access and utilize the tool for their desired prediction tasks (<ext-link xlink:href="http://pmlabqsar.pythonanywhere.com/TROLLOPE" ext-link-type="uri">http://pmlabqsar.pythonanywhere.com/TROLLOPE</ext-link>). It is anticipated that TROLLOPE could be utilized to accelerate the large-scale identification of potential TCE-HCV from non-characterized peptides. However, there are some limitations that can be addressed in future work. Firstly, although our probabilistic features have more discriminative ability in TCE-HCV identification, there is still room for further improvement. For future work, we plan to fuse our probabilistic features with fingerprint descriptors (i.e., Estate, MACCS, and PubChem [<xref rid="pone.0290538.ref085" ref-type="bibr">85</xref>–<xref rid="pone.0290538.ref087" ref-type="bibr">87</xref>]) and sequence-to-vector encodings (i.e., word2vec). Secondly, the performance of TROLLOPE might be improved by combining it with powerful deep learning (DL) approaches, such as deep neural network (DNN) and transfer learning [<xref rid="pone.0290538.ref088" ref-type="bibr">88</xref>, <xref rid="pone.0290538.ref089" ref-type="bibr">89</xref>]. Thirdly, we are motivated to develop a new ML framework that are capable of identifying multiple viral agents.</p>
  </sec>
  <sec id="sec016" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pone.0290538.s001" position="float" content-type="local-data">
      <label>S1 File</label>
      <caption>
        <p>(DOCX)</p>
      </caption>
      <media xlink:href="pone.0290538.s001.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pone.0290538.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Manns</surname><given-names>M. P.</given-names></name><etal>et al.</etal>, "<article-title>Hepatitis C virus infection</article-title>," <source><italic toggle="yes">Nat Rev Dis Primers</italic></source>, vol. <volume>3</volume>, p. <fpage>17006</fpage>, <month>Mar</month><day>2</day><year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrdp.2017.6</pub-id><?supplied-pmid 28252637?><pub-id pub-id-type="pmid">28252637</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Pol</surname><given-names>S.</given-names></name> and <name><surname>Lagaye</surname><given-names>S.</given-names></name>, "<article-title>The remarkable history of the hepatitis C virus</article-title>," <source><italic toggle="yes">Genes Immun</italic></source>, vol. <volume>20</volume>, no. <issue>5</issue>, pp. <fpage>436</fpage>–<lpage>446</lpage>, <month>May</month>
<year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41435-019-0066-z</pub-id>
<?supplied-pmid 31019253?><pub-id pub-id-type="pmid">31019253</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>E.</given-names></name>, <name><surname>Ghany</surname><given-names>M. G.</given-names></name>, and <name><surname>Liang</surname><given-names>T. J.</given-names></name>, "<article-title>The application and mechanism of action of ribavirin in therapy of hepatitis C</article-title>," <source><italic toggle="yes">Antivir Chem Chemother</italic></source>, vol. <volume>23</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>12</lpage>, <month>Sep</month><day>25</day><year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3851/IMP2125</pub-id><?supplied-pmid 22592135?><pub-id pub-id-type="pmid">22592135</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Dustin</surname><given-names>L. B.</given-names></name>, <name><surname>Bartolini</surname><given-names>B.</given-names></name>, <name><surname>Capobianchi</surname><given-names>M. R.</given-names></name>, and <name><surname>Pistello</surname><given-names>M.</given-names></name>, "<article-title>Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy</article-title>," <source><italic toggle="yes">Clin Microbiol Infect</italic></source>, vol. <volume>22</volume>, no. <issue>10</issue>, pp. <fpage>826</fpage>–<lpage>832</lpage>, <month>Oct</month><year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cmi.2016.08.025</pub-id><?supplied-pmid 27592089?><pub-id pub-id-type="pmid">27592089</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Bhattacharjee</surname><given-names>C.</given-names></name>, <name><surname>Singh</surname><given-names>M.</given-names></name>, <name><surname>Das</surname><given-names>D.</given-names></name>, <name><surname>Chaudhuri</surname><given-names>S.</given-names></name>, and <name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name>, "<article-title>Current therapeutics against HCV</article-title>," <source><italic toggle="yes">Virusdisease</italic></source>, vol. <volume>32</volume>, no. <issue>2</issue>, pp. <fpage>228</fpage>–<lpage>243</lpage>, <month>Jun</month><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s13337-021-00697-0</pub-id><?supplied-pmid 34307769?><pub-id pub-id-type="pmid">34307769</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Manns</surname><given-names>M. P.</given-names></name> and <name><surname>Maasoumy</surname><given-names>B.</given-names></name>, "<article-title>Breakthroughs in hepatitis C research: from discovery to cure</article-title>," <source><italic toggle="yes">Nat Rev Gastroenterol Hepatol</italic></source>, vol. <volume>19</volume>, no. <issue>8</issue>, pp. <fpage>533</fpage>–<lpage>550</lpage>, <month>Aug</month>
<year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41575-022-00608-8</pub-id>
<?supplied-pmid 35595834?><pub-id pub-id-type="pmid">35595834</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><collab>WHO</collab>, <source>Global progress report on HIV, viral hepatitis and sexually transmitted infections</source>, <year>2021</year>. [Online]. Available: <ext-link xlink:href="https://www.who.int/publications/i/item/9789240027077" ext-link-type="uri">https://www.who.int/publications/i/item/9789240027077</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><collab>WHO</collab>, <source>Updated recommendations on treatment of dolescents and children with chronic HCV infection, and HCV simplified service elivery and diagnostics</source>., <year>2022</year>. [Online]. Available: <ext-link xlink:href="https://www.who.int/publications/i/item/9789240052734" ext-link-type="uri">https://www.who.int/publications/i/item/9789240052734</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Manne</surname><given-names>V.</given-names></name>, <name><surname>Ryan</surname><given-names>J.</given-names></name>, <name><surname>Wong</surname><given-names>J.</given-names></name>, <name><surname>Vengayil</surname><given-names>G.</given-names></name>, <name><surname>Basit</surname><given-names>S. A.</given-names></name>, and <name><surname>Gish</surname><given-names>R. G.</given-names></name>, "<article-title>Hepatitis C Vaccination: Where We Are and Where We Need to Be</article-title>," <source><italic toggle="yes">Pathogens</italic></source>, vol. <volume>10</volume>, no. <issue>12</issue>, <month>Dec</month><day>14</day><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/pathogens10121619</pub-id><?supplied-pmid 34959574?><pub-id pub-id-type="pmid">34959574</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Hedskog</surname><given-names>C.</given-names></name><etal>et al.</etal>, "<article-title>Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification</article-title>," <source><italic toggle="yes">Open Forum Infect Dis</italic></source>, vol. <volume>6</volume>, no. <issue>3</issue>, p. ofz076, <month>Mar</month><year>2019</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Vanwolleghem</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>47</volume>, no. <issue>6</issue>, pp. <fpage>1846</fpage>–<lpage>55</lpage>, <month>Jun</month><year>2008</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.22244</pub-id><?supplied-pmid 18452146?><pub-id pub-id-type="pmid">18452146</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Meuleman</surname><given-names>P.</given-names></name><etal>et al.</etal>, "<article-title>In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>53</volume>, no. <issue>3</issue>, pp. <fpage>755</fpage>–<lpage>62</lpage>, <month>Mar</month><year>2011</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.24171</pub-id><?supplied-pmid 21319203?><pub-id pub-id-type="pmid">21319203</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Bukh</surname><given-names>J.</given-names></name><etal>et al.</etal>, "<article-title>Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge</article-title>," <source><italic toggle="yes">J Virol</italic></source>, vol. <volume>89</volume>, no. <issue>17</issue>, pp. <fpage>9128</fpage>–<lpage>32</lpage>, <month>Sep</month><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.01194-15</pub-id><?supplied-pmid 26085160?><pub-id pub-id-type="pmid">26085160</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>J. R.</given-names></name><etal>et al.</etal>, "<article-title>Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance</article-title>," <source><italic toggle="yes">J Clin Invest</italic></source>, vol. <volume>125</volume>, no. <issue>1</issue>, pp. <fpage>437</fpage>–<lpage>47</lpage>, <month>Jan</month><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1172/JCI78794</pub-id><?supplied-pmid 25500884?><pub-id pub-id-type="pmid">25500884</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>El-Diwany</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1</article-title>," <source><italic toggle="yes">PLoS Pathog</italic></source>, vol. <volume>13</volume>, no. <issue>2</issue>, p. <fpage>e1006235</fpage>, <month>Feb</month><year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.ppat.1006235</pub-id><?supplied-pmid 28235087?><pub-id pub-id-type="pmid">28235087</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>A. L.</given-names></name>, "<article-title>Challenges and Promise of a Hepatitis C Virus Vaccine</article-title>," <source><italic toggle="yes">Cold Spring Harb Perspect Med</italic></source>, vol. <volume>10</volume>, no. <issue>2</issue>, <month>Feb</month><day>3</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/cshperspect.a036947</pub-id><?supplied-pmid 31548228?><pub-id pub-id-type="pmid">31548228</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Lechner</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Analysis of successful immune responses in persons infected with hepatitis C virus</article-title>," <source><italic toggle="yes">J Exp Med</italic></source>, vol. <volume>191</volume>, no. <issue>9</issue>, pp. <fpage>1499</fpage>–<lpage>512</lpage>, <month>May</month><day>1</day><year>2000</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1084/jem.191.9.1499</pub-id><?supplied-pmid 10790425?><pub-id pub-id-type="pmid">10790425</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>K. M.</given-names></name><etal>et al.</etal>, "<article-title>Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>33</volume>, no. <issue>1</issue>, pp. <fpage>267</fpage>–<lpage>76</lpage>, <month>Jan</month><year>2001</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/jhep.2001.21162</pub-id><?supplied-pmid 11124845?><pub-id pub-id-type="pmid">11124845</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Grakoui</surname><given-names>A.</given-names></name><etal>et al.</etal>, "<article-title>HCV persistence and immune evasion in the absence of memory T cell help</article-title>," <source><italic toggle="yes">Science</italic></source>, vol. <volume>302</volume>, no. <issue>5645</issue>, pp. <fpage>659</fpage>–<lpage>62</lpage>, <month>Oct</month><day>24</day><year>2003</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1088774</pub-id><?supplied-pmid 14576438?><pub-id pub-id-type="pmid">14576438</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Schulze Zur Wiesch</surname><given-names>J.</given-names></name><etal>et al.</etal>, "<article-title>Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence</article-title>," <source><italic toggle="yes">J Exp Med</italic></source>, vol. <volume>209</volume>, no. <issue>1</issue>, pp. <fpage>61</fpage>–<lpage>75</lpage>, <month>Jan</month><day>16</day><year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1084/jem.20100388</pub-id><?supplied-pmid 22213804?><pub-id pub-id-type="pmid">22213804</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Abdel-Hakeem</surname><given-names>M. S.</given-names></name>, <name><surname>Bedard</surname><given-names>N.</given-names></name>, <name><surname>Murphy</surname><given-names>D.</given-names></name>, <name><surname>Bruneau</surname><given-names>J.</given-names></name>, and <name><surname>Shoukry</surname><given-names>N. H.</given-names></name>, "<article-title>Signatures of protective memory immune responses during hepatitis C virus reinfection</article-title>," <source><italic toggle="yes">Gastroenterology</italic></source>, vol. <volume>147</volume>, no. <issue>4</issue>, pp. <fpage>870</fpage>–<lpage>881 e8</lpage>, <month>Oct</month><year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/j.gastro.2014.07.005</pub-id><?supplied-pmid 25038432?><pub-id pub-id-type="pmid">25038432</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>S.</given-names></name>, <name><surname>Lauer</surname><given-names>G.</given-names></name>, <name><surname>Isba</surname><given-names>R.</given-names></name>, <name><surname>Walker</surname><given-names>B.</given-names></name>, and <name><surname>Klenerman</surname><given-names>P.</given-names></name>, "<article-title>Cellular immune responses against hepatitis C virus: the evidence base 2002</article-title>," <source><italic toggle="yes">Clin Exp Immunol</italic></source>, vol. <volume>128</volume>, no. <issue>2</issue>, pp. <fpage>195</fpage>–<lpage>203</lpage>, <month>May</month><year>2002</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01840.x</pub-id><?supplied-pmid 11985510?><pub-id pub-id-type="pmid">11985510</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Thimme</surname><given-names>R.</given-names></name>, "<article-title>T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine</article-title>," <source><italic toggle="yes">J Hepatol</italic></source>, vol. <volume>74</volume>, no. <issue>1</issue>, pp. <fpage>220</fpage>–<lpage>229</lpage>, <month>Jan</month><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jhep.2020.09.022</pub-id><?supplied-pmid 33002569?><pub-id pub-id-type="pmid">33002569</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Shirai</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines</article-title>," <source><italic toggle="yes">J Infect Dis</italic></source>, vol. <volume>173</volume>, no. <issue>1</issue>, pp. <fpage>24</fpage>–<lpage>31</lpage>, <month>Jan</month><year>1996</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/infdis/173.1.24</pub-id><?supplied-pmid 8537666?><pub-id pub-id-type="pmid">8537666</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Engler</surname><given-names>O. B.</given-names></name><etal>et al.</etal>, "<article-title>A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins</article-title>," <source><italic toggle="yes">Vaccine</italic></source>, vol. <volume>23</volume>, no. <issue>1</issue>, pp. <fpage>58</fpage>–<lpage>68</lpage>, <month>Nov</month><day>15</day><year>2004</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.05.009</pub-id><?supplied-pmid 15519708?><pub-id pub-id-type="pmid">15519708</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Christiansen</surname><given-names>D.</given-names></name><etal>et al.</etal>, "<article-title>Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine</article-title>," <source><italic toggle="yes">Sci Rep</italic></source>, vol. <volume>8</volume>, no. <issue>1</issue>, p. <fpage>6483</fpage>, <month>Apr</month><day>24</day><year>2018</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-24762-9</pub-id><?supplied-pmid 29691437?><pub-id pub-id-type="pmid">29691437</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>J. R.</given-names></name>, <name><surname>Barnes</surname><given-names>E.</given-names></name>, and <name><surname>Cox</surname><given-names>A. L.</given-names></name>, "<article-title>Approaches, Progress, and Challenges to Hepatitis C Vaccine Development</article-title>," <source><italic toggle="yes">Gastroenterology</italic></source>, vol. <volume>156</volume>, no. <issue>2</issue>, pp. <fpage>418</fpage>–<lpage>430</lpage>, <month>Jan</month><year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.060</pub-id><?supplied-pmid 30268785?><pub-id pub-id-type="pmid">30268785</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Yechezkel</surname><given-names>I.</given-names></name>, <name><surname>Law</surname><given-names>M.</given-names></name>, and <name><surname>Tzarum</surname><given-names>N.</given-names></name>, "<article-title>From Structural Studies to HCV Vaccine Design</article-title>," <source><italic toggle="yes">Viruses</italic></source>, vol. <volume>13</volume>, no. <issue>5</issue>, <month>May</month><day>4</day><year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/v13050833</pub-id><?supplied-pmid 34064532?><pub-id pub-id-type="pmid">34064532</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Duncan</surname><given-names>J. D.</given-names></name>, <name><surname>Urbanowicz</surname><given-names>R. A.</given-names></name>, <name><surname>Tarr</surname><given-names>A. W.</given-names></name>, and <name><surname>Ball</surname><given-names>J. K.</given-names></name>, "<article-title>Hepatitis C Virus Vaccine: Challenges and Prospects</article-title>," <source><italic toggle="yes">Vaccines (Basel)</italic></source>, vol. <volume>8</volume>, no. <issue>1</issue>, <month>Feb</month><day>17</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/vaccines8010090</pub-id><?supplied-pmid 32079254?><pub-id pub-id-type="pmid">32079254</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Sunita</surname><given-names>A.</given-names></name><name><surname>Sajid</surname><given-names>Y</given-names></name>. <name><surname>Singh</surname></name>, and <name><surname>Shukla</surname><given-names>P.</given-names></name>, "<article-title>Computational tools for modern vaccine development</article-title>," <source><italic toggle="yes">Hum Vaccin Immunother</italic></source>, vol. <volume>16</volume>, no. <issue>3</issue>, pp. <fpage>723</fpage>–<lpage>735</lpage>, <month>Mar</month><day>3</day><year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/21645515.2019.1670035</pub-id><?supplied-pmid 31545127?><pub-id pub-id-type="pmid">31545127</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Memarnejadian</surname><given-names>A.</given-names></name>, <name><surname>Roohvand</surname><given-names>F.</given-names></name>, <name><surname>Arashkia</surname><given-names>A.</given-names></name>, <name><surname>Rafati</surname><given-names>S.</given-names></name>, and <name><surname>Shokrgozar</surname><given-names>M. A.</given-names></name>, "<article-title>Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice</article-title>," <source><italic toggle="yes">Protein Pept Lett</italic></source>, vol. <volume>16</volume>, no. <issue>7</issue>, pp. <fpage>842</fpage>–<lpage>50</lpage>, <year>2009</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/092986609788681788</pub-id><?supplied-pmid 19601916?><pub-id pub-id-type="pmid">19601916</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Arashkia</surname><given-names>A.</given-names></name>, <name><surname>Roohvand</surname><given-names>F.</given-names></name>, <name><surname>Memarnejadian</surname><given-names>A.</given-names></name>, <name><surname>Aghasadeghi</surname><given-names>M. R.</given-names></name>, and <name><surname>Rafati</surname><given-names>S.</given-names></name>, "<article-title>Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice</article-title>," <source><italic toggle="yes">Virus Genes</italic></source>, vol. <volume>40</volume>, no. <issue>1</issue>, pp. <fpage>44</fpage>–<lpage>52</lpage>, <month>Feb</month><year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11262-009-0417-3</pub-id><?supplied-pmid 19882243?><pub-id pub-id-type="pmid">19882243</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Memarnejadian</surname><given-names>A.</given-names></name> and <name><surname>Roohvand</surname><given-names>F.</given-names></name>, "<article-title>Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine</article-title>," <source><italic toggle="yes">Cell Immunol</italic></source>, vol. <volume>261</volume>, no. <issue>2</issue>, pp. <fpage>93</fpage>–<lpage>8</lpage>, <year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cellimm.2009.11.005</pub-id>
<?supplied-pmid 20056196?><pub-id pub-id-type="pmid">20056196</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Dhanda</surname><given-names>S. K.</given-names></name>, <name><surname>Gupta</surname><given-names>S.</given-names></name>, <name><surname>Vir</surname><given-names>P.</given-names></name>, and <name><surname>Raghava</surname><given-names>G.</given-names></name>, "<article-title>Prediction of IL4 inducing peptides</article-title>," <source><italic toggle="yes">Clinical and Developmental Immunology</italic></source>, vol. <volume>2013</volume>, <year>2013</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2013/263952</pub-id><?supplied-pmid 24489573?><pub-id pub-id-type="pmid">24489573</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Bukhari</surname><given-names>S. N. H.</given-names></name>, <name><surname>Jain</surname><given-names>A.</given-names></name>, <name><surname>Haq</surname><given-names>E.</given-names></name>, <name><surname>Mehbodniya</surname><given-names>A.</given-names></name>, and <name><surname>Webber</surname><given-names>J.</given-names></name>, "<article-title>Machine learning techniques for the prediction of B-cell and T-cell epitopes as potential vaccine targets with a specific focus on SARS-CoV-2 pathogen: A review</article-title>," <source><italic toggle="yes">Pathogens</italic></source>, vol. <volume>11</volume>, no. <issue>2</issue>, p. <fpage>146</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/pathogens11020146</pub-id><?supplied-pmid 35215090?><pub-id pub-id-type="pmid">35215090</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Galanis</surname><given-names>K. A.</given-names></name>, <name><surname>Nastou</surname><given-names>K. C.</given-names></name>, <name><surname>Papandreou</surname><given-names>N. C.</given-names></name>, <name><surname>Petichakis</surname><given-names>G. N.</given-names></name>, <name><surname>Pigis</surname><given-names>D. G.</given-names></name>, and <name><surname>Iconomidou</surname><given-names>V. A.</given-names></name>, "<article-title>Linear B-cell epitope prediction for in silico vaccine design: A performance review of methods available via command-line interface</article-title>," <source><italic toggle="yes">International journal of molecular sciences</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>3210</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijms22063210</pub-id><?supplied-pmid 33809918?><pub-id pub-id-type="pmid">33809918</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Attique</surname><given-names>M.</given-names></name>, <name><surname>Alkhalifah</surname><given-names>T.</given-names></name>, <name><surname>Alturise</surname><given-names>F.</given-names></name>, and <name><surname>Khan</surname><given-names>Y. D.</given-names></name>, "<article-title>DeepBCE: Evaluation of deep learning models for identification of immunogenic B-cell epitopes</article-title>," <source><italic toggle="yes">Computational Biology and Chemistry</italic></source>, vol. <volume>104</volume>, p. <fpage>107874</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2023.107874</pub-id><?supplied-pmid 37126975?><pub-id pub-id-type="pmid">37126975</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Vita</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>The immune epitope database (IEDB) 3.0</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>43</volume>, no. <issue>D1</issue>, pp. <fpage>D405</fpage>–<lpage>D412</lpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gku938</pub-id><?supplied-pmid 25300482?><pub-id pub-id-type="pmid">25300482</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>W. L.</given-names></name>, <name><surname>Tsai</surname><given-names>M. J.</given-names></name>, <name><surname>Hsu</surname><given-names>K. T.</given-names></name>, <name><surname>Wang</surname><given-names>J. R.</given-names></name>, <name><surname>Chen</surname><given-names>Y. H.</given-names></name>, and <name><surname>Ho</surname><given-names>S. Y.</given-names></name>, "<article-title>Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development</article-title>," <source><italic toggle="yes">BMC Med Genomics</italic></source>, vol. <volume>8</volume>, no. <issue>Suppl 4</issue>, p. <fpage>S3</fpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1755-8794-8-S4-S3</pub-id><?supplied-pmid 26680271?><pub-id pub-id-type="pmid">26680271</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Garstka</surname><given-names>M. A.</given-names></name><etal>et al.</etal>, "<article-title>The first step of peptide selection in antigen presentation by MHC class I molecules</article-title>," <source><italic toggle="yes">Proc Natl Acad Sci U S A</italic></source>, vol. <volume>112</volume>, no. <issue>5</issue>, pp. <fpage>1505</fpage>–<lpage>10</lpage>, <month>Feb</month><day>3</day><year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1416543112</pub-id><?supplied-pmid 25605945?><pub-id pub-id-type="pmid">25605945</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Wieczorek</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation</article-title>," <source><italic toggle="yes">Front Immunol</italic></source>, vol. <volume>8</volume>, p. <fpage>292</fpage>, <year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2017.00292</pub-id><?supplied-pmid 28367149?><pub-id pub-id-type="pmid">28367149</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Piacham</surname><given-names>T.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>iQSP: A Sequence-Based Tool for the Prediction and Analysis of Quorum Sensing Peptides Using Informative Physicochemical Properties</article-title>," <source><italic toggle="yes">International Journal of Molecular Sciences</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, p. <fpage>75</fpage>, <year>2019</year>.<pub-id pub-id-type="pmid">31861928</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name><etal>et al.</etal>, "<article-title>AMYPred-FRL is a novel approach for accurate prediction of amyloid proteins by using feature representation learning</article-title>," <source><italic toggle="yes">Scientific reports</italic></source>, vol. <volume>12</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>14</lpage>, <year>2022</year>.<pub-id pub-id-type="pmid">34992227</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>SAPPHIRE: A stacking-based ensemble learning framework for accurate prediction of thermophilic proteins</article-title>," <source><italic toggle="yes">Computers in Biology and Medicine</italic></source>, p. <fpage>105704</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.105704</pub-id><?supplied-pmid 35690478?><pub-id pub-id-type="pmid">35690478</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, and <name><surname>Manavalan</surname><given-names>B.</given-names></name>, "<article-title>Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework</article-title>," <source><italic toggle="yes">Iscience</italic></source>, vol. <volume>25</volume>, no. <issue>9</issue>, p. <fpage>104883</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.isci.2022.104883</pub-id><?supplied-pmid 36046193?><pub-id pub-id-type="pmid">36046193</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>J.-H.</given-names></name>, <name><surname>Sun</surname><given-names>D.-W.</given-names></name>, and <name><surname>Pu</surname><given-names>H.</given-names></name>, "<article-title>Combining the genetic algorithm and successive projection algorithm for the selection of feature wavelengths to evaluate exudative characteristics in frozen–thawed fish muscle</article-title>," <source><italic toggle="yes">Food chemistry</italic></source>, vol. <volume>197</volume>, pp. <fpage>855</fpage>–<lpage>863</lpage>, <year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.11.019</pub-id><?supplied-pmid 26617027?><pub-id pub-id-type="pmid">26617027</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Welikala</surname><given-names>R. A.</given-names></name><etal>et al.</etal>, "<article-title>Genetic algorithm based feature selection combined with dual classification for the automated detection of proliferative diabetic retinopathy</article-title>," <source><italic toggle="yes">Computerized Medical Imaging and Graphics</italic></source>, vol. <volume>43</volume>, pp. <fpage>64</fpage>–<lpage>77</lpage>, <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.compmedimag.2015.03.003</pub-id><?supplied-pmid 25841182?><pub-id pub-id-type="pmid">25841182</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Chiangjong</surname><given-names>W.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab172</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab172</pub-id><?supplied-pmid 33963832?><pub-id pub-id-type="pmid">33963832</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackDPPIV: A novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides</article-title>," <source><italic toggle="yes">Methods</italic></source>, vol. <volume>204</volume>, pp. <fpage>189</fpage>–<lpage>198</lpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ymeth.2021.12.001</pub-id><?supplied-pmid 34883239?><pub-id pub-id-type="pmid">34883239</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Qiang</surname><given-names>X.</given-names></name>, <name><surname>Zhou</surname><given-names>C.</given-names></name>, <name><surname>Ye</surname><given-names>X.</given-names></name>, P.-f. Du, R. Su, and L. Wei, "<article-title>CPPred-FL: a sequence-based predictor for large-scale identification of cell-penetrating peptides by feature representation learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, pp. <fpage>11</fpage>–<lpage>23</lpage>, <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bby091</pub-id><?supplied-pmid 30239616?><pub-id pub-id-type="pmid">30239616</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>DeepVF: a deep learning-based hybrid framework for identifying virulence factors using the stacking strategy</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>3</issue>, p. <fpage>bbaa125</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbaa125</pub-id><?supplied-pmid 32599617?><pub-id pub-id-type="pmid">32599617</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Hasan</surname><given-names>M. M.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Manavalan</surname><given-names>B.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>UMPred-FRL: A new approach for accurate prediction of umami peptides using feature representation learning</article-title>," <source><italic toggle="yes">International Journal of Molecular Sciences</italic></source>, vol. <volume>22</volume>, no. <issue>23</issue>, p. <fpage>13124</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijms222313124</pub-id><?supplied-pmid 34884927?><pub-id pub-id-type="pmid">34884927</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref053">
      <label>53</label>
      <mixed-citation publication-type="journal"><name><surname>Arif</surname><given-names>M.</given-names></name><etal>et al.</etal>, "<article-title>StackACPred: Prediction of anticancer peptides by integrating optimized multiple feature descriptors with stacked ensemble approach</article-title>," <source><italic toggle="yes">Chemometrics and Intelligent Laboratory Systems</italic></source>, vol. <volume>220</volume>, p. <fpage>104458</fpage>, <year>2022</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref054">
      <label>54</label>
      <mixed-citation publication-type="journal"><name><surname>Wolpert</surname><given-names>D. H.</given-names></name>, "<article-title>Stacked generalization</article-title>," <source><italic toggle="yes">Neural networks</italic>,</source> vol. <volume>5</volume>, no. <issue>2</issue>, pp. <fpage>241</fpage>–<lpage>259</lpage>, <year>1992</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Porpoise: a new approach for accurate prediction of RNA pseudouridine sites</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab245</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab245</pub-id><?supplied-pmid 34226915?><pub-id pub-id-type="pmid">34226915</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Mishra</surname><given-names>A.</given-names></name>, <name><surname>Pokhrel</surname><given-names>P.</given-names></name>, and <name><surname>Hoque</surname><given-names>M. T.</given-names></name>, "<article-title>StackDPPred: a stacking based prediction of DNA-binding protein from sequence</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>3</issue>, pp. <fpage>433</fpage>–<lpage>441</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty653</pub-id><?supplied-pmid 30032213?><pub-id pub-id-type="pmid">30032213</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><name><surname>Dao</surname><given-names>F.-Y.</given-names></name><etal>et al.</etal>, "<article-title>Identify origin of replication in Saccharomyces cerevisiae using two-step feature selection technique</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>12</issue>, pp. <fpage>2075</fpage>–<lpage>2083</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty943</pub-id><?supplied-pmid 30428009?><pub-id pub-id-type="pmid">30428009</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref058">
      <label>58</label>
      <mixed-citation publication-type="journal"><name><surname>Ding</surname><given-names>C.</given-names></name>, <name><surname>Yuan</surname><given-names>L.-F.</given-names></name>, <name><surname>Guo</surname><given-names>S.-H.</given-names></name>, <name><surname>Lin</surname><given-names>H.</given-names></name>, and <name><surname>Chen</surname><given-names>W.</given-names></name>, "<article-title>Identification of mycobacterial membrane proteins and their types using over-represented tripeptide compositions</article-title>," <source><italic toggle="yes">Journal of proteomics</italic></source>, vol. <volume>77</volume>, pp. <fpage>321</fpage>–<lpage>328</lpage>, <year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jprot.2012.09.006</pub-id><?supplied-pmid 23000219?><pub-id pub-id-type="pmid">23000219</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>C.-Q.</given-names></name><etal>et al.</etal>, "<article-title>iTerm-PseKNC: a sequence-based tool for predicting bacterial transcriptional terminators</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>35</volume>, no. <issue>9</issue>, pp. <fpage>1469</fpage>–<lpage>1477</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty827</pub-id><?supplied-pmid 30247625?><pub-id pub-id-type="pmid">30247625</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>H.-Y.</given-names></name><etal>et al.</etal>, "<article-title>iProEP: a computational predictor for predicting promoter</article-title>," <source><italic toggle="yes">Molecular Therapy-Nucleic Acids</italic></source>, vol. <volume>17</volume>, pp. <fpage>337</fpage>–<lpage>346</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.omtn.2019.05.028</pub-id><?supplied-pmid 31299595?><pub-id pub-id-type="pmid">31299595</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref061">
      <label>61</label>
      <mixed-citation publication-type="journal"><name><surname>Pedregosa</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>Scikit-learn: Machine learning in Python</article-title>," <source><italic toggle="yes">the Journal of machine Learning research</italic></source>, vol. <volume>12</volume>, pp. <fpage>2825</fpage>–<lpage>2830</lpage>, <year>2011</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref062">
      <label>62</label>
      <mixed-citation publication-type="journal"><name><surname>Azadpour</surname><given-names>M.</given-names></name>, <name><surname>McKay</surname><given-names>C. M.</given-names></name>, and <name><surname>Smith</surname><given-names>R. L.</given-names></name>, "<article-title>Estimating confidence intervals for information transfer analysis of confusion matrices</article-title>," <source><italic toggle="yes">The Journal of the Acoustical Society of America</italic></source>, vol. <volume>135</volume>, no. <issue>3</issue>, pp. <fpage>EL140</fpage>–<lpage>EL146</lpage>, <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1121/1.4865840</pub-id><?supplied-pmid 24606307?><pub-id pub-id-type="pmid">24606307</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref063">
      <label>63</label>
      <mixed-citation publication-type="journal"><name><surname>Mandrekar</surname><given-names>J. N.</given-names></name>, "<article-title>Receiver operating characteristic curve in diagnostic test assessment</article-title>," <source><italic toggle="yes">Journal of Thoracic Oncology</italic></source>, vol. <volume>5</volume>, no. <issue>9</issue>, pp. <fpage>1315</fpage>–<lpage>1316</lpage>, <year>2010</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/JTO.0b013e3181ec173d</pub-id><?supplied-pmid 20736804?><pub-id pub-id-type="pmid">20736804</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref064">
      <label>64</label>
      <mixed-citation publication-type="journal"><name><surname>Ullah</surname><given-names>M.</given-names></name>, <name><surname>Han</surname><given-names>K.</given-names></name>, <name><surname>Hadi</surname><given-names>F.</given-names></name>, <name><surname>Xu</surname><given-names>J.</given-names></name>, <name><surname>Song</surname><given-names>J.</given-names></name>, and <name><surname>Yu</surname><given-names>D.-J.</given-names></name>, "<article-title>PScL-HDeep: image-based prediction of protein subcellular location in human tissue using ensemble learning of handcrafted and deep learned features with two-layer feature selection</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>6</issue>, p. <fpage>bbab278</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab278</pub-id><?supplied-pmid 34337652?><pub-id pub-id-type="pmid">34337652</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Ashkenazi</surname><given-names>S.</given-names></name>, <name><surname>Snir</surname><given-names>R.</given-names></name>, and <name><surname>Ofran</surname><given-names>Y.</given-names></name>, "<article-title>Assessing the relationship between conservation of function and conservation of sequence using photosynthetic proteins</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>28</volume>, no. <issue>24</issue>, pp. <fpage>3203</fpage>–<lpage>3210</lpage>, <year>2012</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bts608</pub-id><?supplied-pmid 23080118?><pub-id pub-id-type="pmid">23080118</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Van Der Maaten</surname><given-names>L.</given-names></name>, "<article-title>Accelerating t-SNE using tree-based algorithms</article-title>," <source><italic toggle="yes">The Journal of Machine Learning Research</italic></source>, vol. <volume>15</volume>, no. <issue>1</issue>, pp. <fpage>3221</fpage>–<lpage>3245</lpage>, <year>2014</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Van der Maaten</surname><given-names>L.</given-names></name> and <name><surname>Hinton</surname><given-names>G.</given-names></name>, "<article-title>Visualizing data using t-SNE</article-title>," <source><italic toggle="yes">Journal of machine learning research</italic></source>, vol. <volume>9</volume>, no. <issue>11</issue>, <year>2008</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>Q.</given-names></name><etal>et al.</etal>, "<article-title>Identification of active molecules against Mycobacterium tuberculosis through machine learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>5</issue>, p. <fpage>bbab068</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab068</pub-id><?supplied-pmid 33822874?><pub-id pub-id-type="pmid">33822874</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Lv</surname><given-names>Z.</given-names></name>, <name><surname>Cui</surname><given-names>F.</given-names></name>, <name><surname>Zou</surname><given-names>Q.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, and <name><surname>Xu</surname><given-names>L.</given-names></name>, "<article-title>Anticancer peptides prediction with deep representation learning features</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>22</volume>, no. <issue>5</issue>, p. <fpage>bbab008</fpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab008</pub-id><?supplied-pmid 33529337?><pub-id pub-id-type="pmid">33529337</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>C.</given-names></name><etal>et al.</etal>, "<article-title>ILGBMSH: an interpretable classification model for the shRNA target prediction with ensemble learning algorithm</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>6</issue>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbac429</pub-id><?supplied-pmid 36184189?><pub-id pub-id-type="pmid">36184189</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Bi</surname><given-names>Y.</given-names></name><etal>et al.</etal>, "<article-title>Clarion is a multi-label problem transformation method for identifying mRNA subcellular localizations</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>6</issue>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbac467</pub-id><?supplied-pmid 36341591?><pub-id pub-id-type="pmid">36341591</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>H.-L.</given-names></name>, "<article-title>Propensity scores for prediction and characterization of bioluminescent proteins from sequences</article-title>," <source><italic toggle="yes">PloS one</italic></source>, vol. <volume>9</volume>, no. <issue>5</issue>, p. <fpage>e97158</fpage>, <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0097158</pub-id><?supplied-pmid 24828431?><pub-id pub-id-type="pmid">24828431</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref073">
      <label>73</label>
      <mixed-citation publication-type="journal"><name><surname>Vasylenko</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>SCMBYK: prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides</article-title>," <source><italic toggle="yes">BMC bioinformatics</italic></source>, vol. <volume>17</volume>, no. <issue>19</issue>, pp. <fpage>203</fpage>–<lpage>217</lpage>, <year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12859-016-1371-4</pub-id><?supplied-pmid 28155663?><pub-id pub-id-type="pmid">27153986</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref074">
      <label>74</label>
      <mixed-citation publication-type="journal"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>, <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>, <name><surname>Chen</surname><given-names>H.-A.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, <name><surname>Huang</surname><given-names>H.-L.</given-names></name>, and <name><surname>Ho</surname><given-names>S.-Y.</given-names></name>, "<article-title>SCMPSP: Prediction and characterization of photosynthetic proteins based on a scoring card method</article-title>," <source>in <italic toggle="yes">BMC bioinformatics</italic></source>, <year>2015</year>, vol. <volume>16</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>16</lpage>: BioMed Central. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2105-16-S1-S8</pub-id><?supplied-pmid 25708243?><pub-id pub-id-type="pmid">25708243</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref075">
      <label>75</label>
      <mixed-citation publication-type="journal"><name><surname>Liou</surname><given-names>Y.-F.</given-names></name><etal>et al.</etal>, "<article-title>SCMMTP: identifying and characterizing membrane transport proteins using propensity scores of dipeptides</article-title>," <source><italic toggle="yes">BMC genomics</italic></source>, vol. <volume>16</volume>, pp. <fpage>1</fpage>–<lpage>14</lpage>, <year>2015</year>.<pub-id pub-id-type="pmid">25553907</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref076">
      <label>76</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>H.-L.</given-names></name><etal>et al.</etal>, "<part-title>Prediction and analysis of protein solubility using a novel scoring card method with dipeptide composition</part-title>," <source>in <italic toggle="yes">BMC bioinformatics</italic></source>, <year>2012</year>, vol. <volume>13</volume>, pp. <fpage>1</fpage>–<lpage>14</lpage>: <collab>Springer</collab>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref077">
      <label>77</label>
      <mixed-citation publication-type="journal"><name><surname>Raoufi</surname><given-names>E.</given-names></name><etal>et al.</etal>, "<article-title>Epitope prediction by novel immunoinformatics approach: a state-of-the-art review</article-title>," <source><italic toggle="yes">International Journal of Peptide Research and Therapeutics</italic></source>, vol. <volume>26</volume>, pp. <fpage>1155</fpage>–<lpage>1163</lpage>, <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10989-019-09918-z</pub-id><?supplied-pmid 32435171?><pub-id pub-id-type="pmid">32435171</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref078">
      <label>78</label>
      <mixed-citation publication-type="journal"><name><surname>FAUCHÈRE</surname><given-names>J. L.</given-names></name>, <name><surname>Charton</surname><given-names>M.</given-names></name>, <name><surname>Kier</surname><given-names>L. B.</given-names></name>, <name><surname>Verloop</surname><given-names>A.</given-names></name>, and <name><surname>Pliska</surname><given-names>V.</given-names></name>, "<article-title>Amino acid side chain parameters for correlation studies in biology and pharmacology</article-title>," <source><italic toggle="yes">International journal of peptide and protein research</italic></source>, vol. <volume>32</volume>, no. <issue>4</issue>, pp. <fpage>269</fpage>–<lpage>278</lpage>, <year>1988</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1399-3011.1988.tb01261.x</pub-id><?supplied-pmid 3209351?><pub-id pub-id-type="pmid">3209351</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref079">
      <label>79</label>
      <mixed-citation publication-type="journal"><name><surname>Dewi</surname><given-names>S. K.</given-names></name>, <name><surname>Ali</surname><given-names>S.</given-names></name>, and <name><surname>Prasasty</surname><given-names>V. D.</given-names></name>, "<article-title>Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus</article-title>," <source><italic toggle="yes">Current computer-aided drug design</italic></source>, vol. <volume>15</volume>, no. <issue>2</issue>, pp. <fpage>120</fpage>–<lpage>135</lpage>, <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/1573409914666181003151222</pub-id><?supplied-pmid 30280672?><pub-id pub-id-type="pmid">30280672</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref080">
      <label>80</label>
      <mixed-citation publication-type="journal"><name><surname>Ivanyi-Nagy</surname><given-names>R.</given-names></name><etal>et al.</etal>, "<article-title>Analysis of hepatitis C virus RNA dimerization and core–RNA interactions</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>34</volume>, no. <issue>9</issue>, pp. <fpage>2618</fpage>–<lpage>2633</lpage>, <year>2006</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkl240</pub-id><?supplied-pmid 16707664?><pub-id pub-id-type="pmid">16707664</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref081">
      <label>81</label>
      <mixed-citation publication-type="journal"><name><surname>Mehrpour</surname><given-names>K.</given-names></name>, <name><surname>Mirzaei</surname><given-names>S. A.</given-names></name>, <name><surname>Savardashtaki</surname><given-names>A.</given-names></name>, <name><surname>Nezafat</surname><given-names>N.</given-names></name>, and <name><surname>Ghasemi</surname><given-names>Y.</given-names></name>, "<article-title>Designing an HCV diagnostic kit for common genotypes of the virus in Iran based on conserved regions of core, NS3-protease, NS4A/B, and NS5A/B antigens: an in silico approach</article-title>," <source><italic toggle="yes">Biologia</italic></source>, vol. <volume>76</volume>, pp. <fpage>281</fpage>–<lpage>296</lpage>, <year>2021</year>.</mixed-citation>
    </ref>
    <ref id="pone.0290538.ref082">
      <label>82</label>
      <mixed-citation publication-type="journal"><name><surname>Sneath</surname><given-names>P.</given-names></name>, "<article-title>Relations between chemical structure and biological activity in peptides</article-title>," <source><italic toggle="yes">Journal of theoretical biology</italic></source>, vol. <volume>12</volume>, no. <issue>2</issue>, pp. <fpage>157</fpage>–<lpage>195</lpage>, <year>1966</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0022-5193(66)90112-3</pub-id><?supplied-pmid 4291386?><pub-id pub-id-type="pmid">4291386</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref083">
      <label>83</label>
      <mixed-citation publication-type="journal"><name><surname>Dhanda</surname><given-names>S. K.</given-names></name>, <name><surname>Usmani</surname><given-names>S. S.</given-names></name>, <name><surname>Agrawal</surname><given-names>P.</given-names></name>, <name><surname>Nagpal</surname><given-names>G.</given-names></name>, <name><surname>Gautam</surname><given-names>A.</given-names></name>, and <name><surname>Raghava</surname><given-names>G. P.</given-names></name>, "<article-title>Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics</article-title>," <source><italic toggle="yes">Briefings in bioinformatics</italic></source>, vol. <volume>18</volume>, no. <issue>3</issue>, pp. <fpage>467</fpage>–<lpage>478</lpage>, <year>2017</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbw025</pub-id><?supplied-pmid 27016393?><pub-id pub-id-type="pmid">27016393</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref084">
      <label>84</label>
      <mixed-citation publication-type="journal"><name><surname>Donnison</surname><given-names>T.</given-names></name><etal>et al.</etal>, "<article-title>A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice</article-title>," <source><italic toggle="yes">Hepatology</italic></source>, vol. <volume>76</volume>, no. <issue>4</issue>, pp. <fpage>1190</fpage>–<lpage>1202</lpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hep.32470</pub-id><?supplied-pmid 35313015?><pub-id pub-id-type="pmid">35313015</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref085">
      <label>85</label>
      <mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>A. A.</given-names></name>, <name><surname>Chotpatiwetchkul</surname><given-names>W.</given-names></name>, <name><surname>Phanus-Umporn</surname><given-names>C.</given-names></name>, <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors</article-title>," <source><italic toggle="yes">Journal of Computer-Aided Molecular Design</italic></source>, vol. <volume>35</volume>, pp. <fpage>1037</fpage>–<lpage>1053</lpage>, <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10822-021-00418-1</pub-id><?supplied-pmid 34622387?><pub-id pub-id-type="pmid">34622387</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref086">
      <label>86</label>
      <mixed-citation publication-type="journal"><name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Anuwongcharoen</surname><given-names>N.</given-names></name>, <name><surname>Moni</surname><given-names>M. A.</given-names></name>, <name><surname>Lio</surname><given-names>P.</given-names></name>’, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>StackPR is a new computational approach for large-scale identification of progesterone receptor antagonists using the stacking strategy</article-title>," <source><italic toggle="yes">Scientific Reports</italic></source>, vol. <volume>12</volume>, no. <issue>1</issue>, p. <fpage>16435</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-022-20143-5</pub-id><?supplied-pmid 36180453?><pub-id pub-id-type="pmid">36180453</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref087">
      <label>87</label>
      <mixed-citation publication-type="journal"><name><surname>Schaduangrat</surname><given-names>N.</given-names></name>, <name><surname>Anuwongcharoen</surname><given-names>N.</given-names></name>, <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>, and <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>, "<article-title>DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists</article-title>," <source><italic toggle="yes">Journal of Cheminformatics</italic></source>, vol. <volume>15</volume>, no. <issue>1</issue>, p. <fpage>50</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13321-023-00721-z</pub-id><?supplied-pmid 37149650?><pub-id pub-id-type="pmid">37149650</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref088">
      <label>88</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>G.</given-names></name><etal>et al.</etal>, "<article-title>TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>24</volume>, no. <issue>3</issue>, p. <fpage>bbad116</fpage>, <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbad116</pub-id><?supplied-pmid 36960769?><pub-id pub-id-type="pmid">36960769</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref089">
      <label>89</label>
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>F.</given-names></name><etal>et al.</etal>, "<article-title>MHCRoBERTa: pan-specific peptide–MHC class I binding prediction through transfer learning with label-agnostic protein sequences</article-title>," <source><italic toggle="yes">Briefings in Bioinformatics</italic></source>, vol. <volume>23</volume>, no. <issue>3</issue>, p. <fpage>bbab595</fpage>, <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbab595</pub-id><?supplied-pmid 35443027?><pub-id pub-id-type="pmid">35443027</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref090">
      <label>90</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Z.-R.</given-names></name>, <name><surname>Lin</surname><given-names>H. H.</given-names></name>, <name><surname>Han</surname><given-names>L.</given-names></name>, <name><surname>Jiang</surname><given-names>L.</given-names></name>, <name><surname>Chen</surname><given-names>X.</given-names></name>, and <name><surname>Chen</surname><given-names>Y. Z.</given-names></name>, "<article-title>PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence</article-title>," <source><italic toggle="yes">Nucleic acids research</italic></source>, vol. <volume>34</volume>, no. <issue>suppl</issue>_2, pp. <fpage>W32</fpage>–<lpage>W37</lpage>, <year>2006</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkl305</pub-id><?supplied-pmid 16845018?><pub-id pub-id-type="pmid">16845018</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref091">
      <label>91</label>
      <mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>K.-C.</given-names></name>, "<article-title>Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes</article-title>," <source><italic toggle="yes">Bioinformatics</italic></source>, vol. <volume>21</volume>, no. <issue>1</issue>, pp. <fpage>10</fpage>–<lpage>19</lpage>, <year>2005</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bth466</pub-id><?supplied-pmid 15308540?><pub-id pub-id-type="pmid">15308540</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref092">
      <label>92</label>
      <mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>K. C.</given-names></name>, "<article-title>Prediction of protein cellular attributes using pseudo‐amino acid composition</article-title>," <source><italic toggle="yes">Proteins</italic>: <italic toggle="yes">Structure</italic>, <italic toggle="yes">Function</italic>, <italic toggle="yes">and Bioinformatics</italic></source>, vol. <volume>43</volume>, no. <issue>3</issue>, pp. <fpage>246</fpage>–<lpage>255</lpage>, <year>2001</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/prot.1035</pub-id><?supplied-pmid 11288174?><pub-id pub-id-type="pmid">11288174</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref093">
      <label>93</label>
      <mixed-citation publication-type="journal"><name><surname>Tomii</surname><given-names>K.</given-names></name> and <name><surname>Kanehisa</surname><given-names>M.</given-names></name>, "<article-title>Analysis of amino acid indices and mutation matrices for sequence comparison and structure prediction of proteins</article-title>," <source><italic toggle="yes">Protein Engineering</italic></source>, <source><italic toggle="yes">Design and Selection</italic></source>, vol. <volume>9</volume>, no. <issue>1</issue>, pp. <fpage>27</fpage>–<lpage>36</lpage>, <year>1996</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/protein/9.1.27</pub-id>
<?supplied-pmid 9053899?><pub-id pub-id-type="pmid">9053899</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref094">
      <label>94</label>
      <mixed-citation publication-type="journal"><name><surname>Dubchak</surname><given-names>I.</given-names></name>, <name><surname>Muchnik</surname><given-names>I.</given-names></name>, <name><surname>Holbrook</surname><given-names>S. R.</given-names></name>, and <name><surname>Kim</surname><given-names>S.-H.</given-names></name>, "<article-title>Prediction of protein folding class using global description of amino acid sequence</article-title>," <source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source>, vol. <volume>92</volume>, no. <issue>19</issue>, pp. <fpage>8700</fpage>–<lpage>8704</lpage>, <year>1995</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.92.19.8700</pub-id><?supplied-pmid 7568000?><pub-id pub-id-type="pmid">7568000</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0290538.ref095">
      <label>95</label>
      <mixed-citation publication-type="journal"><name><surname>Ahmad</surname><given-names>S.</given-names></name><etal>et al.</etal>, "<article-title>SCORPION is a stacking-based ensemble learning framework for accurate prediction of phage virion proteins</article-title>," <source><italic toggle="yes">Scientific reports</italic>,</source> vol. <volume>12</volume>, no. <issue>1</issue>, pp. <fpage>1</fpage>–<lpage>15</lpage>, <year>2022</year>.<pub-id pub-id-type="pmid">34992227</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
